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Summary
The first part of this thesis describes the expression, purification, and characterization
of the membrane protein CCR5 and its ligand RANTES. The second part is concerned
with the effect of pressure on the hydrogen bond network in proteins and nucleic acids.
The G protein-coupled receptor CCR5 is the major HIV-1 coreceptor and thus a very
important target for the development of HIV-1 entry inhibitors. The large-scale expres-
sion and purification of CCR5, leading to 1 mg of pure protein per liter cell culture
after purification, is described. The receptor’s functionality is shown via recognition by
a conformation-dependent antibody and by binding of the endogenous ligand RANTES.
The possibility to obtain large amounts of functional CCR5 overcomes a major bottle-
neck for the structural characterization of this membrane protein (Nisius et al. 2008).
The receptor and its ligand were further characterized by NMR spectroscopy. First he-
teronuclear solution state NMR spectra of selectively labeled CCR5 were obtained. The
interaction of the receptor with the chemokine RANTES was studied by solution NMR as
well as in a lipid environment using solid state NMR experiments. In these experiments,
binding of RANTES to CCR5 is observed.
Many chemokines undergo dimerization in the low micro- to millimolar range, but the
biological relevance of this phenomenon is under debate. The temperature and pressure
dependence of the RANTES monomer – dimer equilibrium was characterized by NMR
spectroscopy. This study reveals the enthalpy and entropy contributions to RANTES
dimerization. In addition, a pressure-induced unfolded state was observed for the first
time.
A solely monomeric mutant of RANTES was designed and shown to inhibit HIV-1 in-
fection in vitro. This is the basis for further studies of the complex between RANTES
and CCR5 as well as CCR5-derived peptides (Nisius et al., manuscript in preparation).
Hydrogen bonds are extremely important to stabilize the structures of proteins and nu-
cleic acids. In this thesis, methods to measure the scalar couplings across hydrogen
bonds in these biomolecules are described (Dingley et al. 2008, Cordier et al. 2008).
They were applied to study pressure-dependent changes in the hydrogen bond scalar
couplings in ubiquitin. The most pressure-labile regions of the protein were identified.
These largely correspond to regions which are destabilized at elevated temperature (Ni-
sius and Grzesiek, manuscript in preparation).
Pressure- and temperature-dependent hydrogen bond scalar couplings have also been
measured in a small RNA hairpin. The data indicate that the average pressure-induced
changes of hydrogen bond length are similar in nucleic acids and proteins.
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1 Introduction
1 The G protein-coupled receptor CCR5 and its
interactions with the chemokine RANTES
1.1 Introduction
1.1.1 Membrane proteins
Membranes are crucial for all cells since they enclose their content and separate them
from the environment. They maintain the essential differences between the intracellular
and extracellular space and surround organelles such as mitochondria and the nucleus in
eucaryotic cells. As important as the separation of organelles and cells is, so important
is the exchange of matter and information.
Therefore, biological membranes are not only made up of lipid bilayers but also contain
a substantial amount of proteins. These membrane proteins can serve as pores or trans-
porters, as enzymes, adhesion molecules, receptors and much more. Approximately 30%
of a eucaryotic genome encode the various membrane proteins, that can be classified as
either peripheral or integral (von Heijne 2007). Peripheral membrane proteins are mainly
water-soluble and tethered to the lipid bilayer via a fatty acid chain or other hydropho-
bic anchors. In contrast, integral membrane proteins are water-insoluble and span the
membrane one or more times. Their transmembrane segments can be either α-helical
or made up of β-sheets forming a β-barrel (von Heijne 1996). Despite their vast abun-
dance, membrane proteins are underrepresented in the protein data bank (PDB) with
less than 1% of the structures deposited there (Lacapere et al. 2007).
The first low-resolution model of a membrane protein, bacteriorhodopsin in purple mem-
brane, was derived using electron microscopy (Henderson & Unwin 1975). Nowadays,
data from electron microscopy of two-dimensional crystals can yield high-resolution struc-
tures (e.g. AQP0 has been resolved to 1.9 A˚ resolution (Gonen et al. 2005)). On the
other end of the scale, cryo-electron microscopy is suited to study very large complexes
in a single particle approach, although at relatively low resolution (Robinson et al. 2007).
X-ray crystallography is the most successful technique for the determination of three-
dimensional high-resolution structures, not only of proteins in general but also for mem-
brane proteins. The introduction of new crystallization methods such as lipidic cubic
phases (Landau & Rosenbusch 1996) allows resolution beyond 2 A˚ (Lacapere et al.
2007).
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Nuclear magnetic resonance (NMR) spectroscopy is an alternative to x-ray crystallogra-
phy for atomic resolution studies of proteins that cannot be crystallized. NMR spectro-
scopy can be performed in solution using detergent-solubilized membrane proteins with
the major drawback being size limitation. Alternatively, solid state NMR spectroscopy
can be applied to study lipid-embedded membrane proteins. While x-ray structures
provide a static view on membrane proteins, NMR spectroscopy can also reveal their
dynamics.
1.1.2 NMR spectroscopy of membrane proteins
Membrane proteins for NMR spectroscopy have to be heterologously overexpressed, since
large amounts are needed and most experiments require the introduction of NMR-active
isotopes (2H, 13C, 15N). The proteins then need to be solubilized and purified before
they can be prepared for solution or solid state NMR experiments.
NMR spectroscopy in solution
For liquid state NMR spectroscopy, membrane proteins have to be prepared in a soluble
form. This can be achieved in various ways, such as detergent micelles, small bicelles
(Park et al. 2006), nanodiscs (Lyukmanova et al. 2008), reversed micelles, or even or-
ganic solvents (Rastogi & Girvin 1999). The major obstacles in studying membrane
proteins in solution is the large size of protein/detergent or protein/lipid complexes lea-
ding to long rotational correlation times and thus extensive line broadening (Opella &
Marassi 2004). A second problem can arise from the protein’s dynamics, since many
membrane proteins have a less compact structure in micelles than they have in their
native environment. This can lead to conformational exchange-based line broadening
(Sanders & So¨nnichsen 2006). With the resonances broadened by these factors, sen-
sitivity and signal overlap become severe problems and it is more difficult to measure
NMR parameters for structure determination such as NOEs (nuclear Overhauser effect),
J couplings, and RDCs (residual dipolar couplings) (Sanders & So¨nnichsen 2006).
In recent years, methods have been developed to extend the size limit in solution state
NMR spectroscopy. The use of transverse relaxation-optimized spectroscopy (TROSY)
(Pervushin et al. 1997) as a building block in pulse sequences can improve the spectral
quality by selecting only the slowly relaxing components. This allows measurements of
complexes with a molecular weight of up to 100 kDa. Combination of TROSY with
cross-correlated relaxation-enhanced polarization transfer (CRINEPT) can push the li-
mits of NMR spectroscopy in solution even further (Riek et al. 1999).
Another possibility to overcome the fast transverse relaxation rates of membrane proteins
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in large complexes is their perdeuteration, thus reducing the dipole-dipole relaxation. The
benefits of protein perdeuteration are also used in the ILV-labeling approach (Gardner
& Kay 1998). Here, the methyl groups of isoleucine, leucine, and valine are protonated
in otherwise deuterated proteins. This allows the measurement of methyl-methyl NOEs
and was used in the structure refinement of OmpX in DHPC micelles (Ferna´ndez et al.
2004).
Problems arising from signal overlap especially in α-helical membrane proteins can be
circumvented by segmental (Yagi et al. 2004) or selective labeling strategies. The lat-
ter has been applied to study rhodopsin with solution state NMR spectroscopy (Klein-
Seetharaman et al. 1999, Werner et al. 2008).
The combined use of all these approaches has enabled the elucidation of nearly 20 struc-
tures of membrane proteins and even more fragments thereof by NMR spectroscopy in
solution to date1.
Solid state NMR spectroscopy
Solid state NMR spectroscopy allows the investigation of membrane proteins in a native-
like environment. In this technique, the spectral resolution and the sensitivity are limited
by the size- and orientation-dependence of the nuclear spin interactions, such as chemi-
cal shifts and dipolar couplings (Luca et al. 2005). Thus spectra of non-oriented, static
samples suffer from extremely broad lines. This problem can be overcome by either using
oriented samples or magic angle spinning (MAS) (Andrew et al. 1958).
Under MAS-conditions, a variety of spin-spin interactions that are directly related to
internuclear distances can be measured (Luca et al. 2005), thus providing distance re-
straints for structure calculation. With respect to membrane proteins, bacteriorhodopsin
and rhodopsin have been extensively studied using MAS-based methods (Herzfeld &
Lansing 2002). Even if a membrane protein is not available in isotope-labeled form,
solid state NMR spectroscopy offers the possibility to study binding of a labeled ligand.
This was shown for neurotensin (Luca et al. 2003) and bradykinin (Lopez et al. 2008)
binding to their respective G protein-coupled receptors.
For solid state NMR spectroscopy in oriented membranes, the proteins can either be
embedded in bilayers on a glass support or in magnetically aligned bicelles. Using polari-
zation inversion spin-exchange at the magic angle (PISEMA) high-resolution separated
local field spectra of aligned proteins can be obtained. These spectra can be used to
determine the tilt of helices with respect to the bilayer and for resonance assignment
of the membrane protein (Opella & Marassi 2004). Several structures of membrane
1(www.drorlist.com/nmr/MPNMR.html)
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spanning peptides and proteins have been solved using oriented samples (Opella et al.
1999, Wang et al. 2001, Park et al. 2003).
1.1.3 G protein-coupled receptors
G protein-coupled receptors form the largest group of cell surface receptors involved in
signal transduction, accounting for more than 2% of the proteins encoded by the human
genome (Takeda et al. 2002). The large abundance of these membrane proteins is also
refelected by the wide range of ligands, which include neurotransmitters, hormones, small
proteins and peptides, and odorants. Even photons can trigger siganling via GPCRs.
Thus it is not surprising that GPCRs are involved in many physiological processes as
well as numerous diseases. In fact, more than 30% of the therapeutics currently in the
market target these receptors (Wise et al. 2002).
Figure 1.1 Activation, signaling, and down-regulation of G protein-coupled receptors.
All GPCRs contain the common structural feature of seven transmembrane helices
connected by loops of varying length. GPCRs are situated in the cell membrane with
the N-terminus at the extracellular side and the C-terminus in the cytosol. With this
architecture, they are well suited to propagate signals from the extracellular side across
the membrane to the interior. Ligand binding at the outside induces structural changes
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in the receptors cytosolic parts, where they are coupled to heterotrimeric G proteins.
This interaction gives rise to the name of the whole receptor family.
The G protein consists of a GDP/GTP binding α subunit and a β/γ subunit. Receptor
activation triggers the exchange of GDP for GTP in the α subunit and its subsequent
dissociation from Gβ/γ. Both, Gα and Gβ/γ then signal through activation or deactiva-
tion of downstream effectors that produce second messengers. After hydrolysis of GTP
to GDP the heterotrimer reassociates and the activation cycle is terminated (De Vries
et al. 2000). The downstream events that can occur after GPCR activation are as diverse
as the processes the receptors are involved in, ranging from regulation of ion channels
to the activation or suppression of gene expression. Which of these cascades is activa-
ted depends on the nature of the G protein α, β, and γ subunits, that belong to gene
families with 16, 5, and 12 known members, respectively (Pierce et al. 2002). As a nega-
tive feedback, the receptors can also be down-regulated. One such mechanism involves
phosphorylation of the GPCR’s C-terminus and subsequent binding of β-arrestin. Since
β-arrestin also interacts with clathrin, the receptor can be internalized in a clathrin-
coated vesicle and thus is not available for signaling until it is recycled to the cell surface
(Goodman et al. 1996). In recent years, also other, G protein-independent signaling
mechanism have been found (McDonald et al. 2000).
GPCRs can be classified into three groups according to specific motifs, relationship to
a reference receptor, etc., with class A being the largest (Mustafi & Palczewski 2009).
This class contains rhodopsin-like proteins such as the biogenic amine receptors or the
olfactoric receptors. From a structural point of view, GPCRs of class A are best cha-
racterized. All high resolution GPCR structures elucidated so far belong to this class.
The first of those was the structure of bovine rhodopsin determined in the year 2000
(Palczewski et al. 2000) and up to now it remains the only one crystallized in its native
state (Lodowski & Palczewski 2009). All other GPCRs with known structure required
substantial mutations to form high quality crystals. These receptors are the human
β2-adrenergic and A2A adenosine receptors as well as the turkey β1-adrenergic receptor
(Cherezov et al. 2007, Rasmussen et al. 2007, Warne et al. 2008, Jaakola et al. 2008).
Structurally, these receptors show a high degree of overall similarity with very distinct
differences in the ligand binding site. The fact that even small differences in the helix
arrangement can have a large effect on the ligand binding interface makes it very difficult
to model the structure of other GPCRs and predict the topology of the binding sites
(Schlyer & Horuk 2006).
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1.1.4 The CC chemokine receptor 5
The chemokine receptors are class A GPCRs that occur on the surface of leukocytes.
Their endogenous ligands are chemotactic cytokines (chemokines), which are involved
in leukocyte activation and migration. According to conserved cystein residues in their
N-terminus, chemokines can be divided into four classes, α (CXC), β (CC), γ (C),
and δ (CX3C) (Sodhi et al. 2004). Chemokines can also be classified by function into
homeostatic and inflammatory subgroups. Most chemokines can bind to and activate
more than one type of receptor and conversely, one chemokine receptor usually has more
than one ligand.
Figure 1.2 CCR5’s role in physiology and disease. a Chemokine binding to CCR5 acti-
vates G protein-linked signaling pathways, leading for example to activation of macrophages.
b The HI virus uses CCR5 as a coreceptor for entry into the host cell. This process requires
the ternary complex of the viral envelope glycoprotein gp120, CD4 and CCR5. c Binding of
the endogenous ligands such as RANTES inhibits the gp120/CCR5 interaction.
Some chemokine receptors can even bind non-chemokine ligands, for example the re-
ceptors CCR5 and CXCR4 can interact with the HIV-encoded glycoprotein gp120. In
fact, these two chemokine receptors function as HIV-1 coreceptors and are necessary
for the viral entry into host cells. Different expression of these two receptors forms the
basis of HIV-1 – tropism, dividing virus subtypes into R5- or macrophage-tropic and X4-
or T-cell-tropic strains. Normally, in initial stages of infection, CCR5 is utilized as a
coreceptor whereas CXCR4 is associated with progression of the disease (Oberlin et al.
1996). The fundamental role of CCR5 in HIV infections is emphasized by a truncated
form of the receptor, ∆32-CCR5, that leads to slower progression (heterozygous case)
or even to resistance against infection (homozygous case) (Liu et al. 1996).
Prior to infection, the viral and host cell membranes have to come in contact to even-
tually fuse. This is possible by the initial interaction of the viral envelope glycoprotein
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gp120 with CD4 on the host cell that leads to a conformational change in the glycopro-
tein. Thereby the CCR5 interaction side becomes accessible and gp120 can also bind
to its coreceptor. This induces another structural rearrangement that also affects the
glycoprotein gp41, which is associated with gp120 and connects it to the viral mem-
brane. After conformational change, gp41 can be inserted into the host cell membrane.
In turn, gp41 forms a 6-helix bundle, bringing the two membranes so close together to
allow their fusion (Lederman et al. 2006).
The β chemokines MIP-1α, MIP-1β, and RANTES are able to prevent this process
when bound to CCR5. Thus, a number of chemically modified analogues, especially of
RANTES, have been developed and shown to be very effective in inhibiting HIV infec-
tions, e.g. PSC-RANTES (Lederman et al. 2004). A drawback of such molecules is that
they cannot be cheaply produced in large amounts. Therefore, also fully recombinant
chemokines have been engineered with the aim to separate the anti-HIV activity from
the the ability to signal via CCR5 (Gaertner et al. 2008).
In addition to these variants of CCR5-natural ligands also a number of small molecule
anti-HIV CCR5 antagonists has been developed. The first of those was TAK-779 (Baba
et al. 1999), which is used only in research. The only compound approved for clinical
use so far is maraviroc, showing a high anti-viral potency and good pharmacological
properties (Dorr et al. 2005, Wood & Armour 2005). Maraviroc is predicted to form
a strong salt bridge with Glu283 in CCR5. Further interactions are assumed with the
residues Trp86, Tyr108, Tyr251, and Ile198. These predictions are based on a homology
model of CCR5 using the known structure of bovine rhodopsin (Kondru et al. 2008).
However, the antagonist binding pocket of the modeled structure was too small for any
known ligand and therefore could only be refined using the size and shape of known small
molecule ligands. This shows the difficulties in rational drug design if only homology
models but no structures of a GPCR are available and emphasizes the need of more
high-resolution structures as well as information on receptor dynamics.
While the antagonist binding site seems to be situated between the transmembrane he-
lices, for the interaction with the chemokines and gp120 also the N-terminus and the
extracellular loops are important. Binding of these ligands to the N-terminus requires
the unusual posttranslational O-sulfation of tyrosines (Farzan et al. 1999). Although
in CCR5 the tyrosine residues 3, 10, 14, and 15 could be sulfated, it was shown that
modification of Y10 and Y14 is sufficient for the binding of gp120. A structure of gp120
in complex with CD4 and a tyrosine-sulfated antibody has been determined and used
for docking of a NMR structure of a double-sulfated CCR5 N-terminal peptide (Huang
et al. 2007). With respect to RANTES binding it was also shown that the interaction
7
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Figure 1.3 Schematic representation of CCR5’s topology depicting the posttranslational
modifications. CCR5 is sulfated at several tyrosines in the N-terminus, O-glycosylated at serine
6, and palmitoylated at three cysteins in the C-terminus. The structure is stabilized by two
disulfide bonds in the extracellular part. EL1 – EL3 marks the extracellular loops, IL1 – IL3
are the intracellular loops. Helix positions are drawn according to (Oppermann 2004).
between the chemokine and a sulfated, CCR5-derived peptide is two orders of magni-
tude stronger compared to the unsulfated peptide (Duma et al. 2007). In addition to
sulfation, the CCR5 N-terminus is also glycosylated at serine 6 with O-glycans contai-
ning negatively charged sialic acid residues (Farzan et al. 1999). The negatively charged
surface formed by both, the sialic acid and the sulfotyrosines, is necessary for binding of
the chemokines which have a positively charged surface area. A further characteristic
of CCR5 are two disulfide bonds connecting the extracellular loops EL1 and EL2 as well
as the N-terminus and EL3. These disulfide bridges stabilize CCR5 and are mandatory
for chemokine binding, but not absolutely necessary for HIV infection (Blanpain et al.
1999). As many other GPCRs CCR5 is palmitoylated at cysteins 321, 323, and 324 in its
C-terminus (Blanpain et al. 2001) which can function as an additional membrane anchor.
In the receptors C-terminus there are also several serines that can be phosphorylated by
G protein-coupled receptor kinases (GRK) in order to regulate cell signaling.
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Organization of the chapter
In chapter 1.2, the large-scale expression and purification of CCR5 and its characteriza-
tion is described. The following section (chapter 1.3) shows initial results that have been
obtained using solution and solid state NMR spectroscopy to investigate the receptor
and its interaction with maraviroc and the chemokine RANTES. Finally, in chapter 1.4
the design of a solely monomeric RANTES mutant is described and the temperature-
and pressure-dependence of the RANTES monomer/dimer equilibrium is discussed.
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11.2 Large-scale expression and purification of the major HIV-1
coreceptor CCR5 and characterization of its interaction with
RANTES
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G protein-coupled receptors (GPCRs)1 form the largest group of 
cell-surface receptors involved in signal transduction. They account 
for about one third of all membrane proteins in humans and share 
a conserved global structure comprising seven transmembrane 
helices [1]. In response to interaction with agonists at their extra-
cellular surface, GPCRs provoke extremely diverse physiological 
reactions by modulation of the intracellular G-protein signaling 
cascade. Their prominent role in signaling malfunction and disease 
is emphasized by the fact that over 30% of the total drugs in the 
market target GPCRs [2]. Despite their importance, only two high-
resolution structures of GPCRs have been solved so far: the crystal 
structures of bovine rhodopsin [3] and of the b2-adrenergic recep-
tor [4,5]. This shortage of data results from the well-known dif­fi-
culties impeding quantitative studies of membrane proteins, i.e. 
low yields in expression, low stability, and the amphiphilic nature 
of the membrane protein’s surface, which leads to problems in sol-
ubilization, purification, and reconstitution into a functional state 
amenable to structural and biophysical analysis.
The GPCR CCR5 (CC chemokine receptor 5, where CC indicates 
a conserved double cysteine motif in the cognate chemokines) is 
involved in the regulation of immune cell traf­ficking. It is activated 
after binding the endogenous chemokines MIP-1a (macrophage 
inflammatory protein 1a), MIP-1b, and RAN­TES (regulated on acti-
vation, normal T-cell expressed and secreted) [6]. CCR5 also plays a 
crucial role in human immunodeficiency virus-1 (HIV-1) infections 
[7,8]. The entry of HIV-1 into host cells usually requires the sequen-
tial interaction of the viral envelope glycoprotein 120 (gp120) 
with the host-cell factor CD4 and with either CCR5 or CXCR4 (CXC 
chemokine receptor 4), leading to fusion of the viral and host-cell 
membranes. During the early stages of HIV infection, viral isolates 
tend to use exclusively CCR5 for cell entry, while later in the dis-
ease, isolates that use CXCR4 emerge in part of the patients [9,10]. 
High-resolution structural information of CCR5 is currently lack-
ing, but a model structure has been derived based on the rhodop-
sin X-ray structure and biochemical interaction data [11]. Recently, 
it has been shown that a peptide derived from the N­-terminus of 
CCR5 becomes a-helical upon binding to gp120 [12].
Binding of the endogenous chemokines obstructs interaction 
of CCR5 with the viral envelope glycoprotein gp120 and thereby 
hinders infection [13]. Of these chemokines RAN­TES is the most 
potent HIV-blocking agent [14–16].
The N­-terminus of CCR5 plays a crucial role in chemokine and 
gp120 recognition, and its post-translational sulfation at tyrosines 
3, 10, 14, and 15 [17] is a prerequisite for high af­finity binding to 
both chemokines [18] and gp120 [17]. N­uclear magnetic resonance 
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The G protein-coupled receptor CCR5 is a human chemokine receptor involved in the activation and 
migration of leukocytes. CCR5 is also the major HIV-1 coreceptor that, together with human CD4 and the 
viral glycoprotein gp120, promotes virus entry into host cells. Thus inhibition of the CCR5-gp120 inter-
action presents a promising route to prevent HIV infections. Atomic structural details of the interaction 
between CCR5 and its cognate chemokines or gp120 are presently unknown due to the general dif­ficulties 
of membrane protein structure determination. Here, we report the high-yield expression of human CCR5 
in baculovirus-infected Sf9 insect cells. Highly purified (>90%) CCR5 is obtained in detergent-solubilized 
form at yields of about 1 mg/l cell culture. The conformational integrity of recombinant CCR5 after puri-
fication is shown by immunoprecipitation with the conformation-dependent monoclonal antibody 2D7, 
CD and N­MR spectroscopy. The detergent micelles contain CCR5 in monomeric and dimeric forms, which 
can be separated by size exclusion chromatography and characterized individually. Further functional 
characterization by isothermal titration calorimetry indicates that the recombinant receptor interacts 
with its cognate chemokine RAN­TES. This interaction is strongly suppressed when sulfation of CCR5 is 
inhibited in the insect cells.
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(NMR) chemical shift mapping has revealed the interaction surface 
of the CCR5 N-terminus on the RANTES structure and corroborates 
the requirement of sulfation for strong binding [19]. Further post-
translational modifications include O-glycosylation at serine 6 [18] 
and palmitoylation at cysteines 321, 323, and 324 [20]. Whereas 
palmitoylation presumably adds conformational stability to the C-
terminus by anchoring to the lipid membrane, the functional role 
of glycosylation is under debate [18].
Both chemokine receptors as well as their cognate chemokines 
can form stable dimers. In particular, CCR5 has been shown to form 
homodimers as well as heterodimers with CCR2 [21]. Similarly, RAN-
TES, MIP-1? and MIP-1? occur in monomeric and dimeric form, 
depending on concentration and pH. The functional role or conse-
quences of dimerization on signaling or HIV-1 coreceptor function 
are currently not understood. However, there is evidence that only 
the chemokine monomers interact with the receptor [19,22].
A more detailed biophysical and structural characterization 
of CCR5 and its interactions will be important for understanding 
chemokine signaling and virus entry as well as for the design of 
HIV entry inhibitors. Such studies require the reliable production 
of functional CCR5 on the tens of milligram scale. Different expres-
sion systems have been reviewed with respect to GPCR production 
[23,24]. A very promising route is the expression via the baculovi-
rus/insect cell system, which allows the production of milligram 
quantities of membrane proteins per liter of cell culture and is 
easy to handle and scale up. In addition, insect cells are able to 
perform post-translational modifications similar to those intro-
duced by mammalian cells. The successful expression of several 
GPCRs has been reported in insect cells, including among others 
[25] the second HIV-1 coreceptor, CXCR4 [26]. For the latter, func-
tional expression could be achieved in Trichoplusia ni (Hi5) insect 
cells with yields of about one milligram of pure protein per 8 l of 
cell culture.
Here, we describe the large-scale recombinant expression of 
human CCR5 in baculovirus-infected Spodoptera frugiperda (Sf9) 
insect cells. Several detergents were tested for the solubilization 
of the receptor with the detergent FosCholine-12 yielding the best 
results. Highly purified protein (>90%) was obtained using a dou-
ble tag strategy, combining immobilized metal affinity and Strep-
Tactin affinity chromatography. Using this procedure routinely 
about one milligram of the receptor can be obtained in purified 
and detergent-solubilized form from one liter of cell culture. This 
material is recognized by several antibodies including the confor-
mation-dependent monoclonal antibody 2D7, it shows the charac-
teristic circular dichroism (CD) and 1H NMR spectra of an ?-helical 
protein, and interacts with RANTES at micromolar affinity. In addi-
tion, monomeric and dimeric forms of the detergent-solubilized 
receptor could be separated and characterized individually.
Experimental procedures
Generation of expression constructs and preparation of recombinant 
baculovirus
A pcDNA3.1 vector (Invitrogen) containing the cDNA encoding 
for human CCR5 C-terminally fused to an additional 6-histidine tag 
(CCR5-His) was kindly provided by Paolo Lusso (San Raffaele Scien-
tific Institute, Milan, Italy). This construct was digested with XhoI 
and NsiI (New England BioLabs). Subsequently, the isolated CCR5-
His DNA fragment was cloned into the pFastBac™Dual vector (Invit-
rogen) under the control of the P10 promoter. After transformation 
into Escherichia coli, clones with the insertion were selected by 
ampicillin. The corresponding plasmid was then used as a template 
to introduce the second C-terminal tag (Strep-tag II) [27] via two 
subsequent PCR steps with the following oligonucleotides as prim-
ers: 1. 5?-CACCATCACC ATCACCATTG GTCCCACCCT TGAATGCATA 
GCATGCGG-3? and 5?-CCGCATGCTA TGCATTCAAG GGTGGGACCA 
ATGGTGATGG TGATGGTG-3?; 2. 5?-CACCATTGGT CCCACCCTCA 
GTTCGAGAAG TGAATGCATA GCATGCGG-3? and 5?-CCGCATGCTA 
TGCATTCACT TCTCGAACTG AGGGTGGGAC CAATGGTG-3?. After this 
step the complete C-terminal double-tag amino acid sequence was 
HHHHHHWSHPQFEK. The resulting double-tagged CCR5 was there-
fore named CCR5HS. Purified plasmid DNA with the confirmed 
incorporation of the 24 bases encoding the Strep-tag II was trans-
formed into DH10Bac™ chemically competent E. coli cells (Invitro-
gen). Positive clones were selected according to the manufacturer’s 
protocol and used for bacmid DNA isolation. Sf9 insect cells were 
transfected with this bacmid using BaculoPORTER (GeneTherapy-
Systems) as a transfection agent. P0 viral stock was isolated after 
5 days, plaque-purified and used to produce high-titer baculoviral 
stock as described in the manufacturer’s protocol.
Sf9 cell culture
Spodoptera frugiperda (Sf9) cells were routinely maintained 
in suspension culture at levels between 0.3 and 4 £ 106 cells/ml 
in serum-free Sf900II insect cell culture medium (Gibco) supple-
mented with antibiotics (25000 U/l penicillin G and 25 mg/l strep-
tomycin). Erlenmeyer flasks (0.1–5 l) were filled to about 10–20% 
and shaken at 80 rpm and 27 °C.
Small-scale expression and analysis
For the optimization of expression conditions, several parame-
ters were varied. Thus 10-ml cell cultures at a density of 2 £ 106 
cells/ml were infected with different amounts of virus at a 
 multiplicity of infection (MOI) of 0.2–5. Furthermore, the addition 
of 0, 10, or 25% of fresh medium at 24 h post infection was tested. 
From each test expression, samples were taken every 2 h from 36 
to 48 h and at 62 h post infection. Cell pellets of these samples were 
resolubilized in RIPA buffer (50 mM Tris, pH 7.4, 300 mM NaCl, 1% 
NP-40 substitute, 0.25% sodium deoxycholate, 0.1% SDS, 10 mM 
?-mercaptoethanol) and subjected to Western blot analysis.
Large-scale expression
For large-scale expression, cells were grown to a density of 
2.0–2.5 £ 106 cells/ml and inoculated with the high-titer baculovi-
rus stock using an MOI of 1. Typically aliquots of 1–1.5 l of cell cul-
ture were kept in 5- l flasks covered with gaze. Twenty-four hours 
post infection, 10% of fresh medium was added to the cell culture. 
Cells were harvested 44 h post infection by centrifugation at 500g 
and washed with PBS once. The resulting cell pellets were stored 
at ¡70 °C. At this temperature, they remained stable for at least sev-
eral months without any obvious sign of degradation such as loss 
of recognition of CCR5 by the conformation-specific monoclonal 
antibody 2D7.
Membrane preparation
All purification steps were carried out at 4 °C. Typically, the cell 
pellet obtained from about 1 l of cell culture was resuspended in 
30 ml buffer A (50 mM NaH2PO4, pH 7.5, 300 mM NaCl, 10% glyc-
erol, 1£ Complete Protein Inhibitor, EDTA-free (Roche)). Cells were 
broken by Dounce homogenization (Wheaton, tight pestle) and 
centrifuged at 3000g for 15 min to separate homogenate and unbro-
ken cells. The resulting pellet was resuspended in 10 ml buffer A, 
homogenized, and centrifuged again at 3000g. Supernatants were 
pooled and centrifuged at 30,000g for 1 h. The supernatant was 
discarded, and the pellet was resuspended in 20 ml buffer A and 
centrifuged at 100,000g for 30 min. The supernatant was again 
discarded, and the pellet containing the membrane fraction was 
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stored at ¡70 °C. Similar to the frozen cell pellets, these membrane 
preparations could be kept at this temperature for several months 
without any obvious signs of degradation.
Two step purification of CCR5HS
Several detergents, i.e. Cymal-5, dodecylmaltoside (DDM), 
dodecylphosphocholine (FosCholine-12), C12E9 (all Anatrace), 
Brij 58, Brij 78, and Digitonin (Sigma–Aldrich) were tested for sol-
ubilization of CCR5HS membrane fractions. Best results (see text) 
were obtained for FosCholine-12. Using this detergent, solubiliza-
tion was carried out in the following way: typically membranes 
obtained from 1 l of cell culture were thawed and resuspended in 
30 ml buffer B (50 mM NaH2PO4, pH 7.5, 300 mM NaCl, 10% glyc-
erol, 1% FosCholine-12). The mixture was gently shaken for 2 h 
and centrifuged at 100,000g for 30 min. The supernatant was sup-
plemented with imidazole to a final concentration of 15 mM and 
loaded onto an equilibrated Ni-column (5 ml, Chelating Sepharose 
fast flow (Amersham Biosciences)). The column was washed con-
secutively with 10 ml buffer C (50 mM NaH2PO4, pH 7.5, 300 mM 
NaCl, 10% glycerol, 1 M NaCl, 0.1% FosCholine-12), 50 ml buffer D 
(50 mM NaH2PO4, pH 7.5, 300 mM NaCl, 10% glycerol, 50 mM imid-
azole, 0.1% FosCholine-12), and 20 ml buffer E (50 mM NaH2PO4, pH 
7.5, 300 mM NaCl, 10% glycerol, 80 mM imidazole, 0.1% FosCholine-
12). The protein was eluted with 15 ml buffer F (50 mM NaH2PO4, 
pH 7.5, 300 mM NaCl, 10% glycerol, 500 mM imidazole, 0.1% Fos 
Choline-12). The eluate was mixed with the same volume of buffer 
G (100 mM Tris, pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.1% FosCholine-
12) and loaded onto an equilibrated Strep-Tactin column (5 ml). The 
column was washed with 50 ml buffer G and the protein eluted 
with 15 ml buffer H (buffer G + 2.5 mM desthiobiotin). Protein con-
centration was determined by UV absorbance at 280 nm and by a 
BCA (bicinchoninic acid) assay.
Immunoprecipitation with 2D7 antibody
Approximately 1 ?g purified CCR5HS was incubated with 
1.25 ?g antibody 2D7 (Becton Dickinson) for 1 h at 4 °C. The mix-
ture was centrifuged for 3 min at 14,000g to separate any possible 
precipitate. The supernatant was added to 50 ?l of 50% equilibrated 
protein A/protein G sepharose beads (Amersham Bioscience). The 
beads were shaken at 1250 rpm for 1 h at 4 °C. Subsequently, the 
supernatant was discarded and the beads were washed three 
times with 1 ml buffer G. Fifty microliters 2£ SDS sample buffer 
(125 mM Tris, pH 6.8, 10% glycerol, 5.5% ?-mercaptoethanol, 3% 
sodium dodecyl sulfate, 0.4% bromphenolblue) were added to the 
beads and shaken at 1250 rpm for 1 h at room temperature. The 
resulting supernatant was subjected to Western blot analysis.
Gel electrophoresis and Western blotting
Protein electrophoresis was performed on precast 4–20% gradi-
ent gels (Pierce) according to the manufacturer’s protocol. Samples 
were mixed with 2£ SDS sample buffer before loading, but not 
heated, since this leads to aggregation of the protein. For high-sen-
sitivity protein detection, gels were silver-stained.
For Western blots, the protein was transferred to nitrocellulose 
membranes using a semidry blotting system. The transfer time 
was 1 h at 0.1 A for a 6 £ 8 cm gel in transfer buffer (50 mM Tris, 
40 mM glycine, 1% SDS, 20% methanol, pH 9.0). The membrane was 
blocked for 1 h in 3% BSA in TBST (Tris-buffered saline with 0.05% 
Tween-20). Subsequently the membrane was incubated (1 h) 
with 2.5 ?g/ml primary antibody (either penta-His antibody (Qui-
agen) or polyclonal anti-human CCR5 N-terminus antibody (eBio-
science)) in TBST supplemented with 1% BSA. This was followed by 
incubation (1 h) with 4 ?g/ml HRP- (horse raddish peroxidase-) con-
jugated secondary antibody (Qiagen) in TBST supplemented with 
5% non-fat dry milk. Washing was performed for 3 £ 2 min after 
incubation with the primary and secondary antibody using TBST. 
Protein bands were visualized using a chemiluminescent HRP sub-
strate (Roche) according to the manufacturer’s instructions.
Size exclusion chromatography and static light scattering
Purified human CCR5HS was concentrated to 3 mg/ml using 
a centrifugal filter device (AmiconUltra4 10 kDa MWCO, Milli-
pore). The concentrated protein was applied to an equilibrated 
Superdex200 10/300 GL size exclusion chromatography column. 
Buffer G was used for equilibration of the column as well as for 
the separation of CCR5HS monomer and dimer. Fractions were ana-
lyzed by UV and static light scattering (Minidawn; Wyatt Technol-
ogy Corporation).
ITC analysis of RANTES-E66S binding
Mutant RANTES-E66S where glutamic acid 66 is replaced by 
serine was expressed and purified as described previously [19]. 
Binding of the chemokine RANTES-E66S to CCR5HS was tested by 
isothermal titration calorimetry (ITC) using a VP ITC instrument 
(Microcal). A 5.25 ?M solution of the purified receptor (2 ml in 
buffer J (50 mM NaH2PO4, pH 7.5, 300 mM NaCl, 0.5% FosCholine-
12)) was placed into the ITC sample cell at 25 °C. RANTES-E66S 
was prepared in identical buffer at a concentration of 50 ?M and 
titrated into the sample cell in steps of 10 ?l. As a control, the 
experiment was repeated under identical conditions using buffer J 
devoid of CCR5. ITC data were analyzed using the programs Origin 
(OriginLab) and Matlab (The MathWorks).
CD spectroscopy
CD spectra of purified CCR5HS were recorded on a Chirascan CD 
spectrometer (Applied Photophysics Ltd.). The protein (0.375 ?M) 
was in phosphate buffered saline (PBS) with 0.1% Cymal-5. Mea-
surements were performed in a 10 mm quartz cuvette at 20 °C. Four 
spectra were averaged and corrected for the buffer contribution.
NMR spectroscopy
Purified human CCR5HS was separated via gel filtration, and 
the fractions containing monomeric or dimeric CCR5HS were 
pooled and concentrated to a final volume of 200 ?l in buffer J sup-
plemented with 5% D2O for locking. Concentrations of the NMR 
samples were 30 and 90 ?M for the CCR5HS monomer and dimer, 
respectively. All experiments were performed at 25 °C on a Bruker 
DRX800 spectrometer, equipped with a triple-resonance, Z-gra-
dient cryo-probe. NMR data were processed using xwinnmr 3.5 
and NMRPipe [28]. One-dimensional proton NMR spectra were 
recorded using the 1-1 echo sequence [29]. Pulsed field-gradient 
(PFG) NMR spectroscopy [30] was used to determine the diffusion 
coefficient of the CCR5HS monomer and dimer in solution. Six 1D 
spectra with different gradient strengths were recorded and the 
relative intensities I analyzed according to I/I0 = exp(¡D?2G2?2(? ¡
 ?/3)) where I0 is the intensity in the absence of a gradient, D is 
the diffusion coefficient, G and ? are the magnitude and duration 
of the magnetic field-gradient pulses, respectively, ? is the time 
between field-gradient pulses, and ? is the gyromagnetic ratio of 
the observed nucleus. The hydrodynamic radius RH was calculated 
from the diffusion coefficient via the Stokes–Einstein equation 
RH = kT/6??D, assuming a spherical diffusor and using the viscosity 
? obtained from a reference experiment on a soluble protein (oval-
bumin) of similar size under equal conditions. The hydrodynamic 
radius was then used to calculate the apparent molecular weight m 
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of the detergent-solubilized protein according to m = 4?RH3 ?NA/3, 
where ? is the density and NA Avogadro’s number.
Results
Large-scale expression and purification of CCR5
The cDNA sequence corresponding to the human CCR5 gene fol-
lowed at the C-terminus by the double tag sequence (6£ His/Strep-
tag II, HHHHHHWSHPQFEK) was cloned into the pFastBac™Dual 
expression vector under the control of the strong P10 promotor. In 
the following, this double-tagged protein is referred to as CCR5HS. 
The expression of CCR5HS in Sf9 cells was optimized in terms of 
the multiplicity of infection (MOI) and the expression time using 
10-ml test cultures. An MOI of 1 and addition of 10% fresh medium 
after 24 h gave the best expression results with the optimal har-
vesting time being 44 h post infection. Small-scale membrane 
preparation, solubilization with Cymal-5 [31] and subsequent 
Western blotting revealed that CCR5HS occurs in monomeric as 
well as dimeric form, even in SDS sample buffer. This indicates a 
very high stability of the dimer. A further characterization of the 
monomeric and dimeric forms is given below. On a 4–20% gradi-
ent gel (Fig. 1), the monomer migrates as a 30 kDa band, while the 
theoretical molecular weight is 43 kDa. The dimer band appears 
at an apparent molecular weight of approximately 60 kDa. Expres-
sion of the full-length protein was confirmed by antibody binding 
to the CCR5HS termini (polyclonal anti-human CCR5 N-terminus 
antibody for the N-terminus and penta-His antibody for the C-ter-
minus). Both detections revealed identical bands corresponding to 
the CCR5HS monomer and dimer (vide infra).
Large-scale expression was successfully performed in 5-l shak-
ing flasks filled to about 30% as described in the Experimental pro-
cedures section. Cell pellets were stable at ¡70 °C for at least six 
months. Membranes containing CCR5HS were isolated from these 
cell pellets by several homogenization and centrifugation steps. 
The stability of the resulting membrane preparation stored at 
¡70 °C was checked by recognition with the antibody 2D7, which 
binds to a conformation-dependent motif in the CCR5 second extra-
cellular loop [32]. No differences were observed over a period of at 
least three months. For solubilization of CCR5HS, different deter-
gents were tested (Cymal-5, DDM, FosCholine-12, C12E9, Brij 58, 
Brij 78, Digitonin). In agreement with earlier studies [33], Cymal-
5 and DDM were able to solubilize and stabilize the receptor. In 
addition, FosCholine-12 gave similarly good results for the solubi-
lization and stabilization, but also showed better homogeneity in 
an electron microscopy screen. Therefore, FosCholine-12 was used 
for all further experiments. Purification of CCR5HS was performed 
by subsequent Ni- and Strep-Tactin-affinity chromatography. After 
this two-step procedure, the protein was >90% pure as analyzed by 
silver staining (Fig. 1).
Antibody recognition and secondary structure
For routine analysis, the presence of CCR5HS was detected by 
Western blots with a monoclonal anti-His antibody (Fig. 2a, lane 
1). The insertion of the second purification tag (Strep-tag II) was 
confirmed by binding of a monoclonal antibody (anti-Strep-tag 
II) directed against the eight amino acids (WSHPQFEK) of this tag 
(data not shown). The protein was also tested for binding of a poly-
clonal antibody raised against the N-terminal amino acids 6–20 
(SSPIYDINYYTSEPC) of human CCR5. The recognition by this anti-
body (Fig. 2a, lane 2) confirmed the expression and integrity of the 
entire protein including its N-terminus.
The conformation of CCR5HS was probed by immunoprecipita-
tion with 2D7. This antibody recognizes a conformation-dependent 
epitope on CCR5, which includes the second extracellular loop, and 
is frequently used to assay the structural integrity of CCR5 [33]. 
CCR5HS was also recognized by 2D7 after solubilization and purifi-
cation, suggesting that it retained its proper conformation during 
this process (Fig. 2a, lane 3). The stability of the purified protein 
was assayed by immunoprecipitation with 2D7 after incubation 
for different times at 4 °C and at room temperature. CCR5HS was 
recognized to about 50% after two weeks incubation at 4 °C (Fig. 
2b), whereas the stability at room temperature was much lower. 
This loss of antibody recognition also establishes that the detec-
tion of CCR5 by 2D7 is specific.
The secondary structure of the purified CCR5HS was analyzed 
by CD spectroscopy (Fig. 2c). Although data collection was only pos-
sible down to 200 nm due to the absorption of buffer and detergent, 
the CD spectrum shows typical minima at about 223 and 210 nm 
clearly indicating the high content of ?-helical structure, which is 
expected for a seven transmembrane helix GPCR.
Separation of monomeric and dimeric forms of CCR5
The micelles containing the monomeric and dimeric forms of 
CCR5HS could be separated by size exclusion chromatography. Fig. 
3a shows the UV absorbance of the gel filtration eluate (solid line) 
as well as the molecular masses of the protein-detergent complexes 
(dashed lines) determined by an in-line static light scattering detec-
tor. The light scattering signal corresponds to a molecular weight 
of about 75 and 130 kDa for the CCR5HS monomer and the dimer 
micelles, respectively. Samples of the corresponding fractions after 
gel filtration were analyzed by SDS–PAGE, which confirmed the 
separation into monomeric and dimeric forms of CCR5HS (Fig. 3b). 
After separation, these monomeric and dimeric forms did not inter-
convert even after one week storage at 4 °C.
The separated CCR5HS monomer and dimer micelles were 
also characterized by NMR spectroscopy. Fig. 3c shows the amide 
proton regions of two one-dimensional 1H spectra recorded on 
the CCR5HS monomer and dimer micelles. Both spectra are very 
similar and correspond to the expected low dispersion of an ?-
helical protein. From the similarity of both spectra it may be con-
cluded that there are no major structural differences between the 
monomeric and dimeric forms of CCR5. However, minor confor-
mational changes cannot be excluded. In particular, small confor-
mational changes are likely at the monomer–monomer interface 
and may also be possible at the intracellular and/or extracellular 
interface, thus leading to a differential signaling capacity of the 
two forms.
???
???
???
???
??
??
??
??
??
???????
?? ??
Fig. 1. SDS–PAGE of purified recombinant human CCR5HS. The purified receptor 
was analyzed by SDS–PAGE and subsequent silver staining. The band at about 
30 kDa corresponds to the CCR5HS monomer, whereas the receptor dimer 
migrates at about 60 kDa. The purity of the protein preparation is estimated to 
be more than 90%.
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Fig. 2. Structural integrity of recombinant human CCR5HS. (a) Antibody binding 
and immunoprecipitation of purified CCR5HS. Binding of a C-terminal antibody 
(monoclonal) directed against the His-tag (lane 1) and of an N-terminal antibody 
(polyclonal) directed against the amino acids 6–20 (lane 2) was used to confirm the 
expression of the full-length protein. The structural integrity of purified CCR5HS 
was probed by immunoprecipitation with the conformation-dependent antibody 
2D7 and subsequent Western blot analysis with the anti-His antibody (lane 3). All 
lanes show the monomer as well as the dimer of CCR5HS. In lane 3, the heavy and 
the light chain of the 2D7 antibody can be seen in addition. (b) Decrease of the 
amount of CCR5 recognised by the antibody 2D7 over the course of 14 days at 4 °C. 
(c) CD spectrum of detergent-solubilized CCR5HS. The high content of ?-helical 
structure is evident from the characteristic minima at 223 and 210 nm.
The size of the monomeric and dimeric micelles was also deter-
mined by NMR diffusion measurements. For this purpose, one-
dimensional 1H spectra were recorded at different magnetic field-
gradient strengths on FosCholine-12-solubilized monomeric and 
dimeric CCR5HS. Fig. 3d shows the logarithm of the relative spec-
tral intensities plotted against the square of the relative gradient 
strength. The slope of the linear fits yields diffusion coefficients of 
5.3 £ 10¡11 and 4.4 £ 10¡11 m2 s¡1 for the monomeric and dimeric 
micelles at 25 °C, respectively. An apparent viscosity of 1.27 cP of 
the detergent buffer solution (2% FosCholine-12) was obtained 
from a reference experiment comparing the diffusion of ovalbumin 
(45 kDa) in water and in the detergent buffer solution. Using this 
viscosity value and a density of 1.2 g/cm3 for the micelles, molecu-
lar weights of 102 and 175 kDa are obtained for the monomeric and 
dimeric micelles, respectively. These molecular weights include 
the mass of the water bound to the micelles. Typical hydration of 
proteins amounts to about 30–40% (w/w) [30]. Subtracting e.g. 30% 
hydration water from the total micellar masses yields values of 78 
and 135 kDa (protein + detergent) for the CCR5HS monomer and 
dimer micelles, which are in good agreement with the results from 
static light scattering.
Ligand binding
As a functional test, the binding of the chemokine RANTES to 
detergent-solubilized CCR5HS was assayed by isothermal titra-
tion calorimetry (ITC). Due to the decreased stability of CCR5 
at low pH values, and in order to simulate a physiological envi-
ronment, the binding studies were carried out at pH 7.5. At this 
pH, native RANTES has a high tendency to aggregate. Therefore, 
the binding was assayed by the mutant RANTES-E66S (hereafter 
referred to as RANTES), which has a much lower tendency to 
aggregate at elevated (7.5) pH values, while retaining the biolog-
ical activity and CCR5 binding capacity of the native chemokine 
[19,34,35].
The ITC data show that the titration of RANTES (50 ?M, 10-?l ali-
quots) into a buffer solution of FosCholine-12-solubilized CCR5HS 
(5 ?M, »1.4 ml) releases heat (Fig. 4a). This indicates that the asso-
ciation of CCR5HS and RANTES is exothermic. In contrast, the con-
trol titration of RANTES into an identical buffer/detergent solution 
without CCR5HS causes a small absorption of heat (Fig. 4c). This 
effect appears to result from the dilution of RANTES and the asso-
ciated shift of the monomer–dimer equilibrium towards the mono-
mer. Indeed, a pH-dependent dimer dissociation constant in the 
micromolar range has been observed in NMR studies [19]. The anal-
ysis of the ITC data is complicated by the fact that both RANTES and 
the receptor are in monomeric and dimeric forms. Using the simpli-
fying assumption that all the available receptor is able to bind the 
ligand and that RANTES is predominantly monomeric at the used 
concentrations (<7 ?M), the integrated ITC data can be fitted to a 
binding isotherm with an apparent dissociation constant of approx-
imately 1 ?M (Fig. 4b).
Post-translational modifications
In mammalian cells, the CCR5 N-terminus undergoes post-
translational modifications by the addition of sulfate groups to 
tyrosines 3, 10, 14, and 15 [17] as well as by glycosylation of ser-
ine 6 [18]. In particular, the sulfation of CCR5 is a requirement 
for high affinity interactions with its ligands [17,19]. To probe 
whether sulfation of CCR5HS takes place in Sf9 cells, CCR5HS 
was expressed with the sulfation inhibitor sodium chlorate [36] 
added to the cell culture medium. The expression level was very 
similar to that obtained without the inhibitor, and the protein 
was also recognized by the conformation-dependent antibody 
2D7 (data not shown). The purified protein was then assayed 
for binding of RANTES by ITC experiments under the same con-
ditions as before. Fig. 4d shows that the released heat does not 
vary significantly over the course of the titration (ligand to pro-
tein ratio 0–1.8) and is considerably smaller than for normal 
CCR5HS (Fig. 4a). This indicates that RANTES binding is strongly 
inhibited when CCR5 is expressed in the presence of the sulfa-
tion inhibitor. Thus, it is concluded that CCR5HS is sulfated when 
expressed in normal Sf900II medium, but that sulfation is inhib-
ited in the presence of sodium chlorate. This is in agreement with 
the reported sulfation of CXCR4 in Hi5 cells that also is inhibited 
by sodium chlorate [26].
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Discussion
As the primary HIV-1 coreceptor, CCR5 is of major importance 
for the development of HIV entry inhibitors and microbicides. 
Despite this fact, only very limited structural information is avail-
able about CCR5 and its interactions with ligands. One of the major 
obstacles in such studies is the general lack of efficient procedures 
for high-yield functional expression and purification for membrane 
proteins and GPCRs in particular. In recent years, it has been shown 
that baculovirus-infected insect cells are capable of producing rela-
tively large amounts of functional receptors [25]. Thus, the expres-
sion of the second HIV-1 coreceptor, the CXC chemokine receptor 
CXCR4, has been reported with yields of about one milligram pure 
protein per 8 liter of Hi5 cell culture [26].
Here, we have shown that human CCR5HS can be expressed 
with high yields in Sf9 insect cells using recombinant baculovirus 
as a vector for the gene. Pure protein was obtained by a double 
tag strategy consisting of a large-capacity separation by His-tag/Ni 
affinity chromatography followed by a highly specific separation 
via the Strep-tag II/Strep-Tactin interaction. Elution from both 
these matrices can be performed using small and readily available 
molecules (imidazole and desthiobiotin, respectively). Thus the 
 scale-up of this purification procedure is very easy and convenient. 
The purity of the receptor after these two chromatography steps is 
higher than 90% as judged from silver-stained gels (Fig. 1). An over-
all yield of about one milligram of purified, detergent-solubilized 
human CCR5HS is obtained per liter of cell culture.
The solubilized receptor is recognized by the conformation-
dependent antibody 2D7, which binds to a structural motif in the 
second extracellular loop [32]. This suggests that the recombinant 
CCR5HS is correctly folded even in detergent-solubilized form. The 
expected high content of ?-helical secondary structure was con-
firmed by CD measurements and one-dimensional 1H NMR spec-
troscopy.
Using isothermal titration calorimetry we have been able to 
show that the recombinant human CCR5HS expressed in Sf9 cells 
interacts with one of its ligands, the chemokine RANTES. Using the 
crude assumption of a monomer-to-monomer interaction, a disso-
ciation constant of about 1 ?M is obtained. This magnitude is simi-
lar to the value of 1.2 ?M derived by NMR spectroscopy for binding 
of the N-terminal (residues 1–25, Y10,Y14-sulfated) CCR5 peptide 
to RANTES monomer [19]. The agreement may be fortuitous, since 
the latter data were obtained at pH 3.8 in contrast to the pH 7.5 of 
the ITC titration, considering also that the electrostatic interaction 
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Fig. 3. Separation and characterization of CCR5HS monomer and dimer. (a) Purified CCR5HS was separated by size-exclusion chromatography in order to obtain the mono-
meric and the dimeric form. The eluate was analyzed by its UV absorbance (solid line) as well as by static light scattering (dashed lines). The latter correspond to molecular 
weights of the protein-detergent complexes of about 75 and 130 kDa for the monomer and the dimer, respectively. (b) Silver-stained SDS–PAGE of the separated CCR5HS 
dimer (lane 1) and monomer (lane 2) fractions. (c) 1D 1H NMR spectra of the separated CCR5HS monomer and dimer fractions. Both, the monomer and the dimer show the 
typical pattern of an ?-helical protein. Spectra are scaled to the same size. (d) Results of 1H NMR experiments to determine the diffusion coefficient of the CCR5HS detergent 
micelles in the separated monomer and dimer fractions. The straight-line fits correspond to a diffusion coefficient of 5.3 £ 10¡11 m2 s¡1 for the monomer (open circles) and 
4.4 £ 10¡11 m2 s¡1 for the dimer (filled circles).
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between RANTES and CCR5 [19] is expected to vary significantly 
with pH. Compared to cell binding assays (e.g. KD = 0.4 nM [18]), the 
observed binding of RANTES to the detergent-solubilized receptor 
is rather weak. This may be caused by physico-chemical effects 
such as a destabilization of the receptor structure in the detergent 
micelles. However, it may also be related to recent findings that 
intracellular binding of the G protein to CCR5 switches the recep-
tor from low to high affinity for the chemokine [37]. Thus, the 
absence of the G protein in our system may significantly decrease 
the chemokine affinity.
The interaction with RANTES was also used to probe for the sul-
fation of CCR5HS. For this, the receptor was expressed in the pres-
ence of a sulfation inhibitor. Under these conditions, the CCR5HS 
expression level and binding to 2D7 is similar to that obtained 
under normal cell culture conditions. However, the CCR5HS interac-
tion with RANTES as probed by ITC is strongly reduced. This leads 
to the conclusion, that the receptor is sulfated when expressed in 
the absence of the inhibitor.
Using size exclusion chromatography, we have been able to 
separate micelles containing the receptor monomer and dimer. 
The dimeric form of CCR5HS can be observed even under SDS–
PAGE conditions, suggesting that its assembly is very stable. The 
functional role of GPCR dimerization is controversial [38]. It 
has been shown that coexpression of full-length CCR5 together 
with the deletion mutant CCR5?32 inhibits the transport of the 
full-length receptor to the cell-surface, presumably due to recep-
tor dimerization [39]. This process may be responsible for the 
delayed onset of symptoms in CCR5/CCR5?32 heterozygote HIV 
patients. However, there is currently no conclusive evidence 
whether CCR5 monomers or dimers or both are functionally 
important. The possibility to separate monomeric and dimeric 
detergent-solubilized CCR5 at high yields opens the way for 
detailed biophysical studies on this topic. Efforts in this direction 
are currently underway in our lab.
In conclusion, we have shown that highly purified, detergent-
solubilized, functional CCR5 can be obtained in high yields from the 
baculovirus/insect cell system. The availability of large amounts of 
CCR5 should enable further structural studies as well as a thorough 
biophysical characterization of the interactions of CCR5 with its 
various ligands.
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1.3 NMR spectroscopic study of the CC chemokine receptor
CCR5 and its interaction with maraviroc and RANTES
Abstract
The β chemokine receptor CCR5 is a member of the G protein-coupled receptor (GPCR)
family class A. It shares the typical structural motif of these proteins with seven mem-
brane spanning helices. CCR5 is involved in both, crucial processes of the immune system
as well as infections by the human immunodeficiency virus 1 (HIV-1). Thus the receptor
and its endogenous ligands are very important targets but, as GPCRs in general, difficult
to study. Purified CCR5 has been used to investigate the receptor – ligand interaction
by both, solution and solid state nuclear magnetic resonance (NMR) spectroscopy. Pre-
parations of selectively 15N-isoleucine and 15N-tyrosine labeled CCR5, solubilized by the
detergent FosCholine-12, allowed observation of this membrane protein in two dimensio-
nal 1H/15N HSQC spectra for the first time. Unlabeled, detergent-solubilized CCR5 was
used to investigate the binding of the small molecule antagonist maraviroc as well as
the interaction with the chemokine RANTES. Here, initial proofs for the binding of ma-
raviroc to the recombinant human receptor are shown. NMR spectroscopic interaction
studies with RANTES proved to be more difficult. In NMR titration experiments, ligand
resonances are weakened but not shifted. Solid state NMR spectroscopy was used to in-
vestigate the interaction between RANTES and CCR5 in a membrane-like environment.
The successful reconstitution of CCR5 into lipids and initial RANTES-binding studies
using solid state NMR spectroscopy are reported.
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1.3.1 Introduction
Despite enormous technical progress, the fraction of membrane protein structures depo-
sited in the protein data bank is still very small. Furthermore, among this small number
of three dimensional structures not all classes of membrane proteins are equally well
represented. While there is a number of β-barrel membrane protein and α-helical chan-
nel structures deposited, e.g. (S.Hiller et al. 2008, Hilf & Dutzler 2008), so far there
are only few structures of G protein-coupled receptors available (Palczewski et al. 2000,
Cherezov et al. 2007, Rasmussen et al. 2007, Warne et al. 2008, Jaakola et al. 2008).
More structural information about this protein family would be very important, since
GPCRs account for one third of all mammalian membrane proteins (Pierce et al. 2002)
and many pharmaceutical compounds target these receptors. The lack of structural in-
formation is due to problems at all levels of the structure determination process, starting
with low yield expression, difficult solubilization and purification as well as poor stability
in detergents. Although all GPCR structures elucidated so far were solved by X-ray crys-
tallography, this technique usually requires protein engineering and antagonist binding to
reduce the inherent flexibility of these receptors (Kobilka 2007). Furthermore, extreme
efforts are necessary to find mutants that are stabilized but still functional (Rosenbaum
et al. 2007, Magnani et al. 2008). Therefore, at the moment X-ray crystallography is
limited to receptors in one, mostly inactivated state. If insights into the mechanism of
function are to be gained from the structures, additional information obtained with other
techniques is necessary.
In recent years, NMR spectroscopy has gained more and more importance in the study
of membrane associated and membrane integrated proteins in terms of both, structure
and dynamics (Opella & Marassi 2004). With respect to GPCRs, the tryptophan back-
bone/side chain dynamics of the vertebrate photoreceptor rhodopsin have been studied
by NMR spectroscopy (Klein-Seetharaman et al. 2004, Werner et al. 2007). Further-
more, its C-terminus was characterized by comparison of the partially labeled receptor
with a 19 amino acid peptide (Werner et al. 2008). Progress was also made in stu-
dying the rhodopsin analogue sensory rhodopsin (pSRII) from Natronomonas pharaonis.
This GPCR-like, seven transmembrane helix protein was investigated using both, solid
state NMR (Etzkorn et al. 2007) as well as solution state NMR spectroscopy (Gautier
et al. 2008). The investigation in the solid state concentrated on the proteins secondary
structure, dynamics, and membrane topology. Using solution state NMR spectroscopy,
Gautier et al. could achieve nearly complete backbone assignment, that allowed analysis
of secondary structure and backbone dynamics. This study revealed the importance
of the detergent choice for successful NMR investigations. The experimental time for
example was drastically reduced by changing the detergent from dodecyl maltoside to
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diheptanoyl phosphatidylcholine. The good data quality in this detergent even allowed
structure calculation (D. Nietlispach, personal communication). These studies are en-
couraging and show that NMR spectroscopy, both in the liquid and solid state, is suitable
to study GPCRs and similar proteins. Easier than complete three-dimensional structures,
NMR spectroscopy can provide valuable information about the dynamics of those recep-
tors already characterized by X-ray crystallography.
Here we describe initial investigations of the human CC chemokine receptor 5 (CCR5)
and its interacting ligand RANTES using both, solution and solid state NMR spectro-
scopy. First feasibility studies of the receptor alone were done with a selectively 15N-Ile
labeled sample. Since antagonist binding was helpful in many crystallographic studies of
GPCRs, binding of the antagonist maraviroc was tested using selectively 15N-Tyr labeled
CCR5. Also the isotope-labeled ligand RANTES was used and titrated with unlabe-
led CCR5 in order to study the ligand receptor interaction. With the same goal, the
RANTES/CCR5 complex was reconstituted into lipids and used for solid state NMR
spectroscopy.
1.3.2 Results and Discussion
Choice of the detergent for solution state NMR spectroscopy
The detergent which is used to keep a membrane protein in solution is essential for NMR
spectroscopy. Therefore, several detergents were tested for their ability to solubilize and
stabilize CCR5. The conformation of the receptor was assayed by immunoprecipitation
with the conformation-dependent monoclonal antibody 2D7 (see chapter 1.2). Some
detergents such as octyl glucoside are not able to keep CCR5 in a state that is recogni-
zed by this antibody and were therefore not further tested (Figure 1.4a).
Since the amount of protein required for NMR spectroscopy is rather large, initially elec-
tron microscopy was used to check the quality of preparations in different detergents
(Cymal-5, DDM, FosCholine-12, C12E9, Brij 58, Brij 78, Digitonin). Out of the tes-
ted detergents FosCholine-12 showed the best homogeneity in the electron microscopy
images (Figure 1.4b). Characterization of CCR5 in this detergent is described in chapter
1.2 and revealed that FosCholine-12-solubilized receptor is not only recognized by the
2D7 antibody but also interacts with its ligand RANTES. Therefore, all solution state
NMR experiments described here were performed with CCR5 solubilized by FosCholine-
12.
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Figure 1.4 a Western blot after immunoprecipitation with the antibody 2D7, showing
bands for the heavy (50 kDa) and light (25 kDa) chain of this antibody and the CCR5 mo-
nomer (30 kDa). In the detergents FocCholine-12 (lane 1) and Cymal-5 (lane 2) the protein
is recognized by the antibody whereas octyl glucoside (lane 3) is not suitable. b Electron
micrograph of CCR5 in FosCholine-12 (scale bar: 100 A˚) with some particles enlarged on the
right. Electron microscopy images for the detergent screen were taken by Petr Broz.
Amino acid-type selective labeling of CCR5 in baculovirus-infected insect cells
Large-scale recombinant expression of functional proteins is necessary but not sufficient
for NMR spectroscopic investigations. For many experiments, uniform or selective labe-
ling of the proteins with NMR active isotopes is required.
CCR5 was expressed in Sf9 insect cells as described in chapter 1.2. For these cells,
most amino acids are essential and have to be added to the cell culture medium. Thus
production of isotope-labeled proteins requires a medium without amino acids and any
undefined source of those (Strauss et al. 2003). For amino acid-type selective labeling of
CCR5, the commercially available insect culture medium SF-4 Baculo Express ICM was
custom made by BioConcept (Allschwil, Switzerland) without yeast extract and depleted
of the amino acid that was to be isotope-labeled.
The three amino acids serine, isoleucine, and tyrosine were chosen to test the expression
of selectively labeled CCR5 and for initial NMR spectroscopic studies. Serine is very
abundant in the termini and loop regions while isoleucine is the major amino acid within
the transmembrane helices. In addition, tyrosine was chosen because it represents a very
important point of interaction with RANTES, which binds to sulfated tyrosine residues
in the CCR5 N-terminus (Y3, Y10, Y14, Y15). Figure 1.5 shows the topology of CCR5
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with all serine residues colored yellow, isoleucine residues marked in red and all tyrosine
residues in blue. CCR5 here and in the following discussion refers to the human protein
with an additional C-terminal 6His- and Strep-tag. These purification tags are not shown
in Figure 1.5.
Figure 1.5 Topology of CCR5 highlighting those amino acids, that were chosen for
selective labeling of the receptor (serine (yellow), isoleucine (red), and tyrosine (blue)). Helix
positions are drawn according to (Oppermann 2004).
For the large-scale expression of selectively labeled CCR5, cells were pre-cultured in
full medium (SF-4 Baculo Express ICM). Because it was shown before, that the cell
internal pool of unlabeled amino acids is small (Strauss et al. 2003), the medium was
changed to amino acid-depleted SF-4 medium only prior to infection as described in the
Materials and Methods section. Expression was performed in 5-l shaking flasks filled
with a maximum of 1 l cell culture. Cell harvest, membrane preparation, and purification
was performed as described (see chapter 1.2). The expression levels of CCR5 in amino
acid depleted medium are slightly lower compared to full medium.
One substantial problem during amino acid-type selective labeling is cross-labeling of
other amino acids (scrambling). For Sf9 insect cells, cross-labeling occurs for glycine
(Strauss et al. 2003), alanine, glutamate, and aspartate (Adam et al. 2005). We also
observed scrambling of 15N-serine when incorporated into CCR5 or conversion of other
amino acids into serine. Although normal signal intensities in 1D proton NMR spectra
were obtained, no signals could be observed in 2D 1H-15N HSQC spectra. For labeling
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with isoleucine and tyrosine, scrambling is not problematic, although in the case of
selectively 15N-tyrosine labeled CCR5 some peaks occur in the region where normally
side chain NH2-groups appear. These signals might arise from glutamine, that can be
synthesised from glutamate by the used insect cells after degradation of 15N-tyrosine
(Drews et al. 2000).
Solution state NMR spectroscopy of selectively-labeled CCR5 in detergent
micelles
Solution state NMR spectroscopy of integral membrane proteins is a challenge due to
the slow tumbling of the protein/detergent complex. In GPCRs, an additional difficulty
arises from the low range of signal dispersion resulting from their mainly α-helical struc-
tures. We have shown before that one dimensional 1H NMR spectra of CCR5 can be
obtained and used for diffusion measurements (see Chapter 1.2). From 1D spectra the
amide proton T2 can be estimated to ≈ 4.5 ms at 15 °C.
Figure 1.6 a Selected region of the 1H-15N HSQC spectrum of 100 µM 15N-isoleucine-
labeled CCR5 in FosCholine-12 micelles. The spectrum was measured at 40°C with a total
measurement time of 85 h. Within that time not all of the 32 expected resonances can be
observed. The grey dashed line represents the random coil amide proton shift for isoleucine.
b The strongest observed peak is shown before and after the addition of 1 mM NiSO4 to the
sample. Due to Ni2+-binding to the CCR5 His-tag, the signal is bleached out.
To assess the feasibility of further NMR spectroscopic investigations of detergent-solubi-
lized CCR5 in the liquid state, the receptor was selectively labeled with either 15N-
isoleucine or 15N-tyrosine. These preparations allowed observation of CCR5 in heteronu-
clear NMR experiments for the first time. Figure 1.6a shows the 1H-15N HSQC spectrum
of selectively labeled 15N-Ile CCR5 at 40 °C. The spectrum illustrates that several, even
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though not all resonances of the labeled amino acid can be seen. Taking the strongest
peak as an indicator, it is observed that the intensity decreases by 30% within 48 h,
suggesting that the protein aggregates over time at the elevated temperature.
Out of the observed isoleucine signals, the very strong resonance most probably corres-
ponds to isoleucine 348 in the very C-terminus of CCR5. This amino acid is separated
from the His-tag by only three other residues. This assignment was verified by a Ni-
bleaching experiment using the paramagnetic properties of Ni2+ which lead to very fast
relaxation of nearby nuclei. The 15N-Ile CCR5 sample was titrated with NiSO4 and HSQC
spectra were recorded before and after the addition. With increasing Ni2+ concentra-
tions the peak intensity decreases, since Ni2+ is bound by the His-tag and bleaches out
resonances of amino acids in close vicinity. Figure 1.6b shows the strongest peak of
15N-Ile CCR5 before and after addition of NiSO4. If the Ni
2+ is complexed by EDTA
and washed out, the peak is recovered. The remaining signals cannot be assigned to
certain residues, but most likely they represent isoleucines in the more flexible termini
and loop regions. Nevertheless, compared to the random coil amide proton chemical
shift for isoleucine (8.19 ppm at pH 7.0 and 35 °C (Wu¨thrich 1986)), most observed
signals are shifted upfield, which corresponds to an α-helical conformation.
Figure 1.7 a Selected region of the 1H-15N HSQC spectrum of 15N-tyrosine labeled
CCR5 depicting the strongest peak. The results of four short experiments (1 h) at different
temperatures (5, 15, 35, and 40 °C) are shown. The signal intensity is highest at 15 °C. b
1H-15N HSQC spectrum of 85 µM 15N-tyrosine labeled CCR5 in FosCholine-12 micelles. The
spectrum was acquired for 20 h at 15 °C.
In Figure 1.7a the strongest peak occurring in the 1H-15N HSQC spectrum of 15N-Tyr
CCR5 is shown at different temperatures. This peak can already be seen after short
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measurement times (1 h). It is obvious that the signal intensity is extremely dependent
on the temperature, with the best spectrum obtained at 15 °C. At lower temperature
(5 °C) the resonance is weaker due to slower tumbling. In contrast, at higher tempera-
tures even stronger signals would be expected. The observed decrease in signal intensity
above 15 °C can be explained by motions that are in the intermediate range (µs – ms)
and lead to line broadening. Thus the peaks disappear at higher temperatures. The
different optimal temperature for measurements of 15N-Tyr CCR5 compared to the 15N-
Ile labeled protein can be due to the different nature of these residues. Isoleucine is
more hydrophobic than tyrosine (especially if the latter is sulfated) and its side chain
is likely to stick to the protein rather than point into the solution. Therefore, higher
temperatures are needed to observe these residues in the large complex.
Figure 1.7b shows a selected region of the 1H-15N HSQC spectrum of 15N-Tyr CCR5
after a 20 h experiment at 15 °C. Two major resonances appear at proton chemical shifts
between 8.0 and 8.25 ppm.
The two spectra of selectively labeled CCR5 show that heteronuclear NMR experiments
with this receptor are in principle possible. Nevertheless, the spectral quality has to be
significantly improved. The spectra obtained from 15N-Ile and 15N-Tyr CCR5 show less
peaks than would be expected from the receptor’s amino acid sequence (32 isoleucine
and 18 tyrosine). One reason for the low number of visible peaks could be aggregation of
the receptor under the conditions used. Although this is contradictory to our results from
size-exclusion chromatography-coupled static light scattering and 1D 1H NMR diffusion
measurements, there are factors that could lead to aggregation of CCR5 during the NMR
sample preparation. The selectively labeled protein was concentrated to yield ≈ 100 µM
samples, a procedure which could lead to aggregation. Possibly, FosCholine-12, which
was used for all NMR experiments is not able to prevent aggregation of the receptor
completely, especially at high protein concentrations.
Since the use of highly-concentrated DHPC as detergent was very successful in the study
of sensory rhodopsin pSRII (Gautier et al. 2008) this detergent was also tested for CCR5.
Although the 1D proton NMR spectra do not change very much upon addition of 7%
DHPC, slight improvement in 2D spectra can be observed when DHPC is added to the
old (16 months) 15N-Ile labeled sample (data not shown).
Binding of the antagonist maraviroc to CCR5
The 15N-Tyr labeled CCR5 sample was further used to investigate the effect of the anta-
gonist maraviroc. A five times excess of maraviroc was added from a highly concentrated
H2O stock solution. One dimensional
1H NMR spectra were used to estimate the amide
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proton T2 for both molecules (Figure 1.8a-c). While T2(H
N) of the protein remains
unchanged, the resonances of maraviroc show transverse proton relaxation times in the
order of 28 ms (15 °C) after addition to CCR5, which is much less than observed for
maraviroc alone under the same conditions (102 ms). This indicates that maraviroc at
least partially binds to CCR5.
Figure 1.8 One and two dimensional NMR spectra of selectively 15N-tyrosine labeled
CCR5 and its antagonist maraviroc. a – c 1D 1H NMR spectra of a 300 µM maraviroc, b
85 µM CCR5, and c the receptor/antagonist complex (85 µM CCR5, 425 µM maraviroc).
The buffer conditions for all samples were the same (50 mM NaH2PO4, 300 mM NaCl, 5%
D2O, pH 7.5, ≈ 2% FosCholine-12, 15 °C). Spectra were recorded with the 1-1 sequence with
either a short delay (0.1 ms, black) or a longer delay (2.1 ms, red). The asterisk marks a
small molecular weight impurity that does not relax significantly within the 2 × 2 ms delay
difference. d – f 2D 1H-15N HSQC spectra of d 15N-Tyr labeled CCR5, e the CCR5/maraviroc
complex, and f the overlay of the two.
Figure 1.8d-f shows the comparison of the 1H-15N HSQC spectra of tyrosine labeled
CCR5 with and without maraviroc as well as the overlay of the two. Very small chemical
shift changes in the proton dimension can be observed. Nevertheless, since only two
peaks are observed and they shift to a similar extent in the same direction, this result
should be considered with caution.
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The stability of CCR5 in complex with maraviroc can be estimated from the peak inten-
sities in three consecutive 1H-15N HSQC experiments. The signals decrease in intensity
only marginally within 48 h, with the intensity difference being about 0.5 times the
top-level noise. Thus the sample seems to be more stable compared to 15N-Ile CCR5.
Whether this effect is due to the lower temperature (15 °C versus 40 °C) or binding
of the antagonist maraviroc is currently unclear. However, it was observed before in
antibody binding experiments (see chapter 1.2) that CCR5 is longer recognized if kept
at 4 °C compared to 25 °C.
Figure 1.9 a Chemical structure of the CCR5 antagonist maraviroc. b Two dimensional
1H-15N HSQC spectra of selectively 15N-tyrosine labeled CCR5 in complex with the antagonist
maraviroc. The spectrum was recorded at 15 °C for 140 h.
Figure 1.9b shows the resulting 1H-15N HSQC spectrum after 140 h of measurement
under the above mentioned conditions. In addition to the two major peaks observed
already in shorter experiments, some more resonances appear in the same as well as in
the side chain NH2-region (see above). Nevertheless, the emerging peaks represent only
a fraction of those expected.
Titration of uniformly 15N-labeled RANTES with detergent-solubilized,
unlabeled CCR5
The chemokine RANTES is an endogenous ligand of CCR5 and the most potent natu-
rally occurring anti-HIV-1 agent known to date. The mode of receptor binding is not
yet understood but there is evidence that only monomeric RANTES interacts with the
receptor (Duma et al. 2007). Furthermore it was shown in mutation studies that tyro-
sine sulfation of CCR5’s N-terminus is essential for interaction with chemokines (Farzan
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et al. 1999, Bannert et al. 2001). Since we could show that the CCR5 produced in
insect cells is at least partially sulfated (see chapter 1.2), the unlabeled receptor was
used for the NMR titration of 15N-labeled RANTES (RANTES here refers to the less
aggregation-prone mutant RANTES-E66S; for more details see chapter 1.4).
Figure 1.10 Titration of uniformly 15N-labeled RANTES-E66S with non-labeled CCR5.
a Selected region of the reference 1H-15N HSQC spectrum of 50 µM RANTES-E66S. The spec-
trum was recorded under exactly the same buffer condition as all further titration points (50 mM
NaH2PO4, 300 mM NaCl, 5% D2O, pH 7.5, 2% FosCholine-12, 5 °C). b – d With increasing
amounts of CCR5 in the sample, the intensities of RANTES-E66S resonances decrease. The
CCR5 to RANTES ratios in the shown spectra are 0 to 1.8 from a to d.
Figure 1.10 shows a sequence of 1H-15N HSQC spectra corresponding to different titra-
tion points from 0 : 1 up to 1.8 : 1 (CCR5:RANTES). It should be noted, that all peaks
seen in these spectra correspond to dimeric RANTES, since the equilibrium is shifted to
this form at the pH used in the experiment (pH 7.5). With increasing amounts of the
receptor, signals of the ligand are substantially weakened and no new signals that could
be attributed to a bound state are observed. Since the same result is obtained with
2H/15N-RANTES, it is very likely that the particles present in solution are too big to be
seen, that means more than hundreds of kDa. This is in contrast to our observations
during the characterization of CCR5 by gel filtration-coupled static light scattering as
well as one dimensional proton NMR diffusion measurements. It cannot be excluded
that RANTES, which is prone to aggregation at elevated pH despite the mutation of
glutamic acid 66, is not stable under these conditions. To cope with this problem it
would be necessary to find conditions under which both, the ligand and the receptor are
equally stable.
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Solid state NMR spectroscopy of uniformly 13C/15N-labeled RANTES and its
complex with reconstituted CCR5
In addition to solution state NMR spectroscopic investigations of the RANTES – CCR5
interaction, we also pursued a different approach, namely solid state NMR spectroscopy.
In this approach, 13C/15N-labeled RANTES and unlabeled, lipid-reconstituted CCR5 was
used to investigate the ligand – receptor interaction.
Reconstitution of CCR5 into liposomes Solid state NMR spectroscopy has not
only the advantage of being, in principal, not limited by the size of the system under
investigation. With respect to membrane proteins it also offers the possibility to study
them in a lipid environment similar to the membranes where they naturally occur. CCR5
has been successfully reconstituted into a lipid mixture (POPC, POPE, and DMPA) on
the surface of paramagnetic beads (Mirzabekov et al. 2000). The mixture that was
found to keep CCR5 functional in this study was used to prepare proteoliposomes for
solid state NMR spectroscopy (Figure 1.11a).
Two different reconstitution methods have been used to produce CCR5-containing pro-
teoliposomes. For both attempts, CCR5 was purified in the detergent Cymal-5 since
this was found to be easier removed than FosCholine-12. Figure 1.11b shows a Western
blot of the reconstitution of CCR5 into lipids after detergent removal with BioBeads
(Rigaud et al. 1997). Lane 1 shows the protein after purification and before overnight
incubation with the lipid mixture (lipid-to-protein ration (LPR) = 4 (w/w)). The de-
tergent was removed by addition of 5 mg BioBeads per 5 mg detergent and incubation
for 5 h. Removal was completed by further addition of two times 15 mg beads and
incubation for 1.5 h. Lanes 2 and 3 show the supernatant after centrifugation of the
mixture and washing of the resulting lipid pellet, respectively. To assay the conforma-
tion of reconstituted CCR5 the lipid pellet was resuspended and incubated with the
conformation-dependent antibody 2D7. Lane 4 shows the supernatant after antibody
binding and subsequent centrifugation. The very faint band of 2D7 indicates an excess
of the antibody. The lipid pellet was gently washed with buffer. Tight binding of the
antibody to CCR5 is obvious from the absence of any antibody band in the washing
fraction (lane 5). Lane 6 shows the proteoliposomes solubilized in SDS sample buffer.
CCR5 as well as the 2D7 antibody can be seen in the blot. Figure 1.11b also shows
the result of a control experiment without CCR5 (lanes 4* – 6*), where the antibody is
found only in the supernatant but not in the lipid pellet.
Although the reconstitution of CCR5 using BioBeads works well for high LPRs, it is not
suitable for lower amounts of lipids, since the protein aggregates on the beads.
One limitation in solid state NMR spectroscopy is the volume of the sample rotor (e.g.
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Figure 1.11 a Lipids used to reconstitute CCR5. POPC, POPE, and DMPA were
mixed in a 6:3:1 ratio. b Western blot of the reconstitution and antibody recognition of CCR5
using BioBeads (detection with anti-His antibody). Lanes corresponding to the CCR5-free
control are marked (*). Lane 1 shows the purified CCR5. Lanes 2 and 3 correspond to
supernatants after reconstitution and washing. Lanes 4 and 5 show the supernatants after
addition of the antibody and a washing step. In lane 6 the resolubilized proteoliposomes are
shown. c Resolubilized proteoliposomes after reconstitution of the CCR5/RANTES complex
using methyl-β-cyclodextrin. RANTES monomer and dimer as well as CCR5 monomer, dimer,
and some higher order oligomers can be seen.
60 µL active volume for a 4 mm rotor), thus it is desirable to use low LPRs in order to
maximize the amount of protein. In the study of a neurotensin-hexapeptide for example,
2.5 mg of the receptor were necessary to study the bound ligand by solid state NMR
experiments (Luca et al. 2003). To accomplish a low LPR, a second reconstitution
method was tested, namely the detergent removal with methyl-β-cyclodextrin (MBCD)
(Signorell et al. 2007). CCR5 was purified and incubated with lipids overnight. Since the
aim of our solid state NMR experiments was to study the CCR5/RANTES interaction
the chemokine was added before detergent removal (1:1 RANTES/CCR5 molar ratio).
Cymal-5 was complexed by addition of 1.2 equivalents MBCD over the course of 8 h
and separated from the proteoliposomes by centrifugation. With this procedure, CCR5
could be reconstituted into lipids with a LPR of 2 while bound to its ligand RANTES
as shown in Figure 1.11c. It is important, that the detergent is not removed too fast.
If MBCD was added within only 2 h, protein precipitation was observed. It has been
reported before that the slower the detergent is removed the better the quality of the
reconstitution, in these cases the quality of 2D crystals (e.g. for OmpF or SoPIP2;1 (Si-
gnorell et al. 2007)). Therefore, it might be possible to obtain reconstitution of CCR5
with even lower LPRs and thus higher protein packing densities, if the MBCD addition
time is further extended. This procedure was also used for initial 2D crystallization trials,
carried out by Marco Biasini and Herve´ Re´migy.
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Figure 1.12 One dimensional solid state 13C MAS-NMR spectra of uniformly 13C/15N-
labeled RANTES. a 1D direct 13C excitation spectrum of RANTES together with a lipid
mixture (POPC/POPE/DMPA; 6:3:1). Resonances of both, lipids and protein can be seen. b
1D cross-polarization 13C spectrum of RANTES (red). Only lipid resonances can be observed.
The direct excitation spectrum is also shown for comparison. c 1D direct 13C excitation
spectrum of RANTES with proteoliposomes containing CCR5. Again, resonances of lipid
and protein can be observed. d 1D cross-polarization spectrum of the RANTES/CCR5/lipid
mixture (red). In addition to the lipid resonances also protein peaks can be seen. All spectra
were recorded at ≈ 0 °C (-10 °C VT-gas temperature) and MAS rates of 10 kHz.
One dimensional solid state MAS-NMR spectroscopy Specific binding of the li-
gand to its receptor under the conditions used is a prerequisite for any further structural
studies. In order to test whether RANTES interacts unspecifically with the lipids used to
reconstitute CCR5, 13C/15N labeled protein was added to the lipid mixture and used as
reference without CCR5 (2 mg 13C/15N-RANTES and 20 mg lipids). One dimensional
solid state 13C MAS-NMR spectra were initially used as a quick test for the interaction.
Figure 1.12a shows the spectrum of the reference sample (13C/15N-RANTES and lipids)
after direct carbon excitation at ≈ 0 °C (VT-gas temperature -10 °C). Between 20 and
40 ppm, signals corresponding to the lipid can be seen in addition to the aliphatic car-
bons of RANTES (10 – 50 ppm). The protein’s α-carbon resonances appear around 60
± 10 ppm and its aromatic carbons between 120 and 140 ppm. At 180 ppm, carbonyl
carbon resonances occur and can be used as a monitor for the state of the protein (see
below). In the direct carbon excitation experiment the resonances of all carbons in the
sample are visible.
In contrast, if cross-polarization from 1H to 13C is used (instead of direct excitation)
only those carbons yield signals that are immobile. In cross-polarization (CP) experi-
ments, transverse proton magnetization is generated and spin-locked for a certain time
(mixing time). Simultaneously, a carbon pulse of a specific strength is applied and if
the Hartmann-Hahn conditions are fulfilled (Hartmann & Hahn 1962), polarization is
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transfered by dipolar interaction from the protons to carbon. Cross polarization is only
effective for molecules that are immobile, since dipolar interactions average to zero in
the presence of rotational motion.
Figure 1.12b shows the resulting CP spectrum for the reference sample. Only lipids
are visible. This indicates that the lipids are immobile under these conditions whereas
RANTES is free to move in the remaining water between lipid layers. Thus, RANTES
does not bind unspecifically to the lipid mixture used nor does it form large aggre-
gates under the solid state NMR sample conditions. This is essential for studies of the
CCR5/RANTES complex. Figure 1.12c shows the result of an one dimensional direct
carbon excitation experiment of RANTES together with CCR5 containing proteolipo-
somes. The sample contained ≈ 1.5 mg 13C/15N-RANTES and 7.5 mg CCR5. The
appearance of this spectrum is comparable to the reference, although signal intensities
are lower due to a smaller amount of RANTES in the sample. The corresponding cross-
polarization experiment yields a spectrum in which not only the lipid resonances but
also protein signals are visible, e.g. those of the carbonyl carbons (≈ 180 ppm, Figure
1.12d). This indicates that RANTES is less mobile in this preparation than it is in the
reference sample, suggesting that it binds specifically to CCR5.
Figure 1.13 Two dimensional 13C/13C proton driven spin diffusion spectrum of
RANTES together with a lipid mixture (POPC/POPE/DMPA; 6:3:1). a Full-view of the
spectrum recorded with 11 kHz MAS at -40 °C (VT-gas temperature). Cross peaks between
the carbonyl and Cα as well as the aromatic and aliphatic side chain carbons can be seen.
b Enlargement of the Cα/Caliph-region of the spectrum showing cross peaks between these
carbons.
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Two dimensional solid state CP-MAS NMR spectroscopy Figure 1.13a shows the
two dimensional 13C-13C proton-driven spin diffusion spectrum of the reference sample
at ≈ -40 °C. The low temperature was chosen in order to obtain cross-polarization
spectra even for free RANTES. Correlations between carbonyl carbons and aromatic,
aliphatic, and α-carbons can be seen as well as among Cα and side chain carbons.
The latter are depicted in the the enlarged spectral region (Figure 1.13b). Comparison
to Cα and Cβ chemical shifts predicted with ShiftX (Neal et al. 2003) from the crystal
structure of RANTES (pdb 1eqt) allows several groups of peaks to be assigned to residue
types. For example threonine Cα/Cβ and Cβ/Cγ peaks occur at 65/70 and 25/70 ppm,
respectively. The line width obtained in this experiment is approximately 1 ppm. This is
slightly broader than was reported for a peptide bound to the KcsA potassium channel
(0.7 – 0.8 ppm (Lange et al. 2006)). Nevertheless, the resolution is not high enough to
assign single peaks directly.
Figure 1.14 Two dimensional 13C/13C proton driven spin diffusion spectra of RANTES
with lipids (blue) and with CCR5-containing proteoliposomes (red). The carbonyl to Cα/Caliph
cross peaks as well as the Cα/Caliph-region is shown. For some resonances small changes in
the overlaid spectra can be observed. Both spectra were recorded with 11 kHz magic angle
spinning at -40 °C (VT-gas temperature) and a mixing time of 37.5 ms. The total measuring
time was 112 h for the reference and 224 h for the CCR5-containing sample.
The sample containing the CCR5 – RANTES complex was measured under the same
condition as the reference and data were compared. Figure 1.14 shows an overlay
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of the Cα/Caliph and the carbonyl region of the 13C-13C spin diffusion spectra of uni-
formly 13C/15N-labeled RANTES with either lipids or CCR5-proteoliposomes. The ge-
neral appearance of the two spectra is very similar, indicating that the overall structure
of RANTES is not changed upon binding to the receptor. But for some peaks small
changes can be observed, as indicated by dashed circles in Figure 1.14, e.g. threonine
and alanine. Comparison to earlier solid state NMR studies of GPCR ligands shows,
that also for a neurotensin-peptide in the free and receptor bound form, the side chain
resonances did not change significantly upon receptor binding (Luca et al. 2003).
1.3.3 Conclusion and Perspective
The membrane protein CCR5 can be amino acid-type selectively labeled using the insect
cell – baculovirus system, although for some amino acids scrambling is a problem. This
enabled initial studies of the detergent-solubilized receptor using solution NMR spectro-
scopy. Signals of 15N-isoleucine and 15N-tyrosine CCR5 in heteronuclear 1H/15N corre-
lation spectra have been observed for the first time. Although under our experimental
conditions only a fraction of the labeled residues can be seen, this is an important starting
point for further investigations of CCR5 in solution. The reason for the small number
of resonances observed in 2D 1H-15N HSQC spectra could be either due to aggregation
or due to conformational flexibility on an intermediate timescale. The first argument
would explain why also RANTES, when titrated with detergent-solubilized CCR5, disap-
pears. But it is not in agreement with findings from 1D 1H NMR diffusion experiments
and static light scattering data. This contradiction can be the result of higher CCR5
concentrations in the 15N-isoleucine and 15N-tyrosine labeled NMR samples. For further
solution state NMR investigations it will be necessary to establish conditions that stabi-
lize the receptor and prevent its aggregation. One possibility to decrease confomational
flexibility and trap a single conformation of CCR5 can be the addition of antagonists.
We have shown initial results depicting that the small molecule inhibitor maraviroc binds
to CCR5. The CCR5 – maraviroc interaction could be further characterized by 19F NMR
spectroscopy, since maraviroc contains fluorine, and by saturation transfer difference
experiments. With solid state NMR spectroscopy we could show that RANTES binds
to CCR5 if reconstituted into liposomes, but does not unspecifically interact with the
lipids. Thus, solid state NMR experiments of the RANTES/CCR5 complex are possible,
although higher packing densities within the sample rotor are needed to reduce the mea-
surement time. Comparison of first 2D spectra of free and receptor-bound RANTES
reveals small differences.
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1.3.4 Materials and Methods
Protein Expression
RANTES was prepared as described in chapter 1.4 and the CCR5 expression and purifi-
cation is described in chapter 1.2. Unlabeled CCR5 was either produced in shaking flasks
according to this protocol or in a WAVE bioreactor (GE Healthcare). In the WAVE system
5 – 10 l can be cultured at a time. Cells are precultured to a density of 2 × 106 cells/ml in a
shaking flask and transfered to the WAVE bag, where they are kept at densities between 0.5
and 2 × 106 cells/ml by stepwise dilution until the desired volume is reached. Then the cells
are inoculated with a high-titer baculovirus stock at a multiplicity of infection (MOI) of 1.
24 h post infection 10% fresh medium are added. The culture is warmed to 27 °C and shaken
at a rate of 20 (25) rocks per min with an angle of 7° (8°) before (after) induction. Cells are
harvested ≈ 44 h post infection and treated as those grown in shaking flasks.
Selectively labeled protein was always expressed in shaking flasks. Sf9 insect cells were adapted
to and grown in SF4 insect cell medium (BioConcept) prior to expression. Cells were grown to
a density of 4 × 106 cells/ml, centrifuged at 300g for 5 min and resuspended in SF4 medium
deficient of yeast extract and the amino acids that are to be labeled, to reach a density of 2 ×
106 cells/ml. This medium was supplemented with the 15N-labeled amino acid and antibiotics
(25000 U/l penicillin G, 25 mg/l streptomycin). Cells were inoculated with a MOI of 1 using
a high-titer baculovirus stock. Cell culture and harvest as well as membrane preparation and
protein purification were carried out as described in chapter 1.2.
Solution NMR sample preparation
Purified CCR5 was concentrated to ≈ 100 µM using a centrifugal filter device (AmiconUl-
tra4 10kDa MWCO, Millipore). During concentration, the buffer was exchanged to 50 mM
NaH2PO4, 300 mM NaCl, pH 7.5, 5% D2O. The final concentration of the detergent FosCholine-
12 was about 2%. For experiments with maraviroc, the antagonist was added from a 2.5 mM
H2O stock solution. Maraviroc was a gift from the NIH AIDS Research and Reference Reagent
Program. The RANTES sample for titration with CCR5 was prepared as a 50 µM solution
in the same buffer conditions as the receptor (50 mM NaH2PO4, 300 mM NaCl, pH 7.5, 2%
FosCholine-12, 5% D2O).
Solution NMR measurements and data analysis
All solution state NMR experiments were performed on a Bruker DRX 800 spectrometer equip-
ped with a cryogenic triple-resonance, Z-gradient probe. Measurements were performed in
Shigemi-NMR sample tubes. The 1H-15N HSQC spectra were recorded with acquisition times
of 8.8 ms (15N) and 85 ms (1H). 1D 1H spectra were recorded with the 1-1 sequence using
delays of 0.1 ms and 2.1 ms. NMR data were processed with the NMRPipe suite of programs
(Delaglio et al. 1995) and analyzed using the program PIPP (Garrett et al. 1991).
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Solid state NMR sample preparation
For solid state NMR spectroscopy, CCR5 was purified as described but the detergent was
exchanged from FosCholine-12 to Cymal-5 (0.2% in all buffers) during the two affinity chro-
matography steps. These and all following steps were carried out at 4 °C. After purification
CCR5 was concentrated to 1 mg/ml and mixed with lipids (POPC/POPE/DMPA 6:3:1) so-
lubilized in Cymal-5 to yield a LPR of 2. Lipids were added from a 5 mg/ml stock (50 mM
NaH2PO4, 300 mM NaCl, pH 7.5, 6% Cymal-5). The mixture was gently shaken overnight
before RANTES was added in stoichiometric amounts. After 1 h, Cymal-5 was slowly com-
plexed by methyl-β-cyclodextrin (MBCD) over the course of 8 h. The amount of MBCD to
be added was estimated from the amount of Cymal-5 present after the purification and the
detergent added together with the lipid. About 1.2 equivalents MBCD were added to ensure
complete removal of the detergent. Proteoliposomes and the MBCD/detergent-complex were
separated by centrifugation for 30 min at 50000g. The resulting pellet was gently washed with
buffer before it was packed into a 4 mm sample rotor with spacers at the bottom and top.
The rotor finally contained 7.5 mg CCR5, 1.5 mg 13C/15N-RANTES, and 15 mg lipids.
Solid state NMR measurements and data analysis
All solid state NMR experiments were performed on a Bruker DMX 600 NMR spectrometer
equipped with a MAS probe. For sample cooling the air stream was passed through a bath
of liquid nitrogen before entering the probe. 1D 13C NMR spectra were recorded at ≈ 0 °C
(-10 °C VT-gas temperature) either as direct excitation or as cross-polarization experiments.
The MAS rate was 10 kHz. 2D 13C/13C proton driven spin diffusion spectra were recorded
at ≈ -40 °C (VT-gas temperature) and 11 kHz magic angle spinning as data matrices of
192* (indirect) × 768* (direct) complex points with acquisition times of 13 ms and 18 ms,
respectively. The total experimental time was 112 h for the reference sample without CCR5
and 224 h for the CCR5/RANTES complex. NMR data were processed with the NMRPipe
suite of programs (Delaglio et al. 1995) and plotted using the software SPARKY (Goddard &
Kneller n.d.).
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1.4 Rational design of a monomeric RANTES mutant and
characterization of different RANTES variants
Abstract
The chemotactic protein RANTES (Regulated upon Activation, Normal T cell Expres-
sed and Secreted) belongs to the group of β chemokines and is involved in immune cell
activation and migration. To accomplish its function, RANTES binds to CC chemo-
kine receptors on the cell surface. The most prominent of those is CCR5, which is not
only involved in chemokine signaling but also functions as the major human immuno-
deficiency virus 1 (HIV-1) coreceptor. As an endogenous ligand of CCR5, RANTES is
the most potent known natural inhibitor of HIV infections. As many other chemokines,
RANTES exists in a pH- and concentration-dependent monomer – dimer equilibrium.
Previous studies of the interaction between RANTES and CCR5-derived peptides, mi-
micking the receptors N-terminus, have shown that only monomeric RANTES binds
these peptides. Therefore, we engineered a solely monomeric variant of RANTES by
disrupting the intermolecular β-sheet that forms in the wild-type protein. In the known
mutant RANTES-E66S, which is less prone to aggregation than the wild-type, tyrosine
7 or tyrosine 8 was mutated to lysine to hinder dimerization. The resulting double mu-
tants (RANTES-T7K/E66S and RANTES-T8K/E66S) were characterized by NMR pH
titration and serial dilution. The solely monomeric variant RANTES-T7K/E66S shows
anti-HIV activity in a p24-based assay similar to wild-type RANTES.
The monomer – dimer equilibrium of the single mutant RANTES-E66S was characteri-
zed under the influence of temperature and pressure. The dimerization of this mutant is
influenced by enthalpic and entropic effects to a similar extent. At higher pressures, the
equilibrium is shifted to the dimer and in addition a new, putatively unfolded monomeric
state occurs, that has not been observed before.
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1.4.1 Introduction
Chemokines are small bioactive proteins that regulate leukocyte activation and migration
(Sodhi et al. 2004). Within the chemokine superfamily, these proteins can be classified
into four groups according to a conserved cysteine motif in their N-terminus: α (CXC),
β (CC), γ (C), and δ (CX3C). Structurally, all chemokines share a similar topology with
a C-terminal α-helix, at least three β-pleated sheets and an additional β-strand in the
N-terminus. The N-terminus is connected to the rest of the protein by one (γ) or two
(α, β, δ) disulphide bonds.
RANTES (CCL5) is a member of the β chemokine family and binds to the CC-type
chemokine receptors CCR1, CCR3, and CCR5. Together with MIP-1α and MIP-1β it
was identified as a natural suppressor of human immunodeficiency virus (HIV) infections
(Cocchi et al. 1995). These chemokines antagonize binding of the viral envelope gly-
coprotein 120 (gp120) to CCR5, a coreceptor playing a crucial role in HIV-1 entry into
macrophages. Although the in vivo use of full-length, unmodified RANTES as anti-HIV
agent is limited due to its inherent proinflammatory activity (Baggiolini et al. 1994, Schall
& Bacon 1994), functional peptide mapping has shown that RANTES-derived peptides
recognize CCR5 and are capable of blocking HIV-1 in vitro (Nardese et al. 2001). More
recently, it was also possible to engineer highly potent variants of RANTES where the
G-protein-linked signaling activity could be separated from the HIV inhibiting property
(Gaertner et al. 2008). One of these candidates (6P4-RANTES) shows a very similar ac-
tivity than an earlier, N-terminal chemically modified form of RANTES, PSC-RANTES,
that was shown to provide protection against vaginal challenge in macaques (Lederman
et al. 2004).
Despite this success, the interaction between CCR5 and RANTES is still not well under-
stood. This is partially due to the fact that wild-type RANTES tends to aggregate above
pH 4, if concentrations higher than 1 µM are used (Appay et al. 1999). The aggregation
can be prevented by mutation of glutamic acid 66 to serine, while retaining the biological
activity (Czaplewski et al. 1999, Appay et al. 1999). Nevertheless, similar to many other
chemokines (Clark-Lewis et al. 1995) RANTES (wild-type and the E66S-mutant) under-
goes a pH- and concentration-dependent shift in the monomer – dimer equilibrium. The
dissociation constant of RANTES-E66S is 17.6 µM at pH 3.8 and 37 °C (Duma et al.
2007). This means that, under the given conditions, a sample with 52.8 µM RANTES
contains equal amounts of monomer and dimer. At higher, more physiological pH va-
lues, the concentration at which both forms are equally populated is even lower (8.7 µM
at pH 6.0) (Duma et al. 2007). This is especially problematic for NMR investigations
since the influence of sample concentration on the measurement time is quadratic. As a
consequence of dissociation constants in the low-µM range only structures of RANTES
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dimers have been elucidated (figure 1.15a) (Skelton et al. 1995, Hoover et al. 2000).
Although the physiological relevance of monomeric, dimeric, and aggregated RANTES
is not yet clear, interaction studies of RANTES-E66S with a peptide corresponding to
the first 25 amino acids of CCR5 revealed that only monomeric RANTES is able to bind
this peptide (Duma et al. 2007). These studies were complicated by the fact, that only
low RANTES concentrations could be used in order to populate the monomeric species.
For the same reason, the study could only be carried out at pH 3.8. Overall, the low
dissociation constant of the RANTES dimer hinders interaction studies, especially at
physiological pH, which is required for work with the full-length protein CCR5.
In contrast, for the CXC-chemokine SDF-1 it was shown that a constitutively dimeric
mutant binds to a N-terminal fragment of its receptor CXCR4 (Veldkamp et al. 2008).
Here we show the rational design of a monomeric RANTES mutant that is able to bind
CCR5 and prevent HIV-1 infection in vitro. Two mutants, RANTES-T7K/E66S and
RANTES-T8K/E66S, were prepared and characterized by NMR pH titration as well as
serial dilution. The T7K variant is monomeric under all tested conditions and was the-
refore examined for CCR5 binding and in vitro HIV-1 inhibition. The T8K mutant does
not have the desired properties and was therefore not investigated further.
In addition, we studied the influence of temperature and pressure on the RANTES-E66S
monomer – dimer equilibrium. This allows a thermodynamic description of RANTES
dimerization in terms of enthalpy and entropy contribution. In the course of these inves-
tigations a pressure unfolded state of RANTES was observed. This state is not described
here in detail, but since the pressure unfolding of RANTES is reversible (at least under
the conditions tested) it can be used as a system to study pressure unfolding by NMR
spectroscopy.
1.4.2 Results and Discussion
Rational design of a monomeric RANTES mutant
The RANTES dimerization interface was analyzed for the rational design of a monome-
ric mutant in which the dimer formation should be disturbed. RANTES dimers form
via an antiparallel β-sheet between the N-termini of the two polypeptide chains (figure
1.15b). This β-sheet is made up of the H-bonding amino acids threonine 8, proline 9,
and cysteine 10. In addition, the side chain of threonine 7 can interact with the side
chain of glutamine 48 in the second chain. On the other side the β-sheet is flanked by
cysteine 11.
Proline 9 is structurally important for the protein backbone. This should be preserved,
since it is desired to prevent dimer formation while maintaining CCR5 binding. Cysteine
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Figure 1.15 Rational design of a monomeric RANTES mutant. a Structure of the
RANTES dimer (pdb 1eqt) showing the intermolecular β-sheet formed by the residues T8,
P9, and C10. Disulfide bonds formed between C10 / C34 and between C11 / C50 within one
chain are marked in yellow. b Detailed view of the dimer-forming sheet with the amino acid 7
to 11 shown with their side chains. Threonine 7 precedes the β-sheet and points towards the
dimerization interface. A side chain hydrogen bond could be formed between T7 of one chain
and Q48 of the second chain. c Hypothetical view of the T7K mutant of RANTES. Mutation
of threonine 7 to lysine introduces a larger and, moreover, charged residue into the interface.
This should prevent the formation of the intermolecular β-sheet due to steric hindrance and
unfavorable electrostatics. The charged side chain of lysin would face a hydrophobic region
with phenylalanine 28 and valine 40 in case the dimer would be formed.
10 forms a disulfide bond with C34 and cysteine 11 with C50, thus limiting the possibili-
ties for mutations in the interaction site to threonines 7 and 8. In two separate mutants
these residues were changed from threonine to lysine in order to add a longer side chain
which can prevent dimer formation by steric hindrance. In case of the T7K mutation,
the additional charge is expected to further repel the two RANTES monomers because
it would face hydrophobic residues in the dimer (V40 and F28, figure 1.15c). Since the
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Figure 1.16 Selected region of the 1H-15N HSQC spectrum of RANTES-T7K/E66S.
The upper part shows the serial dilution at pH 3.8 while the lower part shows the effect of
increasing pH on a 100µM sample. All measurements were performed in 10 mM potassium
phosphate buffer with 5% D2O at 37 °C.
side chain of threonine 8 points to the interior of the protein, a mutation might affect
the attachment of the N-terminus to the protein core more than it would influence the
dimer interface.
NMR spectroscopic characterization of RANTES-T7K/E66S
The monomer – dimer equilibrium of wild-type RANTES (Skelton et al. 1995) as well as
RANTES-E66S (Duma et al. 2007) has been characterized by one- and two-dimensional
NMR spectroscopy. For both proteins, the monomeric and dimeric forms occur concur-
rently as separate species, indicating that they are in slow exchange (koff = 0.1 s
-1)
(Duma et al. 2007) with dissociation constants of 17.5 µM (wt RANTES) (Skelton
et al. 1995) and 17.6 µM (RANTES-E66S) (Duma et al. 2007) at pH 3.8 and 37 °C.
In order to characterize the monomer – dimer equilibrium of RANTES-T7K/E66S, a
series of two-dimensional 1H-15N HSQC spectra was recorded at concentrations between
12.5 and 200 µM (figure 1.16). In contrast to the wild-type and the single mutant
(RANTES-E66S), the double mutant RANTES-T7K/E66S shows only one set of reso-
nances that does not change upon dilution. The chemical shift values of these peaks
correspond to those of monomeric RANTES-E66S. Since the spectra for the RANTES
single and double mutant are very similar (with respect to the monomeric species), the
previously obtained assignment of RANTES-E66S (Duma et al. 2007) was transfered to
RANTES-T7K/E66S.
The monomer – dimer equilibrium of wild-type RANTES and RANTES-E66S was found
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Figure 1.17 Selected region of the 1H-15N HSQC spectrum of RANTES-T8K/E66S.
The upper row shows the concentration dependence at pH 3.8 while the lower row shows the
effect of pH on a 100µM sample. All measurements were carried out at 37 °C in 10 mM
potassium phosphate buffer.
to strongly depend on pH, with the dimer association strengthened at elevated pH values
(Skelton et al. 1995, Duma et al. 2007). Therefore, also the influence of pH on RANTES-
T7K/E66S was investigated in a series of two-dimensional 1H-15N HSQC spectra. Data
were acquired on a 100 µM sample at pH values between 3.8 and 8.0 (figure 1.16).
Independent of the pH, this RANTES double mutant only occurs as monomer. This
indicates that mutation of threonine 7 to lysine is sufficient to prevent the formation of
an intermolecular β-sheet between the N-termini of two RANTES monomers under all
tested conditions. Furthermore, the quality of spectra recorded at high pH is better for
RANTES-T7K/E66S compared to the single mutant, due to an even lower tendency to
aggregate.
NMR spectroscopic characterization of RANTES-T8K/E66S
Similar to the T7K/E66S-double mutant also RANTES-T8K/E66S was tested for its
dimerization behaviour in a serial dilution from 200 µM down to 12.5 µM as well as in a
pH titration (pH 3.8 to 8.0; figure 1.17). While RANTES-E66S shows almost only signals
from the dimer at 200 µM (pH 3.8, not shown), the double mutant RANTES-T8K/E66S
is predominantly monomeric under these conditions. Thus, dilution has no effect as can
be seen for residue K25. In contrast, during the pH titration, the equilibrium is shifted
towards the dimer with both forms being equally populated at pH 6.0.
For residue A51 the situation is more complicated with at least three species occurring
under certain conditions. At the starting point (200 µM, pH 3.8) three peaks can be
observed, two of which overlap. Upon dilution, the intensity ratio between the peaks does
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Figure 1.18 Inhibition of acute HIV-1 infection by wild-type RANTES (black),
RANTES-E66S (red), and RANTES-T7K/E66S (green). The extracellular HIV-1 p24 anti-
gen release was measured at day 6 post infection relative to an untreated culture as control
(Figure courtesy of Luca Vangelista).
not change significantly between 200 and 25 µM. The peak marked m* is probably due
to a second monomeric species. In contrast, upon increasing the pH, another separated
peak occurs for pH values larger than 5.0 and increases in intensity whereas the other
resonances slowly disappear. The newly appearing signal can be assigned to the dimer
of RANTES. It is not clear why A51 and some other residues show more than just the
monomeric and dimeric form. One possible explanation is that K25 is not very close to
the site of mutation whereas A51 is. The mutation might cause some additional local
effects leading to a third conformation in spatial vicinity to threonine 8. Since RANTES-
T8K/E66S did not show the desired properties of being monomeric over a wide pH and
concentration range, it was not investigated further.
CCR5-binding and in vitro activity test of RANTES-T7K/E66S
The release of the HIV-1 capsid protein p24 after infection of PBM cells with HI virus
is a measure of infection efficiency. If the cells are treated with HIV-infection inhibitors,
their potency can be tested.
Inhibition of acute HIV-1 infection by RANTES-T7K/E66S was tested in a p24-based
assay and compared to wild-type RANTES as well as RANTES-E66S. The respective
assays were carried out by Massimiliano Secci and Luca Vangelista (San Rafaelle Institute,
Milan, Italy). After six days, RANTES-T7K/E66S shows a behavior similar to the wild-
type with an average inhibition of extracellular HIV-1 p24 release (ID50) of 0.46 nM
(3.6 ng/ml) and 0.58 nM (4.6 ng/ml), respectively. In contrast, RANTES-E66S has a
much lower ID50 value (0.04 nM (0.3 ng/ml); see Figure 1.18).
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The fact that RANTES-E66S is ten times more potent than the wild-type might be
explained by its lower tendency to aggregate. Therefore, the concentration of active
protein is higher in case of the single mutant. With respect to the double mutant
RANTES-T7K-E66S one would expect even lower ID50 values if the monomer was the
active form. But since the RANTES N-terminus is crucial for CCR5 binding (Oppermann
2004) the single and double mutant cannot be compared easily. Due to the additional
charge in its N-terminus, binding of RANTES-T7K-E66S to CCR5 might be weakened.
Nevertheless, it seems to be similarly effective as the wild-type protein, making it an
interesting alternative for studies of solely monomeric RANTES with both, CCR5-derived
peptides as well as the full length receptor.
Influence of temperature and pressure on the monomer – dimer equilibrium
of RANTES-E66S
Previously, the monomer – dimer equilibrium of RANTES-E66S was investigated as a
function of pH and protein concentration (Duma et al. 2007). Here, we extend this
study to the influence of temperature and pressure. Since RANTES (wild-type and the
E66S mutant) is most stable at pH 3.8, all measurements were carried out at this pH.
A protein concentration of 50 µM was chosen because earlier studies have shown that
monomer and dimer are equally populated under these conditions (pH 3.8, 37°C) (Duma
et al. 2007). 1H-15N HSQC spectra were measured at three additional temperatures as
well as pressures up to 1500 bar.
Temperature-induced effects Figure 1.19a shows the temperature-dependent beha-
vior for residues K25 and A51. For lysine 25 two peaks occur at 17 °C (blue). Due to the
available assignment of both, RANTES monomer and dimer, the peaks can be unambi-
guously attributed to the monomeric and dimeric form of the protein. The stronger peak
of K25 corresponds to the dimer, the very weak signal arises from monomeric RANTES.
With increasing temperature, this peak increases in intensity and, concurrently, the other
peak decreases. The same can be observed for the resonances of alanine 51.
In earlier studies, the relative dimer intensity, defined as I r = I d/(I m+I d), was used to
describe the monomer – dimer equilibrium (Duma et al. 2007). The temperature de-
pendence of this parameter for K25 and A51 is plotted above the spectrum. At 37 °C
and 50 µM concentration, the values fit well to those obtained in earlier studies.
Kd can be calculated for the average of five amino acids (isoleucine 24, lysine 25, glycine
32, valine 49, and alanine 51) according to the equation Kd = [m]
2/[d], where [m] and
[d] are the monomer and dimer concentrations. With increasing temperature also the
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Figure 1.19 a Overlay of a selected region of the 1H-15N HSQC spectra of RANTES-
E66S at 17 (red), 27 (yellow), 37 (green), and 42 °C (blue) showing the resonances of lysine 25
and alanine 51. With increasing temperature, the amount of monomer increases. On top, for
each amino acid the relative dimer intensities are shown as a function of temperature. b van’t
Hoff plot of the temperature-dependence of the RANTES dissociation constant. Kd values
obtained as the average of five amino acids are plotted as the natural logarithm against 1/T.
The slope and intercept of this graph allow calculation of ∆H and ∆S (see text).
dissociation constant rises (e.g. Kd(17°C) = 2.7 µM; Kd(42°C) = 42.2 µM), which is
characteristic for an endothermic reaction. This is in accordance with isothermal titra-
tion measurements (see chapter 1.2), where the RANTES dissociation was shown to
consume energy. Using the van’t Hoff equation also the dissociation enthalpy and the
dissociation entropy can be calculated (figure 1.19b). For this calculation it is assumed
that ∆Hd and ∆Sd do not change with temperature. However, the relation between
lnKd and 1/T is not linear for larger temperature ranges. Thus, the calculated values
are not as accurate as calorimetrically measured values (Atkins 2000).
The enthalpy for the RANTES dissociation amounts to 82.0 kJ/mol (19.6 kcal/mol)
and the dissociation entropy is 0.290 kJ/(mol K) (corresponding to 90.0 kJ/mol (21.5
kcal/mol) at 37 °C). This is in the order of magnitude found for other protein – pro-
tein interactions, e.g. (McDonald et al. 2008). The dissociation free energy at 37 °C
∆Gd(37) = -8.01 kJ/mol, which slightly favors dimer dissociation, is influenced by en-
thalpy and entropy to a similar extent.
The enthalpy (∆Hd(37) = 82.0 kJ/mol) favors dimerization of RANTES. Using a value
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Figure 1.20 Selected region of the 1H-15N HSQC spectrum of RANTES-E66S at 37 °C
(top), 27 °C (middle), and 17 °C (bottom). Each plot shows the overlay of spectra recorded
at 1, 750, and 1500 bar. For clarity, not all peaks are assigned.
of 10 – 20 kJ/mol per bond (Rose et al. 2006), the three backbone hydrogen bonds
forming the intermolecular β-sheet in the dimer would account for about 40% – 70%
of this enthalpy. The positive dissociation entropy suggests, that the system must gain
substantial disorder upon dissociation. Most of this effect can probably be attributed to
the presence of two monomers instead of one dimer.
Pressure-induced effects The effect of pressure on the monomer – dimer equilibrium
was investigated in the range from atmospheric pressure up to 1500 bar. Figure 1.20
(top) shows a selected region of the 1H-15N HSQC spectrum of RANTES-E66S at 1, 750,
and 1500 bar at 37 °C. In addition to the pressure-induced changes in chemical shifts
the resonances corresponding to the monomer are significantly weakened with increasing
pressure, while the dimer intensities are only slightly altered. Thus, the monomer is
converted into the dimer only to a small extend. Instead, an additional set of peaks
appears at 750 bar and increases in intensity at higher pressures. Due to the narrow
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distribution range of the amide proton chemical shifts for these resonances, it is very
likely that they correspond to an unfolded state of RANTES.
Since the solely monomeric mutant RANTES-T7K/E66S shows a very similar pressure
dependent behavior with respect to unfolding, this RANTES variant was used to assign
some of the newly appearing peaks from two dimensional 15N exchange spectra. The
assignment in this case is easier, because no dimer peaks occur in the spectra and thus
the overlap is reduced. The obtained assignment could be easily transfered to the 1H-15N
HSQC of RANTES-E66S. Thus, the intensities of monomer, dimer, and the unfolded
state can be compared for five residues.
Figure 1.21 shows the relative peak intensities of all three species observed for iso-
leucine 24, lysine 25, glycine 32, valine 49, alanine 51, and for the average of those
five. At 37 °C, on average the dimer accounts for 64% at 1 bar and slightly increases
relative to the other species to 69% at 1500 bar. Concurrently, the monomer population
decreases from 36% at 1 bar to 12% at 1500 bar. At the same time the unfolded species
rises from 0% at 1 bar to 18% at 1500 bar. These data illustrate that the unfolded state
builds up on the expence of monomeric RANTES according to the following equilibria:
D
Kd⇀↽M
Ku⇀↽ U (1.1)
where D, M , and U are the dimer, monomer, and unfolded state of RANTES and Kd
and Ku are the equilibrium constants for the respective transitions. The dissociation
constant under the given conditions at 1 bar is Kd = 20.2 µM and decreases to 2.2 µM
at 1500 bar. The volume change associated with RANTES dissociation differs between 1
and 1500 bar by ∆V0 = 63 A˚
3. In contrast, the equilibrium constant between monomer
and the unfolded state rises from Ku = 0.4 at 750 bar to 1.5 at 1500 bar. It can be
concluded that the dimer is more compact than the monomer, since it is favored at
higher pressures and it seems to be stabilized against pressure denaturation. This is
supported by the fact that at lower temperature where there is less monomer present
also the unfolded state is less populated (see figure 1.20), e.g. at 17 °C resonances of
the unfolded species are barely visible even at 1500 bar. The same is observed for higher
concentrated samples in which the dimer is predominant. In contrast, the monomeric
mutant RANTES-T7K/E66S changes from the completely monomeric form at 1 bar to
a distribution of 40% monomer and 60% unfolded protein at 1500 bar.
For this mutant, a rate constant for the exchange between the monomer and the unfolded
state was estimated from exchange spectra (not shown) to be approximately 2.5 Hz.
The pressure-induced unfolding observed for both, RANTES-T7K/E66S and RANTES-
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Figure 1.21 Distribution of the monomer (red), dimer (blue), and unfolded state (green)
peak intensities at three pressures for five residues of 50 µM RANTES-E66S (pH 3.8, 37 °C)
and their average. At atmospheric pressure only the monomer and dimer are populated. With
increasing pressure, the dimer peak intensity changes only marginally, whereas the unfolded
state builds up on the expense of monomeric RANTES.
E66S, is completely reversible.
1.4.3 Conclusion and Perspective
It was shown that it is possible to obtain monomeric RANTES in a functional form (with
respect to in vitro HIV inhibition). Obviously the mutation in the ligands N-terminus
does not affect the anti-HIV activity very much. RANTES-T7K/E66S is the mutant
of choice to study the interaction of a solely monomeric chemokine with both, CCR5-
derived peptides as well as the full-length receptor. RANTES-T8K/E66S is in between
the single mutant (RANTES-E66S) and the T7K-variant with respect to the monomer
– dimer distribution. Since it forms a significant amount of dimer and the mutation
of threonine 8 not only affects the dimerization interface but also the protein core, it
does not properly resemble the wild-type protein. Thus, it is not well suited for further
studies.
In addition, the monomer – dimer equilibrium of RANTES-E66S was investigated as
a function of temperature and pressure. Measurements at different temperatures were
used to calculate the enthalpy and entropy for the dissociation of RANTES dimer to
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monomers.
Increasing pressure shifts the monomer – dimer equilibrium of RANTES-E66S to the
dimeric form. This is in line with other studies, where it was shown that high pressures
have a similar effect than low temperatures (see chapter 2.4). More interestingly, pres-
sure induces an unfolded state, that is reversibly formed on the expense of monomeric
RANTES. In contrast, the RANTES dimer seems to be stable against pressure unfolding.
It would be interesting to compare this finding with other ways of unfolding. If the dimer
is generally more stable than the monomer this might have implications on the view of
chemokine dimers, since their role in vivo is very controversial.
Formation of the unfolded state is reversible under all conditions tested and occurs with
a rate constant of approximately 2.5 Hz at 37 °C and 1500 bar. Therefore, the mono-
meric mutant of RANTES, RANTES-T7K/E66S, could be used to further characterize
the pressure unfolded state and investigate the folding / unfolding mechanism.
1.4.4 Materials and Methods
Expression and purification
Three RANTES constructs encoding the single (RANTES-E66S) as well as the double
mutants (RANTES-T7K/E66S, RANTES-T7K/E66S) were expressed as C-terminal fu-
sions to the protein G domain B1 separated by an 11 amino acid linker (GB1-LVPRGS-
DDDDK-RANTES). These mutants differ from wild-type RANTES by one or two point
mutations. All three have glutamic acid 66 exchanged to serine and in the double mu-
tants additionally either threonine 7 or threonine 8 is replaced with lysine. Otherwise
they consist of the amino acid sequence of mature human RANTES (S1 – S68). All
constructs were expressed and purified as described (Duma et al. 2007). Briefly, proteins
were expressed in E. coli BL21(DE21) and cells harvested by centrifugation. Cell rupture
was performed in a French press after resuspension in 50 mM sodium citrate, pH 3.9.
The resulting lysate was centrifuged for 20 min at 9000g and the pellet dissolved in 7 M
urea, 20 mM sodium citrate, pH 3.9. After ultracentrifugation for 30 min at 100,000g the
supernatant was applied to an equilibrated SP-sepharose column. A salt gradient (0.05
- 2 M sodium chloride) leads to elution of the protein and RANTES containing fractions
were dialyzed against 50 mM Tris-HCl, pH 7.5, 20 mM NaCl for subsequent cleavage
with enterokinase (37 °C, 16 h) to remove the fusion protein. After cleavage, the protein
was further purified on an equilibrated SP-sepharose column (50 mM Tris-HCl, pH 7.5,
2 mM EDTA). After elution and dialyzation against 5 mM potassium phosphate, pH 3.8,
the protein was concentrated by ultrafiltration (VivaSpin 20, MWCO 3 kDa). Masses
for all three proteins were confirmed by ESI-MS.
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NMR sample preparation
For the pH titrations and serial dilutions 15N-labeled samples containing 50 mM potas-
sium phosphate and 5% D2O were used. Starting from a concentration of 200 µM,
samples were diluted in the same buffer (pH 3.8) to concentrations of 100 µM, 50 µM,
25 µM, and 12.5 µM. pH titrations were carried out on 100 µM samples. The pH was
adjusted to 5.0, 6.0, 7.0, and 8.0 with NaOH.
Pressure and temperature-dependent measurements were carried out on 50 µM samples
(50 mM potassium phosphate, 5% D2O, pH 3.8)
NMR spectroscopy and data processing
All NMR experiments were performed on a Bruker DRX 800 spectrometer, equipped with
a triple-resonance, Z-gradient cryo-probe. The measuring temperature was 37 °C, unless
otherwise stated. Measurements under high pressure were performed in a commercial
high-pressure NMR-cell (tube1, see chapter 2.4) connected to a pressure generator. The
1H-15N HSQC spectra were recorded with acquisition times of 50 ms and 85 ms for 15N
and 1H, respectively. NMR data were processed with the NMRPipe suite of programs
(Delaglio et al. 1995) and analyzed using the program PIPP (Garrett et al. 1991).
Calculation of thermodynamic parameters
Kd values for different temperatures were calculated from the average monomer and di-
mer intensities of five well separated peaks according to Kd = [m]
2/[d]. The temperature-
dependent Kd values in turn were used in the van’t Hoff plot and fitted to the equation
lnKd =
−∆H
RT
+
∆S
R
(1.2)
Equation 1.2 was used to calculate ∆H from the slope and ∆S from the intercept of
the fit lnKd = −9.865/T + 34.935.
The volume change was calculated according to
∆V0 =
RT
∆p
∗ ln Kd(1bar)
Kd(1500bar)
(1.3)
Acute HIV-1 infection assay
The inhibition of acute HIV-1 infection by several RANTES variants was assayed in in
vitro-activated human peripheral blood mononuclear cells (PBMC) (Nardese et al. 2001).
The cells were infected with cell-free HIV-1BaL in the presence and absence of RANTES/
RANTES mutants at different concentrations. Extracellular HIV-1 p24 antigen release
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was measured at day 4 and day 6 post infection. The inhibitory effect was measured
relative to a control (untreated cells).
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2 Hydrogen bonds in proteins and nucleic acids
2.1 Introduction
Proteins need sufficient conformational flexibility to accomplish their function yet they
also need to be stable. A complete description of proteins requires a multidimensio-
nal energy landscape that defines the relative probabilities of the conformational states
(thermodynamics) and the energy barriers between them (kinetics) (Henzler-Wildman &
Kern 2007). Two parameters necessary for the thermodynamic description are tempe-
rature and pressure. Although temperature is the more extensively studied parameter in
biological systems, there is no doubt that pressure is equally important as a thermody-
namic variable (Smeller 2002). The pressure/temperature – phase diagram for proteins
is ellipsoidal as shown in Figure 2.1. Within certain boundaries for temperature and
pressure, a given protein can exist in its native state whereas high and low temperature
as well as high pressure lead to denaturation.
Figure 2.1 Schematic illustration of the elliptic phase diagram of proteins. a Three-
dimensional representation of the influence of temperature and pressure on the free energy
for the denaturation of a protein. Change of temperature can induce either heat or cold
denaturation whereas an increase in pressure results in pressure denaturation of the protein.
b Two-dimensional projection of the temperature and pressure boundaries within which the
protein is native. c Pressure/temperature – phase diagram of a protein. Figure according to
(Smeller 2002).
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2.1.1 High-pressure investigations of proteins
The effect of pressure on a physicochemical process at equilibrium is governed by its
volume change according to (
δ lnK
δp
)
T
= −∆V
RT
(2.1)
where K is the equilibrium constant of the process, δp is the pressure change at constant
temperature, ∆V is the change in volume associated with the process, T is the absolute
temperature, and R is the gas constant (Atkins 2000). The major factors contributing
to volume changes are the electrostriction of charged and polar groups, the minimiza-
tion of packing defects as well as the solvation of hydrophobic moieties (Frye & Royer
1998). Therefore, if a protein exists as different conformers, at elevated pressure those
conformations with lower partial molar volume are favored, making them accessible for
investigations.
Since pressure-denatured and pressure-assisted cold-denatured states have been shown
to contain substantial residual secondary structure and furthermore, application of pres-
sure allows the stabilization of intermediate conformations (Jonas et al. 1998), pressure
has been used to study folding intermediates and denatured states of proteins (Kamatari
et al. 2004). Such states can be characterized in atomic detail in solution using NMR
spectroscopy.
2.1.2 High-pressure NMR spectroscopy of proteins
There are two general approaches to obtain NMR spectra under high pressures. One uti-
lizes a special high-pressure probe (Jonas 2002), which allows pressures of up to 9000 bar.
The other approach uses a high-pressure sample cell and a conventional probe. With
this it is possible to obtain high resolution, but the main limitation until recently was
the low sample volume of only ≈ 20 µl. Nevertheless, many proteins have been studied
with this method at pressures between 1 and 4000 bar as reviewed by Kamatari et al.
(Kamatari et al. 2004). There are several NMR parameters that can be monitored in
dependence of pressure.
A very sensitive probe of conformational changes is the chemical shift since it is highly
dependent on the chemical environment and changes therein. 1H and 15N chemical shift
changes have often been used to map the effect of pressure on protein structures (Inoue
et al. 2000, Kamatari et al. 2001, Kuwata et al. 2002).
Another parameter to characterize changes in the conformational states of proteins is
15N spin relaxation. 15N relaxation rates (R1 and R2) have been shown to be very si-
milar at 30 and 2000 bar for BPTI (Sareth et al. 2000). Similarly, for ubiquitin the R1
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and {1H}-15N-NOE values do not differ significantly between 30 and 3000 bar, but R2
showed changes for some residues at 3000 bar (Kitahara et al. 2005). These data have
been interpreted in the sense that high frequency motions of individual NH bond vectors
are not altered by pressure (Li & Akasaka 2006), whereas the variations in R2 were
attributed to µs- to ns-timescale exchange between different conformations (Kitahara
et al. 2006).
Hydrogen/deuterium exchange experiments were also frequently used to characterize the
transition from the native to the pressure denatured state. 1D 1H NMR of RNase in D2O
was, for example, used to monitor residual structure in the pressure denatured protein
(5000 bar) (Zhang et al. 1995).
2.1.3 Hydrogen bond scalar couplings as monitors of protein conformation
N-H → O=C hydrogen bonds defining the secondary structure of proteins are sensitive
to conformational changes. Since H-bonding has large effects on NMR observables such
as chemical shift and coupling constants of the nuclei involved, these (indirect) parame-
ters have been used to characterize changes in the hydrogen bond network of proteins.
Direct observation of hydrogen bonds in proteins and other biomolecules (see chapter
2.2 and 2.3) is possible due to the discovery of hydrogen bond scalar couplings (Dingley
& Grzesiek 1998, Pervushin et al. 1998, Cordier et al. 1999).
The effect of pressure on the 3hJNC’ coupling constants was investigated for the immu-
noglobulin binding domain of streptococcal protein G (GB1) at 30 and 2000 bar (Li
et al. 2000). Due to the small sample volume (20 µl) and the generally small 3hJNC’
coupling constants in proteins (-0.2 – -0.9 Hz) only eleven out of 34 hydrogen bonds
could be detected. To be able to observe those coupling constants (|3hJNC’| > 0.5 Hz)
measurement times of more than 5.5 days per experiment were required (Li et al. 2000).
These long experimental times prevented the investigation of more pressure points, but
from the differences between 30 and 2000 bar already some conclusions could be drawn.
An interesting observation in this study was that pressure induces not only increased
but for some residues also decreased 3hJNC’ couplings. Decreased coupling constants
correspond to a larger H – O distance in the hydrogen bond or a change in the angles
away from 180 °. Thus pressure does not compress all parts of protein G but mainly the
loop and peripheral regions. Nevertheless, due to the small number of hydrogen bond
scalar couplings observed and the lack of more pressure points, a thorough description
of the changes occurring in the hydrogen bond network with increasing pressure was not
possible.
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New set-up for high-pressure NMR measurements
A main problem in high-pressure NMR investigations so far has been the extremely low
sample volume in tubes that allowed high pressures to be applied and high resolution to
be obtained in the spectra. Therefore, much effort has been made in designing a device
that could satisfy both needs.
Now a commercially available high-pressure NMR cell (Daedalus Innovations LLC) made
of ceramics can be used for pressures up to 2500 bar in standard NMR probes. The inner
diameter of the tube is 3 mm, allowing an active sample volume of 120 µl. This is six
times more than was feasible before and thus reduces the measurement time accordingly.
Organization of the chapter
In the following two chapters, the methods are introduced that are used to measure
hydrogen bond scalar couplings in nucleic acids (chapter 2.2) and proteins (chapter
2.3). In chapter 2.4 the influence of pressure on the 3hJNC’ coupling constants is des-
cribed for the protein ubiquitin. The obtained results are compared to temperature-
and pressure-dependent measurements of the 2hJNN couplings observed in a small RNA
hairpin (chapter 2.5). Finally, the concerted effect of methanol and pressure on ubiquitin
is described (chapter 2.6).
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A nuclear magnetic resonance (NMR) experiment is described for the direct detection of N–H?N hydrogen bonds (H-bonds) in 15N
isotope-labeled biomolecules. This quantitative HNN-COSY (correlation spectroscopy) experiment detects and quantifies electron-
mediated scalar couplings across the H-bond (H-bond scalar couplings), which connect magnetically active 15N nuclei of the H-bond
donor and acceptor. Detectable H-bonds comprise the imino H-bonds in canonical Watson–Crick base pairs, many H-bonds in unusual
nucleic acid base pairs and H-bonds between protein backbone or side-chain N–H donor and N acceptor moieties. Unlike other NMR
observables, which provide only indirect evidence of the presence of H-bonds, the H-bond scalar couplings identify all partners of
the H-bond, the donor, the donor proton and the acceptor in a single experiment. The size of the scalar couplings can be related to
H-bond geometries and as a time average to H-bond dynamics. The time required to detect the H-bonds is typically less than 1 d at
millimolar concentrations for samples of molecular weightrE25 kDa. A 15N/13C-labeled potato spindle tuber viroid T1 RNA domain
is used as an example to illustrate this procedure.
INTRODUCTION
H-bonds are key features of biomacromolecules as these weak,
directional, attractive forces not only provide stabilizing rigidity to
secondary and tertiary structures, but also play key roles in almost all
enzymatic and chemical reactions1. Although X-ray and neutron
diffraction methods have made invaluable contributions to the
present knowledge of biomolecular H-bonds in terms of the exact
positions of donor and acceptor groups, only for the few neutron
diffraction and ultra-high-resolution X-ray structures of biomacro-
molecules have the positions of hydrogen atoms been determined
within the H-bond without the use of fixed standard geometries2–4.
Thus, there is a need for techniques that yield additional quantitative
information on the hydrogen atom and the electronic structure
within individual H-bonds of biomacromolecules.
Currently, only infrared (IR) and NMR spectroscopy are able to
provide such quantitative information on biomolecules. Whereas
IR spectroscopy has severe limitations since single H-bonds can
only be resolved via individual isotope-labeling schemes5, NMR
spectroscopy can usually resolve many individual H-bonds in
uniformly isotope-labeled proteins or nucleic acids in one
single experiment. A large number of NMR observables are sensitive
reporters of H-bonding. These comprise hydrogen exchange rates,
fractionation factors, chemical shifts, and quadrupolar and various
scalar coupling constants6. The most direct of these parameters are
H-bond scalar couplings (HBCs), which connect magnetically
active nuclei on both sides of the hydrogen bridge. HBCs can be
observed across the H-bonds of regular secondary structure
elements in nucleic acids7,8 and proteins9,10, as well as in small
chemical compounds11–14. Due to the requirement that the HBCs
connect NMR observable nuclei, their observation in biomolecules
has been limited to HBCs between 15N, 13C, 1H or 31P nuclei, but
excludes oxygen, for which no suitable isotope exists.
Since the initial observation of HBCs for NH?N H-bonds
in Watson–Crick base pairs of nucleic acids (Fig. 1) and backbone
NH?O¼C H-bonds in proteins (see ref. 15), there have been
numerous reports detailing the measurement of HBCs for other
H-bond moieties in biomacromolecules (for reviews, see refs. 16–19).
Besides the experimental observations of HBCs, a number of
theoretical quantum chemical studies have improved our under-
standing of the nature of HBCs (reviewed by Grzesiek et al.19).
Scalar couplings via H-bonds are caused by the same nucleus-
electron - nucleus magnetization transfer that also underlies
conventional couplings across covalent bonds. Consequently, the
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Figure 1 | Watson–Crick RNA base pairs indicating the N–H?N H-bond that
can be detected by h2JNN correlations. Similar detectable NH?N H-bonds
are found in many other base pair types.
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same experiments for the detection, quantification or magnetiza-
tion transfer are applicable to HBCs.
HBCs can be used to identify donor and acceptor groups in
individual H-bonds from COSY-type experiments. In favorable
cases, complete H-bond networks in biomacromolecules can be
established, thereby providing valuable data for structure determi-
nation. As the HBCs are caused by the overlap of H-bond donor
and acceptor electronic wave functions, their magnitude is propor-
tional to the square of the overlap integral20. Thus, HBCs provide a
very sensitive measure of H-bond geometries, that is, they depend
exponentially on donor–acceptor distances21 as well as on certain
H-bond angles19. Such applications of HBCs have been reviewed
extensively in ref. 19.
The strongest detectable HBCs in nucleic acids are two-bond
15N15N couplings (h2JNN), which connect a 15N H-bond donor
nucleus to a 15N acceptor nucleus across NH?N H-bonds (the
symbol hnJAB is used for HBCs between nuclei A and B to emphasize
that one of the n bonds connecting the two nuclei in the chemical
structure is actually an H-bond) (Fig. 1). The magnitude of the h2JNN
couplings is primarily influenced by H-bond geometry rather than
base pair type with sizes ranging between 5 and 11 Hz. The HNN-
COSY experiment is the simplest two-dimensional (2D) technique by
which h2JNN couplings between
15N imino donor and 15N aromatic
acceptor nuclei can be detected and quantified in nucleic acid base
pairs. At the same time, the HNN-COSY yields the resonance
frequencies of the 15N donor and acceptor nuclei as well as of the
H-bonding proton, that is, of all partners within the H-bond. With
suitable modifications, the technique is also applicable to other
NH?N H-bonds, for example, to H-bonds involving amino
NH donors22,23 or to H-bonds between histidine imidazole groups24.
The principal application of HNN-COSY in nucleic acids is the
unequivocal establishment of H-bonding. This applies not only to
NH?N H-bonds in canonical Watson–Crick base pairs7,8, but
also to unusual base pairs that involve U/T-15N3 or G-15N1 to 15N7
nuclei, for example, in GA mismatch, Hoogsteen and reverse
Hoogsteen base pairs19,25. In combination with residual dipolar
couplings, this presents an approach for the fast assignment and
structure determination of nucleic acids26. Due to the strong
dependence on H-bond geometries, the size of the coupling
constants provides a sensitive measure for variations in H-bond
lengths and angles. Such variations can usually be detected as a
result of fraying at the ends of stable structure elements, deviations
from straight H-bond geometries or in response to changes in
temperature or other physicochemical conditions19,22,27–29.
As for any solution NMR experiment on biomolecules, the
detection of H-bonds is limited by sensitivity and molecular
weight. However, as the size of h2JNN is relatively large, these
limitations are not very severe, and the HNN-COSY usually yields
reasonable results when other 15N-edited experiments are applic-
able. Thus, detection of NH?N H-bonds can typically be
achieved in less than 1 d for samples of millimolar concentrations
and molecular weightsrE25 kDa.
Organization of the protocol
The following protocol gives a step-by-step setup and evaluation
procedure for the quantitative HNN-COSY experiment to detect
and quantify h2JNN couplings in NH?N H-bonds between 15N
imino donor and 15N aromatic acceptor nuclei. Example results are
included from a 250 ml sample of 1.5 mM 15N/13C-labeled potato
spindle tuber viroid (PSTVd) T1 RNA domain (mutant U18C/
A344G), which consists of 69 nucleotides and contains three helical
stems30. The data were acquired at 298 K on a Bruker DMX
600 MHz spectrometer equipped with a triple resonance TXI
room temperature probe using the xwinnmr 3.5 acquisition soft-
ware. Data processing and analysis were performed with the
NMRPipe suite of programs31. This software and further informa-
tion is available at http://spin.niddk.nih.gov/NMRPipe.
Experimental design
Figure 2 depicts the pulse scheme of the quantitative HNN-COSY
experiment7,8 used for the detection of h2JNN couplings mentioned
above. The scheme provides both the chemical shifts of the
H-bonding nuclei and the magnitude of the h2JNN coupling in a
single 2D experiment. During the first INEPT (insensitive nuclei
enhanced by polarization transfer) period (time points a to b),
magnetization is transferred from the proton within the H-bond
(H) via the covalent 1JNH coupling to the donor
15N nucleus (Nd).
During the 15N15N COSY delay period (time points b to c, total
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Figure 2 | Basic HNN-COSY pulse sequence. The
color shading marks the boundaries of the various
magnetization-transfer steps and the 15N chemical
shift evolution period as presented in the Bruker
pulse sequence code (Supplementary Note 1).
Narrow and wide pulses correspond to flip angles
of 901 and 1801, respectively. Carrier positions are
1H2O (
1H) and 185 ppm (15N). All regular 1H and
15N pulses are applied at radio frequency field
strengths of 31 and 6.3 kHz, respectively. The
radio frequency field strengths are specified for a
600 MHz spectrometer. For different magnetic field
strength (X MHz) spectrometers, the radio
frequency field strengths should be multiplied by
X/600. Low-power (water flip-back) 901 1H pulses
(illustrated as smaller narrow rectangles) are applied at a field strength of 200 Hz. For 13C-labeled samples, a high-power 13C 1801 pulse (25 kHz, shaded gray) is
applied in the middle of the t1 evolution period (see text). Delays: d ¼ 2.25 ms; D ¼ 15 ms (delay period dependent on the length of 15N–15N COSY transfer
employed); e ¼ 0.6 ms. Unless indicated, the pulses are applied along the x axis. Phase cycling: f1 ¼ R1 with R1 ¼ x, y, x, y; f2 ¼ R2, R2 with R2 ¼
(y, x, y, x); f3 ¼ R2, R2, R2, R2; acq. ¼ x, y, x, y. Quadrature detection in the t1 dimension was achieved by simultaneously incrementing f1 and f2
in the States-TPPI manner. Gradients are sine-bell shaped, with an absolute amplitude of 30 G cm1 at their center and durations (directions) of G1,2,3,4,5,6,7 ¼
2.5 (+z), 2.1 (z), 2 (+y), 2 (y), 0.2 (+x), 0.4 (+z) and 0.404 ms (y).
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length 2D), part of this magnetization is transferred via the h2JNN
coupling to the 15N acceptor nucleus (Na), whereas another part
remains on the donor 15N nucleus. Following this COSYdelay, both
donor and acceptor 15N chemical shift frequencies are encoded
during the t1 period (time points d and e). Note that, during the t1
evolution, the small homonuclear 15N–15N couplings are active,
but are usually not resolved. The magnetization is then transferred
back to the donor 15N nucleus during the second 15N15N COSY
interval (time points e to f, total length 2D). Finally (time points f
to g), a transverse relaxation-optimized spectroscopy (TROSY)
detection scheme converts the slowly relaxing component of the
(1H)-15Nd doublet into the slowly relaxing component of the
(15Nd)-
1H doublet, which is detected in the receiver during the t2 period.
The resulting spectrum (Fig. 3) shows ‘cross-peaks’ at frequency
positions (oNa, oH+p1JNH) and ‘diagonal peaks’ at positions
(oNdp1JNH, oH+p1JNH). The intensities of the cross- and diagonal
peaks are proportional to sin2(2ph2JNND) and cos2(2ph2JNND),
respectively. Hence, the intensity ratio presents a simple measure
for the size of the h2JNN coupling. The sign of the coupling cannot
be determined from the HNN-COSY. However, in agreement with
theory, the sign of the h2JNN coupling has been determined as
positive8,32 by an E.COSY experiment33.
MATERIALS
REAGENTS
.Nucleic acid samples must be uniformly 15N-enriched. 13C/15N-enriched
samples can also be used. In this case, additional 13C decoupling should be
applied. Isotope-labeled nucleic acids for NMR studies are prepared using
previously described strategies34–38.
.Samples should be prepared in a buffered solution containing 5% (vol/vol)
deuterium oxide (D2O).
.For good sensitivity, sample concentrations should be Z0.5 mM.
.Necessary sample volumes should range between 250 and 500 ml depending
on the NMR tube type: conventional 5 mm NMR tubes require 400–500 ml
for good shimming; Shigemi NMR tubes require only 250 ml or less. Note
that, the achieved overall sensitivity will depend on the total sample amount
within the active volume of the probe coil.
EQUIPMENT
.A high-resolution NMR instrument (Z500 MHz 1H frequency) with the
following characteristics:
. 15N-enriched nucleic acid samples: two radio frequency channels
(1H, 15N) and double-resonance (1H/15N) probe head optimized for 1H
detection. For 15N/13C-enriched nucleic acid samples, an additional 13C
radio frequency channel and a triple-resonance (1H/13C/15N) probe head
should be available.
. The NMR spectrometer should be equipped with pulsed-field gradients;
otherwise, water suppression can be achieved by other techniques39.
. As sensitivity is a limiting factor, cryogenic probes are beneficial but not
absolutely necessary.
PROCEDURE
Preparation
1| Calibrate 15N (and possibly 13C) power levels on a suitable calibration sample according to Box 1.
2| Set the sample temperature of the NMR spectrometer to a suitable value, which is a compromise between sample stability
and spectral quality. Place your sample in the magnet.
3| Calibrate 1H power levels on your sample according to the different pulse lengths given in Box 1.
4| If you have no idea from previous experiments, determine the imino proton 1HN T2 relaxation time from a suitable spin-echo
experiment, for example, using the 1–1 echo sequence40. This step is not absolutely necessary, but it takes only a few minutes and is a
very good way to characterize the quality of your sample. For the 69-nucleotide PSTVd RNA used in the example, the 1HN T2 is about 12 ms
at 298 K. Note that, in the absence of chemical exchange and internal motions, 1/T2 is proportional to MWT Z/T, where MWT, Z and
T are molecular weight, viscosity of the solvent and absolute temperature of the sample, respectively. Under these conditions also,
the 15N T2 values are proportional to the
1HN T2 (slow motion limit). In the example, the T2 values of the imino donor
15N were about 50 ms.
Parameter setup
5| Load the pulse program for the 2D quantitative JNN HNN-COSY experiment (Fig. 2 and Supplementary Note 1 online).
6| Set pulse lengths and power levels as determined in Steps 1 and 3 (see Box 1).
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Figure 3 | 2D HNN-COSY spectrum recorded on the PSTVd T1 RNA
domain, mutant U18C/A344G (see ref. 30). The data matrix consisted of
100*(15N)  768*(1H) data points (where n* refers to complex points) with
acquisition times of 16.5 (15N) and 64 ms (1H). Total experimental time was
12.6 h. Positive contours (blue) depict the diagonal resonances for the G and
U imino groups. Negative contours (red) correspond to cross-peaks resulting
from scalar 15N–15N magnetization transfer between the donor imino 15N
nucleus and the acceptor 15N nucleus on the opposing base in Watson–Crick
base pairs. For many U imino 15N3 nuclei, additional small cross-peaks are
observed due to intramolecular 2JNN transfer to the U
15N1 nuclei. Resonances
are labeled with assignment information. The inset illustrates the definition
of the scalar h2JNN correlation via the H-bond.
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7| Adjust the radio frequency carrier positions according to Box 1. 1H: set the carrier frequency exactly at the water position
(at this carrier position, a simple 1H pulse-acquire experiment should yield a non-oscillating water free induction decay); 15N: set the
carrier frequency to 185 ppm. This is the midpoint between the chemical shift of the donor imino nuclei (155 ± 10 ppm) and the
chemical shift of the acceptor nitrogen nuclei (210 ± 15 ppm). This ensures maximum excitation of both donor and acceptor 15N nuclei;
13C (for 13C-labeled samples only): set the carrier frequency to 153 ppm. This is the center frequency of the carbon nuclei (i.e., C2 and C6 in
purine bases, C2 and C4 in pyrimidine bases), which are directly bonded to the nitrogen donor and acceptor nuclei. A 13C 1801 decoupling
pulse (shaded gray in Fig. 2) is applied at this frequency in the center of the t1 period to ensure decoupling of these nuclei.
? TROUBLESHOOTING
8| Set 1H and 15N sweep widths and acquisition times according to Box 1.
2D test spectra
9| Record a high sensitivity test spectrum with a short NN transfer time (test spectrum 1). Set the length of the NN transfer
period (2D) close to the smallest possible value, for example, D¼ d27¼ 4 ms, and record a 2D test spectrum with a small number of scans
(NS ¼ 4) and an interscan delay (d1) of about 1 s. This should take 10–15 min. Process the data using parameters similar to the ones
given below (Supplementary Note 2 online). The spectrum should look like a normal 2D TROSY-heteronuclear single quantum coherence
(HSQC) of the imino resonances, which have chemical shift ranges of 140–165 ppm for 15N and 10–14.5 ppm for 1H nuclei (see Fig. 3).
Check whether the peaks have good line shapes and phase behavior and whether all the expected imino resonances are observable.
The sensitivity of test spectrum 1 should be somewhat less but still similar to a normal 2D TROSY-HSQC. If the sensitivity is not sufficient
to observe all relevant resonances, increase the number of scans.
10| Check the signal-to-noise ratio of test spectrum 1. Using appropriate software, determine the ratio of the height (maximum)
of typical imino peaks relative to the noise. In the simplest way, take a 1D trace through a typical peak and estimate its height
relative to the top level of the noise in a region that does not contain peaks. This top level presents your detection limit
for resonances.
You can determine the signal-to-noise ratio, in a more quantitative way, using, for example, NMRDraw in the following way:
(i) press l (for 2D location) and use the left mouse button to select a peak. The header of the window will show you the peak position and its
height. Press z (for zoom) and use the middle mouse button to drag the box in an area without peaks. Press the middle mouse
button somewhere outside the spectrum. This will open a window in which you can see the standard deviation ("SDev"; second row from
bottom) corresponding to the standard deviation of the data points (noise) in the selected area. Typically, this standard deviation is about
one-third of the top-level noise.
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BOX 1 | HNN-COSY PARAMETERS
These parameters (see also the pulse program in Fig. 2) need to be set up by the operator to optimize acquisition.
1. Radio frequency carrier positions.
 1H: exactly on water
 15N: 185 ppm
 13C: 153 ppm (for 13C-labeled samples only)
2. Pulse lengths and power levels. Power levels should be determined according to the specified pulse length. Pulse lengths are specified for a
600 MHz spectrometer. For different field strength (X MHz) spectrometers, pulse lengths should be multiplied by 600/X.
 1H:r10 ms and 1 ms 901 rectangular pulses
 15N:r40 and 200 ms 901 rectangular pulses
 13C:r15 ms 901 rectangular pulse (for 13C-labeled samples only)
3. Sweep width and acquisition times.
1H
 Sweep width:E20 ppm (corresponds to a dwell time (dw)E83 ms at 600 MHz)
 Number of complex increments (Ninc): choose such that the total acquisition time (aq ¼ dw  Ninc) is about 3–5 times T2(1HN). An
acquisition time of 64 ms was used in the example.
15N
 Sweep width:E100 ppm (corresponds to a dwE165 ms at 60 MHz)
 Ninc: choose such that the total acquisition time (aq¼ dw Ninc) gives a reasonable resolution, but that it does not exceed the T2 of donor
and acceptor 15N nuclei. Note that due to their large chemical shift anisotropy, the T2 of the acceptor
15N nuclei is considerably shorter than that
of the donor nuclei. An acquisition time of 16.5 ms was used in the example as a compromise.
4. NN COSY transfer delay.
Delay D
 D ¼ 4 ms for the test spectrum 1
 D ¼ 15 ms for the test spectrum 2 and final spectrum. D may be set to smaller values for very large molecular weight samples.
? TROUBLESHOOTING
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In the example of the 1.5-mM PSTVd RNA, the ratio of the heights of typical imino resonances relative to the top level of the noise
(S/Ntop) is in the range of 10–70:1 after 17 min total experimental time on a 600 MHz instrument with a room-temperature probe.
11| Record a test spectrum with a longer NN transfer time (test spectrum 2). Use the same parameters as for test spectrum 1,
but set the length of the NN transfer period (2D) to 30 ms (d27¼ 15 ms), which is a compromise between good magnetization transfer via
h2JNN to the
15N acceptor and sufficient detection of the 15N donor for small- to medium-sized (rE80 nucleotide) nucleic acids.
The purpose of this spectrum is to estimate how long it will take to acquire the final H-bond spectrum. Record this spectrum also with
a small number of scans. If the signal-to-noise ratio of test spectrum 1 is similar to our example, NS ¼ 4 may be sufficient.
12| Check the signal-to-noise ratio of test spectrum 2. Process the data of test spectrum 2 in exactly the same manner as
in test spectrum 1. Determine the signal-to-noise ratio of the relevant imino resonances. In our example, the S/Ntop is in the range
of 5–20:1 for the imino resonances with NS ¼ 4 after 17 min total experimental time. Many of the cross-peaks to the 15N acceptor
nuclei (15N frequencies between 195 and 225 ppm; Fig. 3) are also already visible with an S/Ntop of up to 5:1.
13| Calculate the necessary experimental time (number of scans) required for the quantitative 2D HNN-COSY. Even if the ‘cross-peaks’ to
the H-bond acceptor 15N nuclei are not yet visible in test spectrum 2, the expected cross-peak intensity can be calculated from the
intensity of the imino donor (‘diagonal’) peaks via the relation Ic/Id ¼tan2(2ph2JNND). Thus, if we want to detect this cross-peak with a
specified signal-to-noise ratio, the required time for the experiment can be calculated. For example, in our experiment on the PSTVd
RNA, certain imino resonances had an S/Ntop of 5:1 after 17 min (NS ¼ 4). If we assume a h2JNN coupling constant of 5 Hz
(which is at the low end of the expected range), the S/Ntop of the cross-peak should be 5 tan2(2p5 Hz15 ms)E 1.3 after 17 min
(neglecting slight differences in the line width of cross- and diagonal peaks). Thus, if we want to observe this cross-peak at an S/Ntop of 9,
the number of scans has to be increased by a factor of (9/1.3)2E 48, as the signal-to-noise ratio increases with the square root of the
number of scans. This would lead to a required number of scans of 192, and a total measuring time of 13.6 h for the final experiment.
In brief, NSrequired ¼ NStest tan4(2ph2JNND)((S/Ncross,desired)/(S/Ndiagonal,test))2.
Data acquisition
14| Record the final 2D quantitative JNN HNN-COSY experiment using the necessary number of scans determined in Step 13 and all other
parameters equal to those in test spectrum 2.
Data processing
15| The data of the experiment are recorded as a phase-sensitive 2D data set, and standard processing is applied. Any suitable
software may be used. As an example, we present the processing with the NMRPipe suite. The processing is divided into the following steps
(see Supplementary Note 2). (a) The raw NMR data are converted into NMRPipe format using the {bruk, var, delta}2pipe
programs, depending on the spectrometer data format. (b) A fourth-order polynomial baseline is subtracted in the t2 time domain for better
water suppression. (c) A 601-shifted squared sine-bell function is applied for filtering in t2. This maximizes resolution and signal-to-noise
ratio under acquisition conditions where t2,maxE T2(1HN) (see TROUBLESHOOTING). (d) The first data point in t2 is multiplied
by 0.5 to avoid baseline offset effects41,42. This is necessary, as the directly detected dimension (t2) is sampled without any initial
delay. (e) Data in the t2 dimension are zero-filled at least once and Fourier transformed. Proper zero- and first-order phase correction is
applied after the Fourier transformation with phases determined empirically from the processed spectrum, for example, by interactive
phase manipulation and visualization in the NMRDraw program. (f) After transposition, the sign of the imaginary part of the t1 domain
data is inverted to account for a reversal of the usual States-TPPI phase-sensitive detection in the t1 dimension, which stems
from the simultaneous incrementation of phases f1 and f2 in the HNN-COSY experiment (Fig. 2). (g) A 601-shifted sine-bell
function is applied for filtering in t1. This maximizes the resolution and signal-to-noise ratio under acquisition conditions where
t1,maxE T2(15N) (see TROUBLESHOOTING). (h) The first data point in t1 is left unchanged (multiplied by 1), as the initial delay of t1
was set to half a dwell time in the pulse program. This leads to zero- and first-order phase corrections in the 15N dimension of 901
and 1801, respectively41. (i) Data in the t1 dimension are zero-filled at least once and Fourier transformed. Proper zero- (901) and
first-order (1801) phase corrections are applied after the Fourier transformation.
? TROUBLESHOOTING
Data analysis
16| Inspect the 2D spectrum. NH?N H-bonds should be apparent from 15N donor (140–165 ppm) and acceptor (195–225 ppm)
cross-peaks, which are aligned according to the common frequency of the imino 1HN nucleus. This may provide valuable information on the
H-bond network of the nucleic acid.
17| For a more quantitative analysis, determine the intensities of the cross- and diagonal peaks by peak integration.
m CRITICAL STEP The quantification of the coupling constants from the intensity ratio of cross- and diagonal peaks is made
difficult by the different line widths of the 15N donor and acceptor resonances (Fig. 3), which are the result of the different relaxation
mechanisms for both nuclei. Whereas the width of donor 15N resonances is narrowed by the partial cancellation of the 1H–15Nd dipole
and 15Nd chemical shift anisotropy (CSA) relaxation in the TROSY scheme, the very large (300–400 ppm) CSA
43 of the 15N acceptor
nuclei in the nucleic bases dominates the relaxation for the acceptor resonances. Due to these differing line widths, it is not sufficient
to approximate the intensity ratios of the cross- and diagonal peaks by the amplitude ratios. Instead, proper peak integration
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should be used to obtain intensities. As a more precise alternative, the intensities, that is, the amplitudes of the oscillations in the
15N time domain, can be obtained from time domain fitting routines (e.g., nlinLS contained in NMRPipe)7,31.
18| Calculate the magnitude of the h2JNN couplings using the formula |
h2JNN| ¼ atan[(INa/INd)1/2]/(2pD), where 2D is the
COSY transfer time.
 TIMING
Following nucleic acid sample preparation and resonance assignments, the entire protocol from Steps 1 to 18 is expected to take no more
than 24 h. Longer experimental times may be required for low sample concentrations or higher molecular weight nucleic acids. Time may
be saved by using a cryogenic probe rather than a conventional probe.
? TROUBLESHOOTING
Step 7 (finite 15N radio frequency strength)
The large frequency separation between 15N donor and acceptor resonances combined with the finite available strength of 15N
radio frequency pulses presents a certain limitation for the simple HNN-COSY experiment depicted in Figure 2. For example, in
Watson–Crick and Hoogsteen H-bonds, the chemical shift separations of the 15N imino donor and aromatic acceptor resonances are in
the range of 50–70 ppm corresponding to 3–4 kHz on a 600 MHz instrument. Typically available 15N radio frequency strengths are
slightly larger than 6 kHz (the largest available radio frequency strength is calculated as 1/(4P90), where P90 is the length of the shortest
possible 901 pulse). Thus, the simple HNN-COSY is still reasonably efficient when the 15N carrier is placed at the midpoint between
donor and acceptor resonances. However, for larger donor–acceptor frequency differences, for example, between amino donor
(B85 ppm) and aromatic acceptor 15N (190–220 ppm) nuclei or for smaller available radio frequency strengths, band-selective
15N pulses should be used22,23.
Step 15 (peak overlap)
Peak overlap in crowded regions of the 2D HNN-COSY spectra can impede accurate calculation of the h2JNN couplings. For
samples with high signal-to-noise ratios, it may be desirable to increase the maximal t1 evolution time beyond the T2 relaxation
time of donor and acceptor 15N nuclei at the expense of signal intensity. During processing, peak overlap may also be alleviated
by using apodization functions, which provide resolution enhancement (again at the cost of lower signal intensity). For example,
in Supplementary Note 2, a 601-shifted sine-bell function is employed in both t1 and t2 dimensions. Shifting the sine-bell to 451 or
lower (setting ‘‘-off ’’ flag to 0.25 or smaller values) will increase resolution.
Larger nucleic acids
The sensitivity for detection of the acceptor nuclei is highest when the total N?N magnetization transfer period (2D) does not
exceed the transverse relaxation time T2 of the
15N donor nucleus. For very large nucleic acids (425 kDa), or at low temperatures,
the T2 may become shorter than the value of 30 ms recommended in Step 11 (Box 1). In these cases (pT2h2JNN{ 1), 2D should be set to the
15N T2 value to achieve optimal transfer.
Unobservable 1H nuclei
For situations where the hydrogen nucleus in the H-bond is not observable due to exchange, or when the experiment is carried out
using a nucleic acid sample dissolved in D2O, additional modifications of the HNN-COSY have been proposed
44–47. In certain cases,
the HNN-COSY can be started and detected on a carbon-bound proton in close vicinity of the acceptor. This is possible for adenosine
and guanosine 15N7 acceptor nuclei as well as for adenosine 15N1 acceptors, which can be connected to the H8 or H2 proton by means
of the covalent 2JH8N7 or
2JH2N1 couplings of approximately 11–15 Hz, respectively.
ANTICIPATED RESULTS
The result of the quantitative HNN-COSY experiment (total experimental time 13 h) carried out on a 1.5 mM sample of the 69-nucleotide
PSTVd T1 RNA domain (mutant U18C/A344G) is shown in Figure 3. Diagonal peaks (blue) are observed for almost all imino
groups at their respective 1HN (10–14.5 ppm) and 15N (guanosine N1, 140–150 ppm; uridine N3, 157–165 ppm) frequencies.
For the NH?N H-bonded imino groups, cross-peaks of opposite sign (Fig. 3; bottom, red) are also observed, which correspond
to 1H3(U)?15N1(A) (B223 ppm) and 1H1(G)?15N3(C) (B197 ppm) correlations according to Watson–Crick base pairing
(Fig. 1). Individual peaks were assigned from additional NOESY (nuclear Overhauser enhancement spectroscopy) data30. For most
uridines, weak-intensity cross-peaks are also observed to 15N nuclei at resonance frequencies of about 145 ppm (Fig. 3, top). These
are the results of intrabase 2JNN couplings between uridine N3 and N1 nuclei, which areE2 Hz in size7. For certain uridine and
guanosine imino groups with 1HN frequencies between 10 and 12 ppm (Fig. 3, right), for example, U7, no H-bond cross-peaks
are observed, as they are not involved in H-bonds of the NH?N type. Quantification of the h2JNN couplings for the
Watson–Crick U–A and G–C base pairs using the time domain fitting program nlinLS, contained within the NMRPipe package31,
yielded values between 6 and 8 Hz in size. This corresponds to the usual size of h2JNN couplings in Watson–Crick base pairs.
Smaller couplings are sometimes observed due to fraying at the ends of helical stems or due to nonlinear H-bond geometries19.
For other base pair types, for example, charged Hoogsteen C+G, the coupling size may increase up toB10 Hz (see ref. 48).
 
 p
u
or
G
 g
n ih si lb
uP
 er
u ta
N
 800 2
©
n
at
ur
ep
ro
to
co
ls
/
m
oc
.
er
ut a
n
.
w
w
w//:ptth
NATURE PROTOCOLS | VOL.3 NO.2 | 2008 | 247
PROTOCOL
Note: Supplementary information is available via the HTML version of this article.
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A nuclear magnetic resonance (NMR) experiment is described for the direct detection of N-H...O¼C hydrogen bonds (H-bonds) in 15N
and 13C isotope-labeled biomolecules. This quantitative ‘long-range’ HNCO-COSY (correlation spectroscopy) experiment detects and
quantifies electron-mediated scalar couplings across the H-bond (H-bond scalar couplings), which connect the magnetically active 15N
and 13C nuclei on both sides of the H-bond. Detectable H-bonds comprise the canonical backbone H-bonds in proteins as well as other
H-bonds in proteins and nucleic acids with N–H donors and O¼C (carbonylic or carboxylic) acceptors. Unlike other NMR observables,
which provide only indirect evidence of the presence of H-bonds, the H-bond scalar couplings identify all partners of the H-bond,
the donor, the donor proton and the acceptor, in a single experiment. The size of the scalar couplings can be related to H-bond
geometries. The time required to detect the NH...O¼C H-bonds in small proteins (rE10 kDa) is typically on the order of 1 d at
millimolar concentrations, whereas H-bond detection for larger proteins (rE30 kDa) may be possible within several days depending
on concentration, isotope composition, magnetic field strength and molecular weight. The proteins ubiquitin (8.6 kDa), dimeric
RANTES (2 3 8.5 kDa) and MAP30 (30 kDa) are used as examples to illustrate this procedure.
INTRODUCTION
H-bonds are key features of biomacromolecules1. NMR techniques
developed in recent years make it possible to observe and quantify
H-bonds in the solution state by COSY (correlation spectroscopy)
experiments. The techniques are based on H-bond scalar couplings
(HBCs), which connect magnetically active nuclei on both sides of
the hydrogen bridge via the magnetic polarization of its electron
cloud. Observable HBCs comprise H-bonds of regular secondary
structure elements in nucleic acids2,3 and proteins4,5 as well as in
small chemical compounds6–9. The HBCs can be used to identify
donor and acceptor groups in individual H-bonds from COSY-type
experiments. In favorable cases, complete H-bond networks in
biomacromolecules can be established, thereby providing valuable
data for structure determination. The size of the HBCs is determined
by the overlap of H-bond donor and acceptor electronic orbitals10
and thus provides a sensitive measure of H-bond geometry, that is,
HBCs depend exponentially on donor–acceptor distances11 as well as
on certain H-bond angles12. Owing to the requirement that HBCs
connect NMR-observable nuclei, their observation in biomolecules
has been limited to HBCs between 15N, 13C, 1H or 31P nuclei, but
excludes oxygen, for which no suitable isotope exists. Experimental
procedures for their detection, theoretical descriptions and applica-
tions of HBCs have been reviewed extensively12–15.
In nucleic acids, strong two-bond 15N15N HBCs (h2JNN) can be
detected across NH?N H-bonds between 15N donor and
acceptor nuclei in Watson–Crick base pairs and many other
noncanonical base pairs. (The symbol hnJAB is used for H-bond
scalar couplings between nuclei A and B to emphasize that one of
the n bonds connecting the two nuclei in the chemical structure is
actually an H-bond.) An accompanying protocol16 describes their
detection by the HNN-COSYexperiment and gives a more detailed
introduction. As oxygen is not observable, protein backbone
NH?O¼C H-bonds cannot be detected via the carbonyl oxy-
gen. However, NH?O¼C H-bonds induce detectable HBCs
(Fig. 1) between the amide 15N donor and the next nucleus on the
other side of the H-bond, the 13C¢ carbonyl acceptor4,5. These
three-bond 15N13C¢ HBCs (h3JNC¢) can be detected and quantified
by the ‘long-range’ HNCO experiment, which is a modification
of the standard HNCO used for protein assignments. In a two-
dimensional version, the ‘long-range’ H(N)CO yields the resonance
frequencies of the amide proton 1HN and the carbonyl 13C¢ nucleus,
whereas in a three-dimensional HNCO version, the frequency of
the amide 15N donor nucleus is also detected such that all partners
of the H-bond are visible.
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Figure 1 | Backbone H-bond network of ubiquitin detected by h3JNC¢
correlations4. Nitrogen donors, amide protons and oxygen acceptors are shown
in dark blue, light blue and red, respectively. The insert illustrates the
definition of the scalar h3JNC¢ coupling via the NH?O¼C H-bond.
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The principal application of the ‘long-range’ HNCO is the
unequivocal establishment of H-bonding for structural analysis.
This primarily applies to protein backbone NH?O¼C
H-bonds. However, H-bonds involving nucleic acid base17 or
protein side-chain NH or O¼C groups11,18,19 can also be detected
by this experiment. Owing to the strong dependence on H-bond
geometries, the size of the coupling constants provides a sensitive
measure for variations in H-bond lengths and angles4,10,11. Such
variations can be detected as a result of ligand binding20 and protein
folding21, in response to changes of pressure22, temperature23 and
amino-acid variations24,25 or other changes of physicochemical
conditions. Applications of this type have been reviewed in ref. 12.
As for any solution NMR experiment on biomolecules, the detec-
tion of H-bonds is limited by sensitivity and molecular weight. h3JNC¢
couplings have typical sizes in the range of 0.1 to 0.9 Hz and are
considerably smaller than h2JNN couplings (511 Hz) in nucleic acids.
Thus, detection of NH?O¼C H-bonds is significantly more
difficult than that of NH?N H-bonds, especially for larger
proteins. Nevertheless, small (10–15 kDa) proteins in 13C/15N-labeled
form are easily accessible, provided they can be measured at con-
centrations of ZB0.5 mM. Additional 2H labeling and the use of
TROSY techniques allows detection of h3JNC¢ HBCs even for medium-
sized proteins of up to about 30 kDa (see ref. 26).
Organization of the protocol
The following protocol gives a step-by-step setup and evaluation
procedure for the quantitative ‘long-range’ HNCO experiment to
detect and quantify h3JNC¢ couplings in NH?O¼C
H-bonds between 15N amide donor and 13C¢ carbonyl acceptor
nuclei (Fig. 1). Example results are included from samples of
ubiquitin (8.6 kDa), dimeric RANTES (2  8.5 kDa) and
MAP30 (30 kDa), recorded on Bruker 800 and 750 MHz spectro-
meters using the xwinnmr 3.5 acquisition software. Data processing
and analysis were performed with the NMRPipe suite of pro-
grams27. This software and further information are available at
http://spin.niddk.nih.gov/NMRPipe.
Experimental design
The ‘long-range’ HNCO experiment4,5 (Fig. 2) used to detect the
h3JNC¢ couplings is a variant of the standard HNCO experiment for
protein backbone assignments with the NC¢ INEPT transfer time
set to larger values. In brief, magnetization is transferred from
the amide proton (H) to the H-bond donor 15N nucleus during
the first INEPT period (time points a to b) via the covalent
1JNH coupling. During the subsequent NC¢ INEPT period
(time points b to c), both h3JNC¢ and the large covalent
1JNC¢
(E15 Hz) couplings are active for a time 2T  2e, where the
length of the delay e is determined by the position of the 13C¢ 1801
pulse (Fig. 2). Optimal transfer from the 15N nucleus via the
H-bond to the 13C¢ nucleus of the acceptor is achieved when
the one-bond coupling 1JNC¢ is approximately refocused, that is,
2T – 2e ¼ n/1JNC¢, and when the total transfer time is set to a
value that is close to the T2 relaxation time of the
15N nucleus.
In practice, a total transfer time of about 133 ms (n¼ 2) works well
for small proteins, which is realized by setting the delays T ¼
66.5 ms and e ¼ 4 ms E 0. During the following t1-evolution
period (time points d to e), the frequencies of the 13C¢ are encoded,
and magnetization is then transferred back to the 15N nucleus via
the C¢N reverse-INEPT step (time points f to g, total active
transfer time 2T  2e). A final TROSY (transverse relaxation
optimized spectroscopy) transfer (time points h to i) converts the
slowly relaxing component of the {1H}–15N doublet into the slowly
relaxing component of the {15N}–1H doublet, which is detected
in the receiver during the t3 period. The resulting spectrum of
the 2D H(N)CO shows ‘cross-peaks’ at frequency positions
(oC¢j, oHi + p1JNH) (Fig. 3). The intensity of these cross-peaks
(Icross) is proportional to cos
2(p1JNC¢2T)sin2(ph3JNC¢2T).
To determine the size of the h3JNC¢ coupling by quantitative
J-correlation, a reference experiment is recorded using the same
total lengths 2T for the NC¢ INEPT and C¢N reverse-INEPT
periods, but with the two 13C¢ 1801 pulses shifted by e¼ 1/(41JNC¢)B
16.5 ms relative to the 15N 1801 pulses. This reduces the effective
time for 15N13C¢ de- and refocusing to (2T  2e) ¼ (n/1JNC¢ 
1/(21JNC¢)) while keeping the relaxation losses identical to the long-
range experiment. In this experiment, the nitrogen-to-carbonyl mag-
netization transfer occurs primarily via the large 1JNC¢ couplings. The
resulting reference spectrum shows resonances at frequency positions
(oC¢i-1, oHi + p1JNH) with intensities proportional to sin2(p1JNC¢2
(T e))cos2(ph3JNC¢2(T e)). Thus, the intensity ratio of cross- and
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Figure 2 | 2D long-range H(N)CO TROSY pulse
sequence. Color-coding highlights the various
magnetization transfer and chemical shift evolution
periods as presented in the Bruker pulse sequence
code (Supplementary Box 2). Pulse durations or
field strengths are given for an 800 MHz
spectrometer. For different magnetic field strength
(X MHz) spectrometers, the radio frequency field
strengths should be multiplied by X/800. Narrow
and wide pulses correspond to flip angles of 901 and
1801, respectively. Carrier positions are 1H2O
(1H), 116.5 ppm (15N), 177 ppm (13C¢) and 56 ppm
(13Ca). All regular 1H and 15N pulses are applied at
radio-frequency field strengths of 25 and 6.25 kHz,
respectively. Small narrow 1H pulses are weak water
flip-back 901 pulses with a duration of 1 ms. The shaped (901) pulse has the profile of the center lobe of a sinx/x function with a duration ofB2 ms. All the 13C¢
pulses have the shape of the center lobe of a sinx/x function and durations of 110 ms (220 ms) for the narrow 901 (wide 1801) pulses. GARP 13C¢ decoupling sequence is
used at a field strength of 1.25 kHz. 13Ca 1801 pulses are rectangular pulses applied at a field strength of 14.0 kHz. Delays: d ¼ 2.7 ms; T, e (see text). Unless
otherwise indicated, the phases of all pulses are along the x axis. Phase cycling: f1 ¼ 4(x), 4(x); f2 ¼ x, x; f3 ¼ y, y, x,x; receiver ¼ x, x, y, y, x, x, y,
y. Quadrature detection in the t1 dimension is achieved by incrementing f2 in the States-TPPI manner. For the 3D version of the experiment, sensitivity-enhanced
quadrature detection in the t2 dimension is achieved by applying f3 either as y, y,x,x or as y, y, x, x for p- and n-type detection. Gradients (sine-bell shaped,
absolute amplitude at the center of 30 G cm1) with durations: G1,2,3,4,5,6,7,8 ¼ 10, 3, 2.7, 2.5, 3.75, 0.888, 0.7, 0.4 ms.
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reference peaks is given by Icross/Iref¼ cos2(p1JNC¢2T)sin2(ph3JNC¢2T)/
[sin2(p1JNC¢(2T  2e))cos2(ph3JNC¢(2T  2e))] and the size of the
coupling can be determined by a numerical inversion of this implicit
equation with the known values of 1JNC¢. As an alternative, the
coupling can be estimated to good approximation as |h3JNC¢| E
(Icross/Iref)
1/2/(2pT), since Icross/IrefE sin2(ph3JNC¢2T)E (ph3JNC¢2T)2
for 1JNC¢ close to 15 Hz and |ph3JNC¢2T|{1.
A 3D version of the long-range HNCO experiment can easily be
implemented at no additional cost in signal intensity by inserting a
15N constant time evolution (t2) period within the C¢N reverse-
INEPT period26. For the 2D H(N)CO version of the experiment
described in the following protocol, the incrementation in t2 is
simply omitted.
For the following protocol, example results are included from the
following 270 ml samples:
 1 mM 15N/13C-labeled or 15N/13C/2H-labeled ubiquitin (MWT
8.6 kDa) pH 6.5, recorded at 298 K on a Bruker DMX 800 MHz
spectrometer equipped with a triple resonance TCI cryogenic
probe.
 2 mM (monomer concentration) 15N/13C-labeled dimeric
RANTES (2  8.5 kDa), pH 3.8, recorded at 310 K on a Bruker
DMX 800 MHz spectrometer equipped with a triple resonance
TCI cryogenic probe.
 0.7 mM 15N/13C/2H-labeled MAP30 (30 kDa) recorded at 313 K
on a Bruker DMX 750 MHz spectrometer equipped with a
triple-resonance TXI room-temperature probe.
MATERIALS
REAGENTS
.Protein samples must be uniformly 13C/15N-enriched. Isotope-labeled
proteins are prepared using previously described strategies28–31
.For highest sensitivity, proteins should also be labeled with
deuterium (2H) for carbon-bonded hydrogen atoms. As this is usually
achieved by growing bacteria in D2O (see refs. 28,32,33), amide hydrogen
atoms must be back-exchanged to 1H nuclei during or after protein
purification
.Samples should be prepared in a buffered solution containing 5% (vol/vol) D2O
.Sample concentrations should be Z0.5 mM
.Necessary sample volumes range between 250 and 500 ml depending on the
NMR tube type (see accompanying protocol16 on the detection of N–H?
N H-bonds)
EQUIPMENT
.A high-resolution NMR instrument (Z500 MHz 1H frequency) with the
following characteristics:
.Three radio frequency channels (1H/15N/13C) and triple-resonance
(1H/13C/15N) probe-head optimized for 1H detection
.For highest sensitivity, the magnetic field strength of the NMR
spectrometer should be 18.8 Tesla (800 MHz 1H frequency) or higher to
make optimal use of the TROSY effect
.The NMR spectrometer should be equipped with pulsed-field gradients;
otherwise, water suppression can be achieved by other techniques34
.As sensitivity is a limiting factor, cryogenic probes are beneficial, but are
not absolutely necessary
PROCEDURE
Preparation
1| Calibrate 15N and 13C power levels on a suitable calibration sample according to Box 1.
2| Set the sample temperature of the NMR spectrometer to a suitable value, which is a compromise between sample stability
and spectral quality. Insert the sample into the magnet.
? TROUBLESHOOTING
3| Calibrate the 1H power levels on the sample according to the different pulse lengths given in Box 1.
m CRITICAL STEP Both the low-power and the shaped pulses are necessary for the water flip-back scheme to maximize water
suppression and to improve signal to noise of the solvent labile amide proton signal.
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Figure 3 | Results of the long-range HNCO.
(a) Selected region of the 2D long-range H(N)CO
TROSY spectrum recorded on a 2 mM sample
of 15N/13C RANTES, pH 3.8, 310 K, 800 MHz
spectrometer with cryogenic probe. The data
matrix consisted of 80*(13C¢, t1)  1,024*(1H, t3)
data points (where n* refers to complex points)
with acquisition times of 40 (13C¢) and 85 ms (1H).
The total experimental time was 46.5 h. Cross-
peaks marked as Resi?Resj are due to h3JNiC¢j HBCs
between the 15N nucleus of residue i and 13C¢
nucleus of residue j (see inset for definition).
Intramolecular and intermolecular h3JNiC¢j
correlations are labeled in red and orange,
respectively. Residue names marked in blue denote
incompletely suppressed sequential correlations
between the 15N nucleus of residue i and 13C¢
nucleus of residue i  1. Residues marked in green correspond to intraresidue two-bond 15Ni–13C¢i correlations. (b) Strip plot of the 3D long-range HNCO TROSY
spectrum recorded previously26 on a 0.7 mM sample of 15N/13C/2H MAP30, pH 5.5, 313 K, 750 MHz spectrometer equipped with a room-temperature probe.
The total experimental time was 91 h. The data matrix consisted of 32*(13C¢, t1)  99*(15N, t2)  768*(1H, t3) data points with acquisition times of 65 (15N),
14 (13C¢) and 79 ms (1H). The strips are labeled by the residue of the NH moiety. H-bond (red), sequential (blue) and intraresidue (green) correlations to
carbonyls are marked with assignment information.
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4| If you have no idea from previous experiments, determine the amide proton 1HN T2 relaxation time from a suitable
spin-echo experiment, for example, using the 1-1 echo sequence35. This step is not absolutely necessary, but it only takes a
few minutes and is a very good way to characterize the quality of your sample. For the 8.6 kDa protein ubiquitin used in the
example, the 1HN T2 is about 35 ms at 298 K for the protonated and 75 ms for the deuterated sample. For the RANTES dimer
(MWT ¼ 2  8.5 kDa), the 1HN T2 is about 28 ms at 310 K.
Parameter setup
5| Load the pulse program for the two-dimensional long-range H(N)CO TROSY experiment (Fig. 2 and Supplementary Box 1
online).
6| Set pulse lengths and power levels as determined in Steps 1 and 3 (see Box 1).
7| Adjust the carrier frequencies according to Box 1:
 1H: set the carrier frequency exactly at the water position. (At this carrier position, a simple 1H pulse-acquire experiment should
yield a non-oscillating water FID (free induction decay).)
 15N: set the carrier frequency to 116.5 ppm
 13C: set the carrier frequency to 177 ppm
8| Set 1H and 13C sweep widths and acquisition times according to Box 1.
9| Optimize the recycling delay between scans, d1, to maximize the signal to noise. The amide proton longitudinal relaxation
time (HN T1) increases with the size of the protein and depends on the level of deuteration. It is, therefore, important to have a
good estimate for HN T1 to evaluate the optimum recycling delay d1 between scans. Generally, a good compromise for d1 is
about 1 s for small- to medium-sized protonated proteins and 2–3 s for larger or deuterated proteins.
1JNC¢ test spectrum
10| Record a high-sensitivity 1JNC¢ test spectrum. This spectrum is a normal HNCO and is a quick check on whether your
parameter setup is correct. Set the total length of the NC¢ transfer period to a small value, which is optimal for 1JNC¢
detection, for example, T ¼ d16 ¼ 16.5 ms, e ¼ d18 ¼ 4 ms. Record the test spectrum with a small number of scans (NS ¼ 4).
This should take about 20–40 min. Process the data using parameters similar to the ones given in Supplementary Box 2 online.
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BOX 1 | LONG-RANGE HNCO PARAMETERS
These parameters (see also the pulse program in Fig. 2) need to be set up by the operator to optimize acquisition.
1. Radio frequency carrier positions.
 1H: exactly on water
 15N: 116.5 ppm
 13C: 177 ppm
2. Pulse lengths and power levels. Power levels should be determined according to the specified pulse length. Pulse lengths are specified
for an 800 MHz spectrometer with cryogenic probe. For different field strength (X MHz) spectrometers, pulse lengths should be multiplied
by 800/X.
 1H:r12 ms and 1 ms 901 rectangular,r2 ms 901 sinc pulse (see Fig. 2)
 15N:r40 ms 901 rectangular pulse
 13C: 17.2 ms 901 rectangular and 110 ms 901 sinc pulses
3. Sweep widths and acquisition times.
1H
 Sweep width:E15 ppm (corresponds to a dwell time dwE 83 ms at 800 MHz)
 Number of complex increments (Ninc): choose such that the total acquisition time (aq ¼ dw Ninc) is about 3–5 times T2(1HN).
An acquisition time of 85 ms was used in the example.
13C¢
 Sweep width:E20 ppm (corresponds to dwE 250 ms at 201 MHz)
 Ninc: for best sensitivity, choose such that the total acquisition time (aq¼ dwNinc) gives reasonable resolution, but does not exceed the
T2 of the
13C¢ nuclei. An acquisition time of 40 ms was used in the examples.
4. NC¢ transfer period.
Delays T and e
 T ¼ 16.5 ms, e ¼ 4 ms for the test experiment
 T ¼ 66 ms, e ¼ 16.5 ms for the reference experiment
 T ¼ 66 ms, e ¼ 4 ms for the cross H-bond experiment
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Details are described in the data-processing section (Step 15) of the HNN-COSY procedure of the accompanying protocol16.
This should result in a normal 2D H(N)CO spectrum. Check whether the peaks have good line shapes and phase behavior and
whether all the expected resonances are observable.
11| Check the signal-to-noise ratio of the test spectrum. Using appropriate software, determine the ratio of the height
(maximum) of typical peaks relative to the noise. See Step 10 of the HNN-COSY procedure. In our examples, the S/Ntop of
typical resonances was about 43 (77):1 for protonated (deuterated) ubiquitin and 10:1 for protonated RANTES with NS ¼ 4
after 20 min total experimental time on an 800 MHz machine equipped with a cryoprobe. If the sensitivity is not high
enough, increase the number of scans.
? TROUBLESHOOTING
1JNC¢ reference spectrum
12| Record a 1JNC¢ reference spectrum. Set the total length of the N–C¢ transfer period to the same value as will be used for
the cross-experiment (T ¼ d16 ¼ 66 ms) and the delay between the 15N and 13C 1801 pulses tuned for the observation of the
1JNC¢ ‘diagonal’ peaks (e ¼ d18 ¼ 16.5 ms). Set all other parameters as for the test spectrum and acquire the data.
13| Check the signal-to-noise ratio of the reference spectrum. Process the data of the reference spectrum exactly as the test
spectrum. Determine the signal-to-noise ratio of the relevant resonances. In our examples, the S/Ntop of typical resonances was
about 13 (27):1 for protonated (deuterated) ubiquitin and 4:1 for RANTES with NS ¼ 4 after 20 min total experimental time.
Note that such signal-to-noise ratios for the reference experiment are usually sufficient, since the error in the value of h3JNC¢
coupling is dominated by the (small) signal-to-noise ratio of the cross-experiment. However, if the sensitivity of the reference
experiment is not high enough, increase the number of scans.
? TROUBLESHOOTING
14| Estimate the experimental time (number of scans) needed for the H-bond experiment. Determine the minimal observable
h3JNC¢ coupling if a cross-experiment (long-range experiment) would be recorded with the number of scans of the reference
experiment (NSref): |Jmin(NSref)| ¼ (Sref/Ntop,ref)1/2/(2pT), where Ntop,ref corresponds to the top level of the noise and Sref
to the signal height of the reference spectrum (Step 13). If the final cross-experiment will be carried out with NScross number
of scans, the respective minimal observable h3JNC¢ coupling will be |Jmin(NScross)| ¼ (NSref/NScross)1/4  |Jmin(NSref)| ¼
(NSref/NScross)
1/4  (Sref/Ntop,ref)1/2/(2pT). Typical |h3JNC¢| values are in the range of 0.2 to 0.9 Hz, with |h3JNC¢| values in
b-sheets larger than in a-helices. Check whether the minimal calculated coupling for your anticipated experiment is sufficient
for the detection of this |h3JNC¢| range. Otherwise increase NScross. Note that the available experimental time rapidly becomes
limiting. For the protonated (deuterated) ubiquitin example, a total experimental time of 12.3 h (NScross ¼ 136) yields
|Jmin(NScross)| ¼ 0.28 (0.07) Hz, which covers most of the usual h3JNC¢ values. For the example of RANTES, a total experimental
time of 46.5 h (NScross ¼ 512) yields |Jmin(NScross)| ¼ 0.36 Hz, which still allows detection of most b-sheet H-bonds.
? TROUBLESHOOTING
Long-range h3JNC¢ experiment
15| Record the h3JNC¢ spectrum. Set the length of the NC¢ transfer period (2T) to the same value used for the reference
experiment (T ¼ d16 ¼ 66 ms) and the delay between the 15N and 13C 1801 pulses close to zero (e ¼ d18 ¼ 4 ms). Adjust the
number of scans according to your calculation in Step 14.
Data processing
16| Process the data in the same way as for the reference experiment.
Data analysis
17| Inspect the long-range HNCO spectrum. NH?O¼C H-bonds should be apparent from cross-peaks at the positions of the
respective (oC¢j, oHi + p1JNH) frequencies. This may provide valuable information on the H-bond network of the protein.
18| Determine the size of the h3JNC¢ couplings from the ratio of cross-peak (oC¢j, oHi + p1JNH) and reference peak (oC¢i-1, oHi +
p1JNH) intensities. The simple approximation |h3JNC¢|E (Icross  NSref/(Iref  NScross))1/2/(2pT) yields good estimates for values
of |1JNC¢| close to 15 Hz and |ph3JNC¢2T|{1. However, for larger deviations of |1JNC¢| from 15 Hz (the typical range of |1JNC¢| is
1317 Hz) or when |ph3JNC¢2T|{1 is not valid, the h3JNC¢ values should be derived from a numerical solution of the equation
Icross  NSref/(Iref  NScross) ¼ cos2(p1JNC¢2T)sin2(ph3JNC¢2T)/[sin2(p1JNC¢(2T  2e))cos2(ph3JNC¢(2T  2e))]. This then requires the
independent determination of the 1JNC¢ coupling constants. The determined values of
h3JNC¢ should be in the range of 0.1 to
0.9 Hz for most protein backbone H-bonds.
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19| If no cross-peaks are observed for a certain H-bond, an upper limit of the coupling size can still be estimated from
the top level of the noise in the cross-experiment (Ntop,cross) and the intensity of the reference peak (Iref), as |
h3JNC¢|
o (Ntop,cross  NSref/(Iref  NScross))1/2/(2pT).
 TIMING
Following protein sample preparation and resonance assignments, the test of the experiment, data acquisition of the reference
and long-range experiments, processing and calculation of the h3JNC¢ coupling is expected to take no more than 16 h for a
small and deuterated protein like ubiquitin at 1 mM concentration. Longer acquisition times will be required for larger and
non-deuterated proteins as well as for lower sample concentrations and if experiments are recorded at lower field strengths
and on a conventional rather than a cryogenic probe.
? TROUBLESHOOTING
Insufficient sensitivity (Steps 2, 11, 13 and 14)
The low sensitivity of the long-range HNCO experiment stems from the necessary N-C¢ transfer times of several hundred
milliseconds. This low sensitivity presents the largest problem in the application of the experiment. If the test spectra reveal
that the signal-to-noise is not high enough, several possibilities may exist to enhance the signal-to-noise.
 Increasing the concentration: if not ruled out by aggregation or lack of available protein material, this may be a simple solution.
 Deuteration: as evident from the examples of ubiquitin, deuteration significantly increases the sensitivity even for a small protein.
 Increasing the temperature: the temperature should be as high as possible without compromising protein stability. As the relaxation
rates are proportional to Z/T, a temperature increase by, for example, 10 K will have significant effects. However, the exchange of
amide protons with water also increases at higher temperatures23, especially for samples at pH 4 B6.5, which may compromise
sensitivity for less-protected amides. In addition, the size of the couplings decreases with increasing the temperature ((Dh3JNC¢/DT)/
h3JNC¢E 2.103 K1), because of the thermal expansion of proteins. Thus, the most suitable temperature has to be chosen
with care23.
 Optimizing the transfer delay T: the sensitivity of cross-peak detection is highest, when the transfer delay is chosen such that 2T is
close to the 15N relaxation time T2 under the condition 2T¼ n/1JNC¢ (with eE 0). For small- to medium-sized proteins, 2T¼ 133 ms
(n ¼ 2) presents a reasonable compromise. However, for larger proteins, 2T ¼ 66 ms (n ¼ 1) may be more sensitive. Vice versa,
for smaller proteins or very long transverse relaxation times, for example, in unfolded proteins, 2T should be set to larger values.
 Increasing the experimental time: increasing the NS very rapidly becomes impractical, as the detection limit of the h3JNC¢ couplings
decrease only with the fourth root of NS.
Peak overlap
For small- to medium-sized proteins, peak overlap in the 2D H(N)CO is usually not a severe problem due to the large
dispersion of 1HN and 13C¢ chemical shifts. Recording the 2D H(N)CO experiment at different temperatures may help to separate
cross-peaks, as there is usually a significant variation in the temperature behavior of the different amide groups. Slight overlap
may also be overcome by increasing the acquisition time of the 13C¢ dimension or by processing with apodization functions
that provide higher resolution (although at the expense of sensitivity).
As an alternative, a 3D version of the long-range HNCO-TROSY can be recorded at no additional cost in sensitivity due to the
sensitivity enhancement scheme implemented in the sequence in Figure 2. For this, the flag NITROGEN has to be defined in
the pulse program in addition to CARBONYL (see Supplementary Box 1). For larger proteins, the 3D version is recommended,
as overlap in the 2D version is unavoidable.
ANTICIPATED RESULTS
Figure 3a shows the result of the 2D long-range H(N)CO experiment carried out on a 2 mM sample of the RANTES dimer (total
MWT 17 kDa) with a total measuring time of 46.5 h. A total of 13 intramolecular backbone H-bond h3JNC¢ correlations (red)
could be detected. In addition, four intermolecular H-bond correlations (orange) are visible, which connect the two RANTES
monomers across an intermolecular antiparallel b-sheet. Besides these H-bonds, the spectrum shows a number of intraresidue
two-bond 15Ni-
13C¢i (green) and sequential one-bond 15Ni-13C¢i  1 (blue) connectivities.
Figure 3b shows the 3D long-range HNCO TROSY spectrum of MAP30 (MWT 30 kDa) acquired previously26 with a total
experimental time of 91.2 h. Strip plots are given for five residues, which are part of the antiparallel b9/b10 b-sheet.
A number of H-bond correlations (red) are visible in addition to the intraresidue (green) and sequential (blue) 15N–13C¢
connectivities.
A quantitative evaluation was carried out previously for protonated4 and deuterated23 ubiquitin. For both deuterated and
protonated samples of ubiquitin, typically more than 30 backbone h3JNC¢ correlations are detected in 12 h experiments using
about 1 mM samples. This corresponds to 480% of all backbone H-bonds expected from the ubiquitin crystal structure with a
proton to carbonyl oxygen distance smaller than 2.2 A˚. Quantification using a reference experiment yields coupling constants
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in the range –0.2 to –0.9 Hz. The size of the coupling constants depends strongly on the H-bond geometry, which has been
parameterized to good approximation by several simple geometric formulae10, the simplest one being36
h3JNC ¼ 357 Hz expð3:2rHO=A˚Þ cos2 y
where rHO presents the H?O distance and y the H?O¼C angle. As b-sheet H-bonds are typically shorter than a-helical
H-bonds, differences can be detected in the values of h3JNC¢ coupling constants: for the two proteins ubiquitin and protein G,
the average h3JNC¢ for H-bonds in b-sheet regions is 0.53 ± 0.15 Hz, whereas a-helical H-bonds have a weaker average h3JNC¢
of 0.36 ± 0.18 Hz (ref. 12).
Note: Supplementary information is available via the HTML version of this article.
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2 Ubiquitin under pressure
2.4 Pressure-dependence of protein hydrogen bonds studied by
NMR spectroscopy
Abstract
The pressure-dependence of 3hJNC’ scalar couplings through hydrogen bonds was measu-
red by nuclear magnetic resonance (NMR) spectroscopy in the range from atmospheric
pressure up to 2500 bar in ubiquitin as a model protein. The quantitative ’long-range’-
HNCO experiment was used to detect changes in electronic orbital overlap between the
hydrogen and acceptor nuclei in ubiquitin’s H-bonds. On average, these couplings are
strengthened with increasing pressure. For some hydrogen bonds in the β-sheets the
3hJNC’ couplings show a non-linear pressure-dependence with initially increasing coupling
constants that decrease above pressures of 1200 – 1500 bar. Together with H-bonds that
are weakened already at low pressures, these residues mark the probably most pressure-
labile regions of ubiquitin. Only for the first β-hairpin and the α-helix of ubiquitin,
where the secondary structure is preserved at high pressures, a correlation between the
pressure-dependent changes of the 3hJNC’ coupling constants and amide proton chemi-
cal shift changes is observed. This correlates with earlier findings that the N-terminal
half of ubiquitin is more stable and also preserved in its A-state under changed solvent
conditions. Comparison of the pressure-induced changes in ubiquitin’s hydrogen bond
network with temperature-induced effects shows that for most residues an increase in
pressure corresponds to a decrease in temperature with respect to the effect on 3hJNC’
coupling constants. Hydrogen bonds that do not follow the global trends mark points,
where local unfolding is likely to be initiated.
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2.4.1 Introduction
The three-dimensional structure of proteins is stabilized by covalent (disulfide bonds) as
well as non-covalent interactions (hydrogen bonds, ionic interactions, metal complexa-
tion, and hydrophobic interactions). Among the latter, hydrogen bonds are crucial for
the formation of secondary and tertiary structural elements.
Scalar couplings across hydrogen bonds allow the direct observation, not only of the do-
nor and acceptor atoms involved in a given hydrogen bond, but also its strength (Cordier
et al. 1999, Cornilescu et al. 1999b). Since the 3hJNC’ scalar couplings connecting the
15N of the hydrogen bond donor with the carbonyl 13C of the acceptor amino acid depend
on the electron orbital overlap between hydrogen and the acceptor atom (Barfield 2002),
they are an extremely sensitive probe of hydrogen bond length (Cornilescu et al. 1999a)
and angles (Grzesiek et al. 2004). Thus, these coupling constants are a good parameter
to observe changes in proteins subjected to different conditions, such as ligand binding
(Cordier et al. 2000), exposure to organic solvents (Jaravine et al. 2001), or variation
in temperature (Cordier & Grzesiek 2002) and pressure (Li et al. 2000). A number of
studies have shown that although the 3hJNC’ couplings in N-H → O=C hydrogen bonds
are small in size, they can be measured reproducibly. Particularly, the influence of tem-
perature on the hydrogen bond network in ubiquitin was studied by NMR spectroscopy
using 3hJNC’ scalar couplings as well as other hydrogen bond parameters (Cordier &
Grzesiek 2002). This study demonstrated that hydrogen bond scalar couplings can be
measured precisely enough to deduce thermally induced changes in H-bond geometry
from variations in the coupling constants. Over the temperature range from 5 °C to
65 °C the average length of hydrogen bonds expands by 0.03 A˚. The most thermolabile
region in ubiquitin is the N-terminal end of β-strand β5 whereas the end of β-sheet
β1/β2 is even stabilized at higher temperatures.
The influence of pressure on a protein’s hydrogen bond network was investigated in the
immunoglobulin binding domain of streptococcal protein G (Li et al. 2000). In this study
it was shown that 3hJNC’ couplings in the core of the protein decrease under pressure
whereas those in loop and peripheral regions increase. Since the experimental set-up
in this study allowed only very small sample volumes, just eleven out of 34 hydrogen
bond scalar couplings could have been detected with sufficient accuracy, namely those
stronger than 0.5 Hz. Due to these problems with measurements under high pressure,
usually not the 3hJNC’ couplings but other H-bond related, better observable parameters,
such as amide proton chemical shift, have been measured.
Here, we present the pressure dependence of 3hJNC’ coupling constants in ubiquitin in
the range from 1 bar up to 2500 bar. Due to a new high-pressure NMR cell that
allows much larger sample volumes than previous set-ups (120 µl vs 20 µl), we could
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follow the changes in 3hJNC’ couplings for almost all hydrogen bonds. Interestingly, no
correlation between hydrogen bond scalar couplings and amide proton chemical shifts
has been observed for some part of ubiquitin, namely the β-sheets 3/4, 3/5, and 1/5.
Furthermore, the pressure-induced variation of the amide proton, nitrogen and carbonyl
carbon chemical shifts has been monitored at different temperatures.
Figure 2.2 a Topology of Ubiquitin with the backbone hydrogen bonds (dotted lines)
between the amide proton (filled circles) and the carbonyl oxygen (open circles). Figure taken
from (Cordier & Grzesiek 2002). b High-resolution X-ray structure of ubiquitin (pdb 1ubq).
The hydrogen bond network is shown with the amide donor group in blue and the carbonyl
acceptor in grey and red. H-bonds between NH and CO, that could be detected by NMR
spectroscopy with the ’long-range’-HNCO experiment, are represented as dashed yellow lines.
2.4.2 Results and Discussion
Pressure-induced changes in 3hJNC’ hydrogen bond scalar couplings
Figure 2.3 shows a plot of the 3hJNC’ scalar couplings of ubiquitin measured at 1, 300,
600, 900, 1200, 1500, 2000, and 2500 bar. The data represent the average of three
independent measurements. The hydrogen bond scalar coupling constants could be
measured very reproducibly, with maximum errors of 0.012 Hz.
On average, the coupling through H-bonds gets stronger up to pressures of 1200 –
1500 bar. Afterwards, two main trends can be observed: some couplings become even
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stronger whereas for others the direction is reversed. There are few hydrogen bonds
that do not fit into these two groups, but show a decrease in strength already at low
pressures.
As indicated by the change in scalar couplings through hydrogen bonds, pressure in-
fluences ubiquitin non-uniformly. The largest effects can be observed for hydrogen bonds
in the parallel β1/β5 and in the antiparallel β3/β5 β-sheets (R42, L67, and L69) as well
as for residue A28 in the α-helix.
Figure 2.3 Pressure-induced changes in 3hJNC’ coupling constants in ubiquitin as a
function of the amino acid sequence. For each hydrogen bond donor-acceptor pair, the coupling
constants at eight pressures (1, 300, 600, 900, 1200, 1500, 2000, and 2500 bar) are shown
as the mean of three measurements. Depicted error bars correspond to the resulting standard
deviation. Donor and acceptor amino acids are given at the bottom while on top the secondary
structural elements are represented. Note that the coupling constants are negative and thus
a numerical decrease corresponds to a stronger coupling. For this reason, the y-axis scale is
inverted.
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Pressure-dependence of H-bond properties in different secondary structural
elements
Figure 2.4 3hJNC’ coupling constant (top) and amide proton chemical shift (bottom)
for the hydrogen bonds within the β1/β2 β-sheet and the α-helix of ubiquitin. Values are
shown for eighth different pressures between 1 and 2500 bar: 1 (purple), 300 (blue), 600
(turquoise), 900 (green), 1200 (orange), 1500 (red), 2000 (magenta), and 2500 bar (brown).
Spacing between data points represents the corresponding difference in pressure.
The β1/β2 β-sheet and the α-helix The geometry of the β1/β2-sheet and the
α-helix in ubiquitin has been described before (Cordier & Grzesiek 2002). Briefly, the
β-sheet 1/2 is influenced by the irregular geometry of the whole β1/β2/β5-region, lea-
ding to a very short I13→V5 H-bond (rOH = 1.71 A˚, according to the X-ray structure
1ubq).
Under pressure, the antiparallel β1/β2-sheet shows non-uniform behavior with three
couplings becoming clearly stronger and one becoming weaker. Starting from the N-
terminus, the first hydrogen bond occurs between V17 and M1, for which the strongest
increase in coupling is observed (-0.40 Hz at 300 bar to -0.54 Hz at 2500 bar). Points
that do not fit very well could be due to a second conformation. Note that the 3hJNC’
coupling constants are negative and thus a lower value corresponds to a stronger cou-
pling. The hydrogen bonds between residues L15/I3 and T7/K11 strengthen to a similar
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extend between 1 and 2500 bar. In contrast, the coupling across the H-bond between
I13 and V5 decreases, but is nevertheless the strongest coupling within β-sheet 1/2 over
the whole range of pressures. Another interesting observation is that the hydrogen bond
scalar couplings for the β1/β2-sheet vary much less at higher pressure, indicating a har-
monization of the 3hJNC’ coupling constants. This reflects a more uniform geometry of
the β-sheet at higher pressure.
The α-helix is uniform in its backbone (φ and ψ angles) between residues I23 and
D32 and slightly more varied at the C-terminal end (K33 to G35). The residues involved
in the hydrogen bond network of the α-helix are V26 to G35 with HN(i) → O(i − 4)
H-bonds. The helix is bent by about 9° (Cordier & Grzesiek 2002).
Figure 2.5 Pressure-induced changes of 3hJNC’ within ubiquitin’s α-helix. Couplings
that become stronger are depicted in blue, H-bonds with weakened couplings are shown in red.
The E34→I30 hydrogen bond shows a curved behavior. H-bonds colored grey do not show
any changes.
Compared to the β-sheets, pressure-induced changes in the α-helix are smaller, with the
largest overall difference observed for the A28→E24 hydrogen bond (see Figure 2.4).
Figure 2.5 illustrates the major changes in the 3hJNC’ coupling constants. The coupling
between A28 and E24 on the helix outside is weakened, indicating an increase in H-bond
length. On the opposite side, the couplings between V26/T22, K27/I23, I30/V26, and
Q31/K27 become stronger. Thus the initial bend in the helix becomes even more pro-
nounced under pressure. Assuming constant angles, the changes in coupling constants
would correspond to an H-bond expansion for A28/E24 by 0.067 A˚. At the same time,
the hydrogen bond between V26 and T22 shortens by a similar amount (0.053 A˚).
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The hydrogen bond scalar coupling for E34→I30 is the largest in the helix and shows a
unique behavior: after an initial strengthening the coupling constant weakens at 2500 bar
to nearly the same value as for 1 bar.
The fact that the couplings for the H-bonds K33→K29 and G35→Q31 are very weak
and flank the hydrogen bond between E34 and I30 with an extremely strong coupling is
another indication for a bended helix. In contrast to the N-terminal end, this C-terminal
part of the helix does not seem to be very much influenced by the pressure as indicated
by nearly constant 3hJNC’ couplings (D32→A28, K33→K29, G35→Q31). The different
behavior of E34→I30 might be rather explained in terms of a slight movement of the
helix towards β-strand 2. This should result in a strengthening of the salt bridge between
E34 and K11, which could induce a change in angles for the E34/I30 hydrogen bond.
Figure 2.6 3hJNC’ coupling constant (top) and amide proton chemical shift (bottom)
for the hydrogen bonds within the β3/β4, β3/β5, and β1/β5 β-sheets and those not involved
in regular secondary structural elements in ubiquitin (see figure 2.4 for a description of the
color coding).
The β3/β4 and β3/β5 β-sheets The backbone φ and ψ angles for the hydrogen
bonded residues in these two β-sheets are uniform with only the C-terminal end of β-
strand 4 (L50) being slightly distorted (Cordier & Grzesiek 2002).
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In the β-sheet 3/4 only two hydrogen bonds are observable via 3hJNC’ couplings (Fi-
gure 2.6). The two observable cross-H-bond coupling constants suggest that the β3/β4
β-sheet is only marginally influenced by pressures up to 2500 bar. Nevertheless, the cor-
responding amide proton chemical shifts decrease in a nearly linear fashion with pressure
by ≈ 0.08 ppm.
As evident from the crystal structure, the β3/β5-sheet shows very uniform geometries
for the hydrogen bonds H68→I44, I44→H68, and V70→R42 (Cordier & Grzesiek 2002).
The 3hJNC’ coupling constants across these hydrogen bonds are -0.58 Hz, -0.55 Hz, and
-0.55 Hz at 1 bar, respectively (Figure 2.6). Although these values are in a very narrow
range, their pressure-dependent behavior is different. The first hydrogen bond scalar
coupling shows a curved behavior, while the coupling across the second hydrogen bond
is nearly constant over the whole pressure range. In contrast, the coupling across the
H-bond V70→R42, although very similar for 1 and 2500 bar, fluctuates rather strongly
in between. This could be due to a second species that becomes visible for residue V70
under pressure. Nevertheless, compared to the β-sheets 1/2 and 1/5, the influence of
pressure on the coupling constants for these three hydrogen bonds is small (∆3hJNC’ =
0.10 Hz vs 0.34 Hz for β1/β2 and 0.35 Hz for β1/β5).
On the contrary, the 3hJNC’ coupling between R42→V70 behaves in a very different way:
the coupling drastically weakens with higher pressures from -0.49 Hz down to -0.32 Hz at
2500 bar. In fact, this coupling is the weakest detected within the β-sheet structures in
ubiquitin. The extreme change in 3hJNC’ by 0.17 Hz indicates an opening of the β3/β5-
sheet from its C-terminus. Surprisingly, the proton chemical shift for R42 is constant
up to 1200 bar before rising. The proton chemical shifts of the second hydrogen bond
donor between these residues, V70, decreases over the whole pressure range and exhibits
the largest overall change (∆δ = 0.25 ppm).
The β1/β5 β-sheet The parallel β1/β5 β-sheet shows a wide distribution of 3hJNC’
coupling constants between -0.45 Hz (L69→K6 at 1 bar) and -0.80 Hz (E64→Q2 at
2000 bar; Figure 2.6). There is a trend of decreasing hydrogen bond scalar couplings from
the N- to the C-terminus in this β-sheet (at 1 bar) which goes in hand with increasing
O–H distances in the crystal structure (1ubq). The β-sheet starts with an irregular
hydrogen bond in strand β5, connecting the amide donor of S65 with the carbonyl
acceptor of Q62 instead of the regular acceptor Q2 (see also Figure 2.7b). Glutamine
2, therefore, is able to form a hydrogen bond to the amide group of E64 (Cordier &
Grzesiek 2002). Coupling across this H-bond is the strongest observed in ubiquitin at all
pressures.
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All hydrogen bond scalar couplings in this β-sheet become stronger with pressures of
up to 900 – 1200 bar. Two out of five couplings increase further at higher pressures,
whereas the others decrease if the pressure is increased further. The strongest effect of
all hydrogen bond scalar couplings in the β1/β5 β-sheet occurs for the coupling across
the terminating H-bond at the sheets C-terminus, L69→K6, which changes over the
whole pressure range from -0.45 Hz at 1 bar to -0.58 Hz at 2500 bar. This might
be induced by an opening of the neighboring β-sheet (R42→V70), which releases the
β5-strand so that it can move closer to β1. Assuming a sole distance dependency, the
hydrogen bond between R42 and V70 would increase in length by 0.101 A˚, while that
between L69 and K6 would decrease by 0.065 A˚.
It can be speculated that the initial strengthening in 3hJNC’ coupling constants in the
β1/β5 as well as in parts of the β1/β2 β-sheet is not only due to a shortening of the
hydrogen bonds but also to a release of the initial twist in this mixed parallel, antiparallel
β-sheet.
Residues not involved in regular secondary structural elements There are five
hydrogen bonds in ubiquitin that are not within a regular secondary structural element.
These are found in the loops flanking the 310-helix and connect I23→R54, L56→D21,
S57→P19, I61→L56, and S65→Q62. The 3hJNC’ couplings across all these hydrogen
bonds increase with pressure (Figure 2.6). In more detail, the strongest coupling is
observed for I23→R54, concatenating the loop between β4 and the 310-helix to the α-
helix (see also Figure 2.7b). The weakest coupling on the other hand is found for the
unusual hydrogen bond between S65 and Q62 at the N-terminal end of the β5-strand.
With respect to the amide proton chemical shift, the five hydrogen bonds outside regular
secondary structural elements behave similarly showing a downfield shift. Only HN of
L56 is not changed over the whole pressure range.
Implications of pressure-induced changes of 3hJNC’ on ubiquitin’s structure
On average, the hydrogen bond scalar couplings in ubiquitin slightly increase over the
pressure range from 1 to 2500 bar (see Figure 2.7a).
The changes in hydrogen bond scalar couplings indicate, that the first two β-strands
and the α-helix in ubiquitin behave rather uniformly under pressure with most couplings
becoming stronger. Only the couplings across the hydrogen bond A28→E24 in the helix
and I13→V5 in the first β-sheet decrease under pressure. In contrast, the hydrogen
bonds between β-strands 1 and 5 show a curved behavior with similar couplings for 1
and 2500 bar and a maximum around 1200 bar. The strength of H-bonds between the
β-strands 3 and 5 decreases, particularly for R42 / V70. These changes might mark the
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starting point for pressure unfolding.
Figure 2.7 a Average pressure-induced change of the 3hJNC’ coupling constants in
ubiquitin for all hydrogen bonds (solid line), for those in β-sheet structures (dashed line),
and for H-bonds in the α-helix (dottet line). b Direction of changes for individual hydrogen
bond scalar couplings marked on the protein’s topology. Couplings that become stronger are
depicted in blue, H-bonds with weakened couplings are shown in red, purple color marks a
curved change in 3hJNC’. H-bonds colored grey do not show any changes.
Correlation between the 3hJNC’ coupling constant and the 1HN chemical shift
It has been shown before that the hydrogen bond scalar coupling constant correlates
with the amide proton chemical shift (Cordier et al. 1999). For ubiquitin, a correlation
between these parameters was shown for the temperature-dependence (Cordier & Grze-
siek 2002) as well as for the influence of the solvent (Cordier & Grzesiek 2004).
Figure 2.8 shows the change of the 3hJNC’ coupling constant under pressure (2500 bar)
versus the 1HN chemical shift difference between 1 and 2500 bar. The values are norma-
lized for the pressure change in both dimensions. Regarding the whole protein, there is
no correlation between the two parameters. This may indicate that the 3hJNC’ coupling
constant and the 1HN chemical shift have a different geometry dependency that only
becomes apparent under pressure. Furthermore, the amide proton chemical shift can be
influenced not only by the hydrogen bond length and angles, but also by electric field
effects.
However, if different structural elements of ubiquitin are regarded separately, the picture
changes. In regions where the hydrogen bonds are strengthened and hence the secondary
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structure is stabilized, a good correlation can be found. In figure 2.8, hydrogen bonds
in the first β-sheet and the α-helix of ubiquitin are depicted in green. If only these
values are fitted, the empirical correlation ∆3hJNC’ = 0.0096 + 0.3735∆δ
1HN can be
found. The values for V17 and A28 do not fit well. In case of V17 the reason for this
is probably that this hydrogen bond is the first in ubiquitin and marks the beginning
of the β1/2-sheet. Furthermore, increased exchange has been shown for this residue.
The hydrogen bond A28→E24 changes dramatically due to helix bending, which could
influence ∆3hJNC’ and ∆
1HN differently. In contrast, for regions where the hydrogen
bonds are weakened, a random change of δ1HN is observed. Fitting of the remaining
data points (orange) shows no correlation between the 3hJNC’ coupling constant and the
1HN chemical shift for the C-terminal part of ubiquitin.
Figure 2.8 Pressure-induced changes in the 3hJNC’ coupling constant versus pressure-
dependent amide proton chemical shift change. Hydrogen bonded residues in the first β-sheet
as well as the α-helix are colored green and grouped together, amino acids involved in the
remaining H-bonds are shown in orange. Straight lines represent the corresponding linear fits.
The correlation is depicted for a pressure difference of 2500 bar (all values are normalized for
this pressure change). The outlayers (V17, R42, and L69) mark beginnings or ends of β-sheets.
Comparison of pressure and temperature effects on 3hJNC’
For several proteins, phase diagrams showing the effect of temperature and pressure
have been obtained (see figure 2.1) (Smeller 2002). According to these phase diagrams,
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an expansion of the protein is expected with increasing temperature, which leads to a
destabilization and finally to heat denaturation. In contrast, increasing pressure, initially
leads to stabilization of the protein, due to a volume reduction. Thus the effect of high
temperature and moderately high pressure oppose each other. Above a certain limit high
pressure also destabilizes and finally unfolds proteins.
The temperature-dependence of the 3hJNC’ coupling has been measured before (Cordier
& Grzesiek 2002). In the following, this temperature-dependent change of 3hJNC’ is
compared with its pressure-dependent variation.
Figure 2.9 illustrates the effect of pressure and temperature on 3hJNC’ for the observable
H-bonds in ubiquitin. For example, leucine 15 and isoleucine 30 show a stronger cou-
pling constant at higher pressures, corresponding to a stronger hydrogen bond (smaller
volume). With increasing temperature, these two hydrogen bonds become weaker, as
indicated by a weakened coupling constant. Thus, the behavior of these amino acids
under the influence of pressure and temperature agrees with that expected from the
whole-protein phase diagram.
In contrast, there are hydrogen bonds which show other behavior than predicted by the
phase diagram that would represent the whole protein. The coupling constant for the
H-bond of isoleucine 13 becomes weaker with both, high pressure and high temperature.
A similar behavior is observed for valine 70, corresponding to an increase in volume in
both cases.
But also an increase in temperature can lead to a strengthening of H-bonds as observable
for isoleucine 3.
Thus, although globally the 3hJNC’ coupling constants become stronger under the pres-
sures applied (max. 2500 bar) and weaker with increasing temperature, there are local
effects, that do not fit into this picture. Therefore, the combined investigation of pres-
sure and temperature effects on the hydrogen bond network of a protein might give
valuable information about local unfolding. Furthermore, such studies might be used to
compare different ways of denaturation. Whereas heat seems to have a more uniform
effect on ubiquitin, high pressure has more pronounced local effects.
Differences in the pressure-dependence of 1HN chemical shifts at high and
low temperature
In order to get a more complete picture of ubiquitin’s behavior under both, different
temperatures and pressures, HSQC and HNCO spectra, giving the 1HN, 15N, and 13C’
chemical shifts, were also measured at 5 °C as a function of pressure. For technical
reasons this was possible only up to pressures of 1500 bar and for rather short times
(1–2 hours). Therefore, no 3hJNC’ coupling constants have been obtained but only the
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Figure 2.9 Change of the 3hJNC’ coupling constant under the influence of pressure
(blue circles from left to right: 1, 300, 600, 900, 1200, 1500, 2000, and 2500 bar at 35 °C)
and with increasing temperature (red circles from left to right: 5, 25, 45, 55, and 65 °C; data
taken from (Cordier & Grzesiek 2002)). Data are shown for the observable hydrogen bond
scalar couplings in ubiquitin and labeled with the donor residue number. For most H-bonds,
the temperature effect opposes the pressure-dependent behavior, only some residues show a
different pattern (see text).
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changes of the chemical shift of the amide proton and nitrogen as well as the carbonyl
carbon have been measured.
Figure 2.10 Pressure-induced changes in the amide proton chemical shift as a function
of the amino acid sequence at 5 °C (top) versus 35 °C (bottom).Data are shown for six different
pressures between 1 and 1500 bar (color coding: 1 (purple), 300 (blue), 600 (turquoise), 900
(green), 1200 (orange), 1500 (red)).
Figure 2.10 compares the pressure-induced amide proton chemical shift changes at 5 °C
and 35 °C as a function of the amino acid sequence. On average, the 1HN chemical
shift clearly shows larger pressure-induced changes at 5 °C compared to 35 °C. For most
residues the resonances are shifted further downfield with pressure at the lower tempera-
ture, indicating a more compact structure. There are only few amino acids whose proton
chemical shift is less influenced by pressure at low temperatures. Most of these residues
are found in the β1/β2-sheet (Q2, I3, V5, T10, and I13), thus in the region where an
effect on the 3hJNC’ coupling constant can be deduced from the amide proton chemical
shift.
Those amino acids with an upfield shift, are less influenced by pressure at the lower tem-
perature. In contrast, residues within the first half of the protein with a pressure-induced
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downfield shift show a stronger effect at 5 °C. Thus, for the coupling constants in the
first β-sheet and the α-helix of ubiquitin one can expect a smaller effect for H-bonds
that are weakened with pressure and a larger effect for those where the coupling becomes
stronger. Thus, for the N-terminal half of ubiquitin, residues that are stabilized by pres-
sure are even more stabilized at the lower temperature and H-bonds that are weakened
are less weakened at the lower temperature.
2.4.3 Conclusion
The pressure-induced changes in ubiquitin’s hydrogen bond network have been descri-
bed and compared to temperature-dependent differences. Both, the 3hJNC’ coupling
constants and the amide proton chemical shifts have been monitored over the range
from 1 to 2500 bar at 35 °C.
For some hydrogen bonds a curved pressure-dependence has been observed. Assuming
that at higher pressures the volume of the protein is lower, the initial increase in strength
of hydrogen bond scalar couplings could be the result of protein compression, for example
due to minimization of internal cavities and release of water from voids. Since the com-
pression is limited, above a certain pressure water penetrates into the protein core and
hydration leads to destabilization of the protein. In this context, intra-protein hydrogen
bonds can be replaced by intermolecular H-bond between the protein and water. Al-
though the pressure applied to ubiquitin seems to be not high enough to denature the
protein, a decrease in coupling constants indicates a destabilization. This is in line with
the general finding that pressure below 1000 – 1500 bar stabilized proteins against ther-
mal unfolding (Cioni & Strambini 1999), but higher pressure can lead to destabilization.
In contrast to all earlier findings, a correlation between the pressure-induced changes in
the 3hJNC’ coupling constant and the amide proton chemical shift has been found only
for the first β-sheet and the α-helix of ubiquitin. In the second part of the protein, no
correlation is observed. This suggests that in the study of pressure-dependent changes in
protein hydrogen bonds by observing chemical shifts, additional factors, such as angular-
dependencies or electric field effects, have to be taken into account. Clearly, the sole
measurement of amide proton chemical shifts is not sufficient to describe pressure ef-
fects on hydrogen bonds. Interestingly, a good correlation between the two parameters
(3hJNC’ and amide proton chemical shift) has been found only in those region, where the
secondary structure is mainly unchanged or even stabilized by pressure. In contrast, in
regions that are destabilized the correlation is not valid.
Most hydrogen bonds in the N-terminal part of ubiquitin (β-sheet 1/2 and α-helix)
increase in strength as is evident from the H-bond scalar couplings. The average streng-
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thening in 3hJNC’ for this part of the protein amounts to 0.04 Hz at 2500 bar considering
only coupling constants that get stronger and 0.02 Hz taking all hydrogen bond scalar
couplings into account. This corresponds to a shortening of the hydrogen bonds by
0.025 A˚ (0.012 A˚), if angular dependencies are neglected.
In contrast, ubiquitin’s C-terminal half shows only initially stronger cross-hydrogen bond
coupling constants. Above 1200–1500 bar about 50% of the H-bonds in this part of the
protein are weakened. Together with the attenuation of the 3hJNC’ couplings between
residues R42 and V70 this marks the most pressure-labile region in ubiquitin, namely the
β-sheets 3/5 and 1/5.
Comparison to the temperature-dependent changes in the 3hJNC’ coupling constants re-
veals, that most hydrogen bonds within ubiquitin become stronger under pressure up to
2500 bar and weaker with increasing temperature between 5 °C and 65 °C. Neverthe-
less, there are H-bonds for which the coupling constant becomes weaker with increasing
pressure, thus marking points where the pressure and cold denaturation of the protein
might start.
2.4.4 Materials and Methods
High-pressure sample cell and pressure generator
All experiments were carried out using commercial high-pressure NMR cells (Daedalus
Innovations LLC) with an inner diameter of 3 mm and an active volume of 120 µl. Tube
1 was rated to 1500 bar and used in combination with a static pressure cell made of
bronze. Tube 2 was rated to 2500 bar and used in an aluminium alloy static pressure
cell. Both cells were connected to a high pressure generator (High Pressure Equipment
Company) via a pressure line. This line as well as the pressure generator were filled with
extra-low viscosity paraffin wax (Sigma-Aldrich product number 95369, CAS 8002-74-2).
NMR measurement and data analysis
All spectra were recorded on a 7.5 mM solution of uniformly 2H/13C/15N-labeled ubi-
quitin in 10 mM phosphate buffer, pH 6.5, supplemented with 10% D2O. A sample
volume of 250 µl was placed in the high-pressure NMR tube and overlaid with paraffin
wax. NMR spectra were measured on a Bruker DRX 800 spectrometer, equipped with a
triple-resonance, Z-gradient cryo-probe. NMR data were processed with the NMRPipe
suite of programs (Delaglio et al. 1995) and analyzed using the program PIPP (Garrett
et al. 1991).
The 3hJNC’ trans H-bond scalar couplings were measured with a long-range water flip-
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back 2D-HNCO experiment as described previously (Cordier et al. 1999, 2008). Long-
range as well as reference spectra were recorded at eight pressures (1, 300, 600, 900,
1200, 1500, 2000, and 2500 bar) with a measurement time of 23.25 hours and 1.5
hours, respectively. Data matrices consisted of 80*(13C’, t1) × 1024*(1HN, t3) data
points (where n* refers to the complex points) with acquisition times of 40 ms (13C’)
and 85 ms (1HN). 3hJNC’ couplings were calculated from the intensity ratio of cross- and
reference peaks as described (Cordier et al. 1999, 2008). Errors were estimated on the
basis of three distinct experiments at each pressure. Data reported here represent the
mean of all measurements with their standard deviation.
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2.5 Pressure- and temperature-dependence of hydrogen bonds
in nucleic acids
2.5.1 Introduction
RNA hairpins are very important secondary structural elements, which are involved in
RNA folding and intermolecular interactions. Tetraloops are the most abundant hairpin
motif. The 14mer tetraloop GGCACUUCGGUGCC was used as a model RNA in NMR
spectroscopy before (Fu¨rtig et al. 2004).
Here, we describe the temperature- and pressure-dependent changes of the hydrogen
bond scalar coupling constants, 2hJNN, in this RNA as measured by NMR spectroscopy.
The HNN-COSY experiment has been used to quantify the two-bond 15N-15N scalar
coupling between the imino donor and the acceptor nuclei in A/U and G/C base pairs.
This experiment is described in more detail in chapter 2.2. The hydrogen bond scalar
coupling constants normally range between 5 and 11 Hz. Thus they are almost one order
of magnitude larger than the 3hJNC’ coupling constants observed in proteins.
The pressure-induced changes in hydrogen bond scalar coupling constants in the model
RNA are compared with data obtained for the protein ubiquitin.
Figure 2.11 HNN-COSY spectra of the RNA hairpin shown on the right. Donor (top)
and acceptor (bottom) resonances are shown for the five hydrogen bonded base pairs at six
different pressures between 1 and 2500 bar at 25 °C: 1 (purple), 500 (blue), 1000 (turquoise),
1500 (green), 2000 (orange), and 2500 bar (red).
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2.5.2 Results and Discussion
Influence of pressure on hydrogen bonds in RNA
Figure 2.11 shows the HNN-COSY spectra of the GGCACUUCGGUGCC RNA hairpin
at 25 °C and different pressures ranging from 1 to 2500 bar. Obviously, the imino
proton chemical shift changes are small for G1 and G2, slightly bigger for G10 and G12,
and largest for U11. Figure 2.12 shows the 2hJNN coupling constant as a function of
pressure at 25 and 35 °C. Experiments were performed at eleven pressures between 1
and 2500 bar (∆p = 250 bar) with three measurements per data point at 25 °C. At 35
°C not all experiments have been repeated three times (spectra at 1000 and 2000 bar
have been recorded only once, no data are available for 250 bar).
The hydrogen bond between G1 and C14 cannot be detected easily, due to low signal
intensities. This is the reason for the large error in the 2hJNN coupling constant for this
H-bond. The low signal intensity is due to conformational exchange between a state with
an open and another state with a closed hydrogen bond. For all other hydrogen bond
scalar couplings measured, the error is much smaller (maximum error at 25 °C: 0.18 Hz;
at 35 °C: 0.26 Hz). The coupling between G2 and C13 is weakened at elevated pressure,
which indicates an opening of the end of the RNA stem. The couplings G12→C3 and
U11→A4 increase with pressure, with the latter being overall larger. The last hydrogen
bond before the loop, G10→C5, does not change significantly with pressures between 1
and 2500 bar. Interestingly, although the errors for the single pressure points are small,
there are substantial fluctuations between different pressure points in the order of 0.2 to
0.3 Hz.
At higher temperature, the overall trends are the same, but the observed fluctuations
are larger. Only the G2→C13 coupling constant shows a different pressure-dependent
behavior with initially decreasing, than increasing and finally again decreasing values
at the higher temperature. One reason for the observed fluctuations can be the large
frequency separation between the 15N donor and acceptor nuclei (3 – 4 kHz with a
600 MHz spectrometer). This can result in non-optimal excitation of the donor and
acceptor nuclei.
Comparison of hydrogen bond scalar couplings in nucleic acids and proteins
The pressure-dependence of 3hJNC’ coupling constants in ubiquitin as a model protein
has been measured at 35 °C (see Chapter 2.4). For this protein, the hydrogen bond
length decreases on average by 0.02 A˚ between 1 and 2500 bar.
In the RNA, the first two base pairs are influenced by fraying of the hairpin end. The
average change in H-bond length for the three remaining base pairs is very similar to the
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Figure 2.12 2hJNN coupling constant as a function of pressure for the five hydrogen
bonded base pairs in the 14mer RNA. Spectra were recorded at eleven equally spaced pressures
between 1 and 2500 bar (∆p = 250 bar) at 25 and 35 °C. The data represent the mean and
standard deviation of three independent experiments (at 35 °C only one set of data was recorded
at 1000 and 2000 bar, no data were recorded at 250 bar).
difference observed in ubiquitin.
2.5.3 Materials and Methods
Uniformly 13C/15N labeled RNA (GGCACUUCGGUGCC) was purchased from Silantes
GmbH (Munich, Germany). All measurements were carried out on a ≈ 0.5 mM RNA
sample in 20 mM phosphate buffer, pH 6.4, 0.4 mM EDTA and 10% D2O. The sample
was heated to 70 °C and cooled rapidly on ice prior to the measurement to ensure hairpin
formation of monomeric RNA. Spectra were acquired at different temperatures between
15 and 50 °C and at pressures between 1 and 2500 bar. All experiments were done in
a 2500 bar – high-pressure NMR sample cell (tube2, see chapter 2.4) on a Bruker DRX
600 spectrometer equipped with a broadband probe with Z-gradient. Each spectrum
consisted of 100* (t1,
15N) × 768* (t2, 1HN) complex data points with acquisition times
of 17.3 ms (15N) and 64 ms (1HN). The 15N – 15N transfer period was set to 40 ms.
NMR data were processed with the NMRPipe suite of programs (Delaglio et al. 1995)
and analyzed using the program PIPP (Garrett et al. 1991).
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2.6 The concerted effect of methanol and pressure on ubiquitin
2.6.1 Introduction
Many proteins adopt partially folded states under certain non-native conditions, such
as extreme pH, presence of denaturants, or in organic solvents. Investigation of these
states can provide information about the initial stages of protein folding. Ubiquitin
exists in such a state in a mixture of water and methanol (40%/60%) at pH 2 and
room temperature (Wilkinson & Mayer 1986). This so-called A-state of ubiquitin was
investigated by CD (Wilkinson & Mayer 1986) and NMR spectroscopy (Brutscher et al.
1997). The NMR study revealed that the first β-sheet present in the native protein (M1
– V17) is preserved in the A-state and also the core of the α-helix is still present under
the changed solvent condition. In contrats, the β-sheets 3, 4, and 5 change completely
to a helix. This structural model of the methanol-induced A-state was confirmed by the
measurement of hydrogen bond scalar couplings (Cordier & Grzesiek 2004). Although
the A-state of ubiquitin has no stable hydrophobic core, it was shown that there is a well
defined hydrogen bond network and thus secondary structural elements.
Application of pressure can lead to protein unfolding. Pressure-induced unfolding is
induced by solvent, penetrating into the proteins core (Harano & Kinoshita 2006). The
free energy of the protein-solvent system for the native state is lower at atmospheric
pressure, but at sufficiently high pressure, a (partially) denatured state can be favored
(Harano et al. 2008).
Here, the combined influence of methanol and pressure on ubiquitin is described. Most
probably, the A-state is induced by disruption of the hydrophobic core in the presence of
methanol. This hypothesis was tested by the influence of pressure on a sample containing
not enough methanol to induce the A-state on its own.
2.6.2 Results and Discussion
Figure 2.13 shows the overlaid HSQC-spectra of ubiquitin in buffer containing 45% me-
thanol at pH 4.6, measured at 1, 750, and 1500 bar. At 1 bar, only peaks corresponding
to the native state of ubiquitin can be seen. If pressure is applied, new resonances appear
and can be assigned to the A-state. At 1500 bar the ratio between the native and the
partially folded state is ≈ 0.6 : 0.4.
Normally, the A-state is induced by increasing the methanol content and for the given
buffer conditions, the two states are equally populated at 56% methanol (Bobby 2008).
Thus, pressure has a similar effect as larger amounts of methanol, indicating that the
effective concentration of methanol is increased at relevant sites in ubiquitin under pres-
sure.
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Figure 2.13 a Selected region of the 1H-15N HSQC spectra of ubiquitin in a solution
containing 45% methanol at 1 bar (blue), 750 bar (green), and 1500 bar (yellow). Conditions:
250 µM 15N-Ubiquitin, 20 mM acetate, pH 4.6, 45% methanol, 10% D2O; 35 °C. With
increasing pressure new peaks appear, which correspond to the A-state of ubiquitin. b Model
of ubiquitin’s A-state showing the preserved β1/β2-sheet and the α-helix (helix B). Helix A
is unique in the A-state, the respective amino acids form a β-strand-rich region in native
ubiquitin. Figure taken from (Brutscher et al. 1997).
While 45% methanol are not sufficient to induce the A-state in ubiquitin under the gi-
ven conditions, pressure assists in partial unfolding. The A-state seems to be induced
under pressure due to an increased packing density of the solvent due to exposure of
hydrophobic groups in the A-state. This leads to an overall lower volume of the system.
Using equation 1.3, a change in the volume difference between 750 and 1500 bar can be
calculated to be ∆V0 = 56 A˚
3. Higher pressures should lead to a complete conversion
of the native to the A-state.
2.6.3 Materials and Methods
Experiments with ubiquitin in the presence of methanol were performed using a 250
µM sample of uniformly 15N-labeled ubiquitin in 20 mM sodium acetate buffer, pH 4.6,
with 45 % methanol and 10 % D2O. All measurements were done in the 1500 bar –
high-pressure NMR sample cell (tube 1, see chapter 2.4) at 35 °C. 1H-15N HSQC spectra
were recorded with acquisition times of 50 ms and 85 ms for 15N and 1H, respectively.
NMR data were processed with the NMRPipe suite of programs (Delaglio et al. 1995)
and analyzed using the program PIPP (Garrett et al. 1991).
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Figure 2.14 a 1H-15N HSQC spectrum of ubiquitin in a solution containing 45%
methanol at 1 bar. Only the native state is visible. b After application of pressure (1500 bar),
also the A-state appears. For clarity, resonances corresponding to the A-state are colored
yellow. Resonances for the A-state have not been assigned. Conditions were as described for
figure 2.13.
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